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RESILIENCE  IN  PARKINSON’S  DISEASE:  AN  EMPIRICAL  EXAMINATION  OF  AGERELATED COMPONENTS OF THE CONSTRUCT
By Andrea M. Garroway, M.S.
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Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2014
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Although Parkinson’s  disease (PD) is commonly characterized by motor symptoms and
physical limitations, there is growing recognition of nonmotor and mood symptoms associated
with the disease as well. There has been limited research exploring how individual coping might
affect the relationships between PD symptoms and mental health outcomes. The resilience
construct was originally developed within the child literature, and it is often used in
conceptualizing how people have adaptive or positive outcomes when facing adversity. Current
resilience measures may not adequately assess the construct within an older population, however,
given the unique emotion regulation and coping skills seen in late life.
This survey study of 139 community-dwelling adults with PD (M age = 64.25 years, SD
= 10.12, range 34-89 years) investigated whether resilience moderated the relationship between
PD-related factors (nonmotor symptoms, functional impairment, and disease symptom-related
QOL) and mental health outcomes (depression, apathy, satisfaction with and adjustment-quality

of life). Further analyses explored whether hypothesized age-related resilience components
(optimism, goal-flexibility, and meaning-making ability), accounted for unique variance above
and beyond a standard resilience measure (Resilience Scale for Adults).
Results indicated that disease symptom-related QOL predicted depression and
adjustment-related QOL, while functional impairment predicted apathy, life satisfaction, and
adjustment related QOL. Participants overall reported moderate to high resilience; resilience
was a significant predictor of all mental health/QOL outcome measures, and those with
comparatively lower self-reported resilience had worse disease symptoms. Resilience did not
moderate the relationship between disease symptoms and mental health/QOL. Meaning-making
ability and goal-flexibility accounted for unique variance above and beyond the standard
resilience measure for several outcome variables. Age was a significant moderator, such that the
protective value of meaning-making ability and optimism on depression were greater for younger
compared to older participants.
This study highlighted the presence of moderate to high resilience in PD patients,
however those with comparatively lower resilience had poorer outcomes. Other coping variables
appear to be important contributors to mental health/QOL beyond a standard resilience measure.
Patient age also affected several outcomes, emphasizing the importance of further integration of
developmental literature into our understanding of resilience in chronic disease management.

Resilience  in  Parkinson’s  disease: An empirical examination of age-related
components of the construct
Parkinson’s  disease  (PD)  is  a  common neurodegenerative disorder, second only to
Alzheimer’s  disease.    PD  onset  typically  occurs  in  middle-aged and older populations, however
people as young as 30 years old can be diagnosed with the disease. PD prevalence rates are 0.5%
to 1% among older adults between ages 65 and 69, with increasing rates of 1% to 3% among
those 80 years or older (Nussbaum & Ellis, 2003). The exact cause of PD is unknown, although
researchers generally believe that genetic factors, environmental triggers, and neurological
indicators, such as Lewy bodies, are potential causes of PD. The four cardinal features of PD are
resting tremor, rigidity, postural instability, and bradykinesia, or the slowness of movement
(Jankovic, 2008; Pandya, Kubu, & Giroux, 2008; Robottom et al., 2012). PD can also involve
sensory symptoms, such as impaired sense of smell, and autonomic symptoms, including
gastrointestinal, urinary, and sexual dysfunction (Pandya et al., 2008).
PD is complex and often affects both physical and cognitive functioning, however the
disease course, severity, and symptom presentation can vary widely across patients. Some
people can become severely disabled and require complete assistance from a caregiver or another
provider, while others experience only minor motor difficulties. In contrast to other
neurodegenerative  diseases,  such  as  Alzheimer’s  disease,  patients  with  PD  may  or  may  not  
experience dementia. Various reviews have estimated that approximately 24% to 31% of PD
patients have dementia (Aarsland, Zaccai, & Brayne, 2005; Anderson, 2004; Pandya et al.,
2008), with dementia and cognitive dysfunction becoming more common in the later stages of
the disease.
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Although PD is often characterized by motor symptoms, it is also associated with mental
health and mood problems. Researchers hypothesize that mood changes are due to both the
distress caused by impairment and actual chemical changes in the brain from the disease itself
(Cummings, 1992). The most common mood disorder associated with PD is depression, with
hypothesized neuronal loss in various subcortical nuclei resulting in serotonin, norepinephrine,
and dopamine depletion. Depressive symptoms in PD often present differently than in people
with idiopathic depression. For example, PD patients report dysphoria, pessimism, irritability,
sadness, and suicidal ideation, but little guilt, blame, or feelings of punishment (Cummings,
1992; Cummings & Masterman, 1999). Prevalence rates of depression are generally between
40%-45% (Cummings, 1992; Lemke, 2008), however the rates can range depending on the
diagnostic criterion used. One review found that 17% of PD patients met criteria for major
depressive disorder, 22% met criteria for minor depression, 13% met criteria for dysthymia,
while 35% of patients exhibited some form of clinically significant depression (Reijnders, Ehrt,
Weber, Aarsland, & Leentjens, 2008). The prevalence of depression in PD is comparable to
depression rates seen in similar neurological disorders, such as approximately 40% in AD
(Holtzer et al., 2005), 41% in MS (Rickards, 2005), and slightly higher prevalence rates
compared to post-stroke patients that range between 10% and 34% (Rickards, 2005).
Apathy is another common psychological symptom in PD that is distinct from
depression, but nonetheless detrimental for quality of life (QOL) (Oguru, Tachibana, Toda,
Okuda, & Oka, 2010). PD patients with depression also have higher rates of anxiety symptoms
(Lemke, 2008), which often coincide with wearing-off or on-off fluctuations associated with
medication dosing (Pandya et al., 2008). Despite their high prevalence, psychiatric symptoms in
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PD are often under-diagnosed, with one study finding that treating neurologists failed to identify
depression and anxiety over half of the time (Shulman, Taback, Rabinstein, & Weiner, 2002).
Typical first-line treatment for PD involves dopamine substitution using levodopa (LDOPA) or dopamine agonists, which help improve muscle movement and delay severe
disability. Depressive symptoms are often treated with antidepressant medications, including
TCAs, and even some dopamine agonists are effective in reducing depression in PD (Andersen,
Aabro, Gulmann, Hjelmsted, & Pedersen, 1980; Rektorova et al., 2003). Since PD is a
degenerative disease, however, and no known neuroprotective or regenerative treatments exist, it
is imperative for researchers to study methods for minimizing disease impact and maintaining
good QOL.
A complementary and growing area of study is resilience, which has gained interest
within geropsychology in recent years. The resilience construct has been used to explain findings
of older patients demonstrating generally positive outcomes in terms of QOL and mental health
despite disease and illness (Bombardier, Ehde, Stoelb, & Molton, 2010; Zautra & Reich, 2011).
There have been some investigations of resilience in later life within a developmental context
(e.g., selective optimization and compensation [Baltes & Baltes, 1990], advanced emotion
regulation due to age [Ong, Bergman, & Boker, 2009]), however there have been other
suggestions for studying late life resilience as its own construct (Smith & Hayslip, 2012).
The current study proposes to delineate the resilience construct within an older disease
population by studying the relationship between PD nonmotor symptoms (NMS) and
impairment, individual psychological factors, and mental health outcomes. More specifically,
the project will explore how resilience and related components are related to depression, apathy,
and QOL within an older PD population. Given the high rates of depression and apathy in PD
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patients, as well as the powerful role of NMS and mental health on overall functioning (Arun,
Bharath, Kumar Pal, & Singh, 2011; Weintraub, Moberg, Duda, Katz, & Stern, 2004), it is
important to gain a better understanding of the psychological factors that can mitigate the
negative  effects  of  PD.    By  learning  more  about  PD  patients’  mental  health,  as  well  as  individual  
characteristics that affect mental health, clinicians may ultimately be able to identify higher-risk
patients and match appropriate treatments to promote better outcomes.
Review of the Literature
Parkinson’s  disease and related factors. Although PD is typically characterized and
often first identified by motor symptoms, a large body of research has examined the role of
mental health and NMS in PD patients. One early study characterized PD patients as part of a
“premature  social  aging”  process  because  compared  to  healthy  elderly  controls,  PD  patients  had  
little interest in social engagement and spent a large amount of time doing solitary activities
(Singer, 1973). Although this term is somewhat misleading and reinforces the stereotype that
aging equates withdrawal and disinterest in engagement, this idea sparked interest in
investigating the psychosocial elements of PD. In line with this approach, more research has
identified NMS in PD patients as an important domain to study, distinct from the cardinal
physical features of PD (Pandya et al., 2008). NMS have gained attention as a major cause of
disability in PD, and these symptoms can include neuropsychiatric (depression, apathy, anxiety),
autonomic (bladder disturbances, sexual dysfunction), and gastrointestinal symptoms (dribbling
of saliva, nausea) (Chaudhuri et al., 2006).
One important confound to recognize is that neuropsychiatric symptoms are often
considered part of the NMS profile in PD patients. Within these neuropsychiatric symptoms,
research generally characterizes depression as the most common psychiatric disorder associated
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with PD. Apathy and QOL are also frequently  studied  as  indicators  of  patients’  mental health and
subjective experiences with PD. Anxiety disorders are also relatively common in PD patients.
One study found that 67% of PD patients with depression had comorbid anxiety, while 92% of
PD patients with anxiety had comorbid depression (Menza, Robertson-Hoffman, & Bonapace,
1993). The anxiety and depression measures were highly correlated (r = 0.74, p < 0.001), with
44% of the variance in anxiety scores explained by depression scores. While both depression and
anxiety are presumed to be associated with underlying neurochemical changes from the PD
itself, anxiety disorders in PD are not well-characterized and often include symptoms that do not
meet standard diagnostic criteria (e.g., episodic anxiety associated with fluctuations in motor
symptoms) (Pontone et al., 2009). Continued research is necessary to better understand anxiety
symptoms in PD patients as they relate to depression and on-off medication periods, therefore
the present study will limit its scope to explore depression, apathy, and QOL in PD patients.
Additionally, the current project will not focus on the effects of motor impairment and physical
manifestations of PD on mental health, although these factors are related to the psychological
outcomes of depression, apathy, and QOL (Cummings, 1992; Schrag, Jahanshahi, & Quinn,
2000). The present study will instead focus on the relationship between other disease-related
factors, specifically NMS and functional impairment, and psychological outcomes, as well as
individual patient variables that presumably affect the relationship.
Nonmotor symptoms in Parkinson’s  disease. Nonmotor symptoms (NMS) are a
historically unexplored area in PD, receiving comparatively less attention than the motor
manifestations of PD (Chaudhuri et al., 2006). Nearly all patients report NMS; one study found
that 98.6% of patients reported at least one NMS within the past month (Barone et al., 2009).
The definition of NMS is relatively broad and includes the following categories of symptoms:
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neuropsychiatric (depression, apathy, anhedonia), sleep disorders (restless legs, insomnia, vivid
dreaming), autonomic (bladder disturbances, sweating, sexual dysfunction), gastrointestinal
(dribbling of saliva, reflux, dysphagia/choking), sensory (pain, olfactory disturbance), and other
symptoms (fatigue, blurred vision) (Chaudhuri, Yates, & Martinez-Martin, 2005). Certain NMS
can generate a notable increase in healthcare costs if they result in the need for institutionalized
care (e.g., falls due to orthostatic hypertension, hallucinations). A cost-analysis study in the UK
found that total annual direct costs for PD patients living in full-time institutionalized care were
more than four times higher than patients cared for at home (Findley et al., 2003). Despite the
high prevalence and high healthcare-related costs of NMS, these symptoms are often underrecognized and under-treated, and only within the last 10 years have researchers begun
developing a formal measure to assess NMS in PD (Chaudhuri et al., 2005).
The under-diagnosis and under-recognition of NMS is an important oversight to consider,
given that early intervention and treatment of NMS in PD patients can have a positive impact on
mental health and QOL outcomes (Charidimou, Seamons, Selai, & Schrag, 2011). Gallagher,
Lees, and Schrag (2010) demonstrated that among all NMS reported by patients, cognitive and
neuropsychiatric  symptoms  were  the  most  commonly  recognized  and  documented  in  physicians’  
clinical notes (61%- 82%), while potentially embarrassing or seemingly unrelated autonomic
symptoms (i.e., urinary symptoms, sexual problems) were more poorly recognized (<50%).
Although neuropsychiatric symptoms were the most recognized, these relatively low rates are
still somewhat surprising (64% recognition for depression/anxiety) given that the evaluations
were from physicians at specialty movement disorders clinics, not simply general practitioners.
Another study found similar results after assessing diagnostic accuracy from PD
clinicians (Shulman et al., 2002), with treating neurologists identifying even fewer NMS than in
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the Gallagher et al. (2010) study. The PD patients in the Shulman and colleagues (2002) study (n
= 101) reported depression and anxiety prevalence rates comparable to other studies (44% and
39%, respectively). The treating neurologists, however, identified depression and anxiety in only
21% and 19% of their patients. Using a diagnostic accuracy calculation based on the
concordance of the physician's impression with the results of the standardized rating scales, the
physicians had an overall diagnostic accuracy rate of 35% for depression and 42% for anxiety.
One difference between these studies is that Gallagher and colleagues (2010) used a specific
NMS questionnaire (NMSQuest; Martinez-Martin et al., 2007), while Shulman et al. (2002)
simply had PD patients report symptoms across a battery of standardized tests. This
methodological difference is important to note, since the NMSQuest has been validated in PD
patients, while only one of the assessment tools used in the Shulman et al. (2002) study has been
validated with PD patients (BDI; Levin, Llabre, & Weiner, 1988). Despite these limitations in
the  Shulman  et  al.  (2002)  study,  one  can  still  conclude  that  the  neurologists’  diagnostic  
impressions were inaccurate relative to the self-reported symptoms on standardized measures
and generally lower than the known prevalence rates in PD patients.
Several studies have also explored the relationship between motor and NMS in PD
patients. There is some evidence that NMS can fluctuate in response to dopaminergic treatment
commonly used to manage motor symptoms, although this treatment is often not sufficient
enough to effectively control the NMS (Poewe & Mahlkne, 2011). NMS are also often more
disabling or subjectively troubling to patients than even the motor symptoms. One study found
that the major causes of disability in PD patients were due to symptoms unimproved by L-dopa,
including falls, autonomic disturbance, neuropsychiatric symptoms, and dementia (i.e., NMS)
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(Hely, Morris, Reid, & Trafficante, 2005). Motor fluctuations and dyskinesia were also
common, but not rated as disabling compared to the NMS.
Another study similarly addressed the frequency and disability of NMS compared to
motor symptoms (Witjas et al., 2002). Witjas and colleagues asked 50 PD patients in a
structured interview to rate whether or not their NMS fluctuations seemed to coincide with their
motor  fluctuations  (e.g.,  “on”,  “pre-on”,  “off”,  “pre-off”  states).  Patients  were  also  asked  to  rate  
the level of disability in each fluctuation subgroup, as well as which fluctuation category was
most incapacitating (motor or nonmotor). Results indicated that NMS fluctuations were generally
linked with motor fluctuations, suggesting that an underlying dopaminergic deficiency may be
implicated. The most commonly reported NMS included mood fluctuations, cognitive slowing,
fatigue, and akathisia (restless legs), with most NMS occurring  during  “off”  states  when  the  
levodopa wears off and causes stiffness. One notable finding from this study was that over ¼ of
the patients (28%) rated their NMS as more incapacitating and disabling than their motor
fluctuations. There were no demographic or other characteristic differences between the patients
who rated NMS fluctuations versus motor fluctuations as most disabling. These studies
underscore the need to address NMS in the conceptualization of PD and expand our research to
study  the  range  of  disease  factors  that  play  a  role  in  patients’  QOL.
Functional impairment in Parkinson’s  disease. The previously mentioned Findley and
colleagues (2003) study in the UK highlighted the potentially costly consequences of NMS and
subsequent  need  for  formal  assistance.    There  are  other  “costs”  due  to  PD,  however,  such  as  
increasing dependence on others and functional impairments. A large literature on caregivers in
PD demonstrates a  relationship  between  patients’  functional  state  (based on activities of daily
living [ADLs])  and  caregivers’  psychosocial  burden  (Martinez-Martin et al., 2005). The present
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study will not focus  on  caregivers’  outcomes  but  will explore how patients’  functional
impairments relate to their own mental health/QOL outcomes. A systematic review of 61 studies
found  that  overall  PD  symptoms  predicted  patients’  functional  abilities  in  physical,  social,  and  
emotional domains (Den Oudsten, Van Heck, & De Vries, 2007). Another study assessed which
factors contributed to poorer QOL and disability in PD patients using a range of disability
measures (Muslimovic, Post, Speelman Schmand, & de Haan, 2008). Axial impairment (postural
instability and gait difficulty) emerged as the best predictor of disability as measured by the
Functional Independence Measure (FIM), a tool that assesses degree of functional impairment.
Although elements of PD physical symptoms and subsequent disability are often a focus for
health providers, it seems that functional impairment reflects a different issue for patients that
may be missed by providers. One study used multiple interview formats to differentiate between
patient concerns and healthcare provider concerns, and they found that when responding to openended questions, PD patients identified functional ability as a more pressing concern than was
expressed during the structured interview questions (Schenkman, Custon, Zhu, & WhettenGoldstein, 2002).
Another study (Shulman et al., 2008) found that functional impairments (as measured by
ADLS and IADLs) were the most sensitive indicators of emerging disability on the Unified PD
Rating Scale (UPDRS) (Fahn & Elton, 1987), a commonly used measure of global disease
progression. Some research suggests that patients overestimate their level of functioning
compared to clinician performance ratings of ADLs and IADLs (Shulman et al., 2006). This is
an important consideration within the context of coping with disease, since patient expectations
and subjective assessment of health are known to influence outcomes (see Mondloch, Cole, &
Frank, 2001 for a review). Additionally, there is evidence that functional impairment is malleable
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and can improve with multidisciplinary rehabilitation interventions (Ellis et al., 2008). Although
the previous research has demonstrated that patients’  functional  impairments  are  rated  as  the  
worst aspects of PD, they are associated with emerging disability in PD, and targeted
interventions can improve functional abilities, there has been limited exploration of the role of
individual coping factors in functional impairment in PD. The single study that examined
resilience in PD patients found that resilience was moderately correlated with less disability on
the UPDRS (Robottom et al., 2012), however there was no direct study of the relationship
between functional impairment, resilience, and mental health outcomes.
Depression in Parkinson’s  disease. Depression in PD is difficult to diagnose due to
overlapping symptoms between the two disorders, including psychomotor retardation or
agitation, fatigue, apathy, and loss of appetite (Lemke, 2008; Schrag, 2006). In current practice,
common depression measures are used to assess depression in PD patients (e.g., the Hamilton
Depression Rating Scale, the Beck Depression Inventory, the Geriatric Depression Scale),
however, there have been recent proposals for a revised DSM-IV definition of depression in PD
patients to address these diagnostic challenges (Marsh, McDonald, Cummings, & Ravina, 2006).
Although it is plausible that depression in PD could occur solely as a secondary reaction to the
motor deficits, there is no linear correlation between depressive symptoms and severity and
course of PD (Cummings, 1992). This is an important distinction for diagnostic purposes
because current DSM-IV criteria would exclude the diagnosis of depression in PD if symptoms
were linked exclusively to a medical condition.
Prevalence and age of onset. The prevalence and presentation of depression in PD
depend somewhat on assessment tools. One comprehensive review of 26 studies found that the
mean frequency of depression was 40%, however variations in the assessment methods across
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studies resulted in a range from 4% to 70% (Cummings, 1992). A more recent review of 36
studies found similar results, with 35% of PD patients exhibiting clinically significant depressive
symptoms and 17% meeting criteria for major depressive disorder (Reijnders et al., 2008). These
rates are comparatively higher than average prevalence rates of depression, with 9% of U.S.
adults meeting criteria for current depression at any given time (CDC, 2010). In the CDC survey
(2010), prevalence rates of U.S. adults followed a U-shaped curve across age-groups, such that
major depression criteria were met in 2.8%, 4.6%, and 1.6% of adults in 18-24 year olds, 45-64
year olds, and ≥ 65 year olds, respectively.
Age of onset is also often examined in relation to depressive symptoms. PD typically
occurs  in  older  populations  with  an  average  age  of  onset  around  60  years  old,  although  “early  
onset”  PD  can  occur  in  people  younger  than  40  (NINDS, 2004). Several studies and systematic
reviews have found no relationship between depression, patient age, or age of onset of PD
(Cummings, 1992; Gotham, Brown & Marsden, 1986). Findings are mixed, however, with some
studies demonstrating that patients with early-onset PD have significantly higher rates of
depression than late onset patients (Kostic et al., 1994; Starkstein, Bertheir, Bolduc, Preziosi, &
Robinson, 1989). These age-related patterns of depressive symptoms are also seen in other
illness contexts, such as cancer (Williamson & Schulz, 1995), pain (Gibson & Helme, 2001), and
heart transplant (Shamaskin et al., 2012). Of note in PD patients, these age-related differences
are nonsignificant after controlling for disease duration (Kostic et al., 1994), which suggests that
depression may be more linked to length of time to adjust to the illness, rather than simply
patient age at onset.
Depression rates in PD are also relatively high when compared to other medically ill
patients. One study found that PD patients had significantly higher Beck Depression Inventory
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(BDI) scores than age- and sex-matched disabled controls, even though the two groups exhibited
comparable levels of functional disability (Ehmann, Beninger, Gawel, & Riopelle, 1990).
Similar results were seen in another study that compared PD and active rheumatoid arthritis (RA)
patients (Cantello, Gilli, Riccio, & Bergamasco, 1986). The PD and RA patients both had
predictable  “mobile”  and  “immobile”  periods,  and  for  both  patient  groups,  “immobile”  periods  
were characterized by temporary increases in disability and worsening of mood. The PD
patients, however, had significantly higher BDI scores than the RA patients during both
“mobile”  and  “immobile”  periods.    
In contrast, one study found similar depression rates in PD and other chronic disease
populations (Gotham et al., 1986). These researchers compared three groups (PD patients,
arthritis patients, and normal elderly controls) and found higher self-rated depressive symptoms
between PD patients and elderly controls, however no differences in depression scores between
PD and arthritis patients. The researchers suggested that the uneven sex ratio between the
arthritis and PD patients (males to females; 1:2.2 versus 1:1, respectively) could explain the
nonsignificant difference in depression scores, given the known correlation between female
gender and depression (Bland, 1997). If one attributes the conflicting results from the Gotham et
al. (1986) study to potential sample bias, the literature suggests a consistent pattern of increased
depressive symptoms in PD patients compared to other medical populations confirmed in
numerous studies (Cummings, 1992; Slaughter, Slaughter, Nichols, Holmes, & Martens, 2001;
Warburton, 1967).
Depression and motor impairment. The literature regarding depressive symptoms and
motor manifestations in PD is somewhat unclear, which may be due to nuanced differences in
how researchers measure motor symptoms versus degree of disability. In his review, Cummings
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(1992) demonstrated that a majority of studies found no association between mood and motor
symptoms of PD (i.e., rigidity, bradykinesia, and tremor). Similar results were seen in Huber,
Paulson,  and  Shuttleworth’s  study  (1988),  which  compared  motor  impairment,  depression,  and  
intellectual functioning in 50 PD patients. Motor impairment was measured using a clinical
condition scale that accounts for purely physical manifestations of PD (H/Y scale; Hoehn, &
Yahr, 1967), depression was measured using the Hamilton Depression Scale (Hamilton, 1960),
and intellectual functioning was measured with the Mini-Mental State Exam (Folstein, Folstein,
& McHugh, 1975). They found a significant correlation between motor and intellectual
impairment, however depression was not related to either variable.
It is possible that measurement tool plays a significant role in understanding the
relationship between motor symptoms and depression. Huber et al. (1988) used the Hoehn and
Yahr staging scale to assess PD progression, which is a 5-stage scale that indicates level of
physical disability (e.g., stage 0 = no PD symptoms, stage 1 = unilateral symptoms, stage 3 =
balance impairment but physically independent, 5 = needing wheelchair or bedridden unless
assisted). The Hoehn and Yahr scale (H/Y) is very commonly used with wide applicability
(Hoehn & Yahr, 1967), however it is somewhat limited in its scope and does not capture all
elements of PD progression, including NMS (Goetz et al., 2004). Other studies use more holistic
scales, such as the Unified PD Rating Scale (UPDRS) (Fahn & Elton, 1987), and in these studies
the relationship between mood and disease progression/severity is more pronounced based on
UPDRS total score (Holroyd, Currie, & Wooten, 2005; Wichowicz, Slawek, Derejko, & Cubala,
2006). The UPDRS is different from the H/Y scale in that it has four sections accounting for
both physical and mental components of the disease. A recent study using two sections of the
UPDRS (UPDRS II = ADLs, UPDRS III = motor examination) and the H/Y scale compared
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presence and severity of depression in PD patients with their degree of motor and functional
disability (Piccinni et al., 2012). These researchers found that PD patients with more severe
depression symptoms had higher scores on the UPDRS II and III, as well the H/Y scale.
The results from Piccinni et al. (2012) somewhat conflict with several previous studies
(e.g., Cummings, 1992; Huber et al., 1988), which found that motor symptoms and mood
symptoms are generally unrelated. Holroyd et al. (2005) demonstrated that some of the
inconsistencies regarding depression and disease progression depend upon how the UPDRS is
analyzed. In their study, depression was associated with an increased UPDRS total score,
however further analysis showed that the UPDRS II subscale (ADLs) was strongly associated
with depression while the UPDRS III subscale (motor examination) was not. Thus, it seems
methodological differences may explain some of the discrepancies between studies. Disease
progression scales that measure exclusively physical symptoms (i.e., H/Y scale, UPDRS III) may
not be as strongly related to depression, while those that incorporate disease impact and could be
affected by coping (i.e., UPDRS total, UPDRS II) are more related to mood symptoms.
Consistent with this hypothesis, various studies have demonstrated a relationship between
depression and functional impairment in PD. This pattern fits with a coping and adjustment
perspective; although depression may not be linked with motor symptoms directly, depression
may be exacerbated by or contribute to how the  motor  symptoms  affect  patients’  lives.  A  few
studies have found no correlation between depression and functional impairment (Robins, 1976;
Warburton, 1967), however most research finds that mood and degree of disability are indeed
related. Liu et al. (1997) found that diagnosis and severity of depression was a significant
predictor of global performance in daily functional activities. Another study with similar results
found that degree of depressive symptoms and cognitive impairment accounted for 37% of the
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variance in disability in PD (measured by UPDRS II), but H/Y score did not contribute
significantly to the model (Weintraub et al., 2004). A more recent study compared PD patients
with and without major depression (matched for gender, age of onset, and disease duration) and
again found that depressed PD patients had significantly higher UPDRS scores (total and
subscales) than the non-depressed controls (Papapetropoulos, Ellul, Argyriou, Chroni, &

Lekka, 2006). There were no significant differences, however, between the two groups on
individual motor manifestations (tremor, rigidity, instability). Another longitudinal study of 132
PD patients found that the relative change in disability over a 1-year period seemed more
important in terms of impact on depression than absolute change in disability (Brown,
MacCarthy, Gotham, Der, & Marsden, 1988). In sum, this pattern of findings suggests that
depression in PD is not simply a reaction to the physical symptoms, but there is a more complex
relationship that likely involves coping with functional disability and disease severity.
Pathophysiology of depression. Although depression in PD is not exclusively a reaction
to the motor manifestations of the disease, there is likely a pathophysiological component to the
neurodegenerative process that contributes to depressive symptoms (Cummings, 1992; Lemke,
2008). The pathophysiology of depression in PD is quite complex, however a hypothesized
explanation, in brief, is that when monoamine neurotransmitters degenerate, such as the
dopaminergic neurons of the ventral tegmental area, the corresponding reward and motivational
response systems are affected. Monoaminergic systems in the brain are closely involved in
reward systems and play an important role in expectancy and anticipation. Therefore,
diminished effectiveness of these systems (as a result of depleted dopamine, norephinephrine,
and serotonin) results in decreased reward mediation, diminished desire to perform activities,
lessened  expectation’s  from  one’s  activities,  and  lessened  sense  of  personal  control. One can
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easily see the link between these neurological changes and how they might contribute to feelings
of low self-esteem, helplessness, anhedonia, and other symptoms of depression.
Depression and quality of life. While there are still unanswered questions regarding the
etiology of depression in PD patients, the literature is very clear regarding the relationship
between depression and QOL in PD patients. Depression is strongly correlated with poorer
QOL, however the relative impact of depression is best understood when compared to the other
disease-related, demographic, and psychosocial factors relating to health-related QOL (HRQOL) in PD patients (see Schrag, 2006 for a review). Disease duration is not strongly correlated
with HR-QOL, while disease severity is only modestly correlated (Schrag et al., 2000). Diseaserelated factors, such as unpredictable on-off  fluctuations  (“off”  periods  occur  when  medications  
wear off in between doses, causing worsening of symptoms) (Chapuis, Ouchchane, Metz,
Gerbaud, & Durif, 2004) and night-time and morning akinesia (loss of control over voluntary
movements) (Kuopio, Marttila, Helenius, Toivonen, & Rinne, 2000) are also associated with
poorer HR-QOL. Of course, HR-QOL is a multifaceted variable affected by numerous
interacting factors that presumably correlate with each other. Schrag (2006) compared several
studies that have assessed HR-QOL in PD patients, and in the studies that used appropriate
multivariate analyses, depression was clearly the most frequent factor correlated with worse HRQOL in PD patients, more so than disease duration or severity.
Depression in PD has a clearly detrimental effect on HR-QOL, perhaps more than other
illnesses due to both the pathophysiological basis of depressive symptoms related to dopamine
depletion in  PD,  along  with  the  typical  “reactive”  adjustment to declines and disability. A recent
hospital-based prospective study compared PD patients (n= 46) to non-PD controls (n = 30) with
chronic medical conditions (Arun et al., 2011). The non-PD controls were recruited from a
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general medical clinic, and their chronic illnesses included diabetes, heart disease, hypertension,
osteoarthritis, and bronchial asthma. Compared to the control group, the PD patient group had
significantly higher prevalence and severity of depression. These authors also used the World
Health Organization Quality of Life Scale—Brief Version (WHOQOL-Bref), a scale that has
four subdomains of QOL (physical health, psychological health, social relationships, and
environment). In all four subdomains, depression was significantly negatively correlated with
QOL within the PD group. One limitation to this study is that the authors did not analyze the
relationship between depression and QOL in the non-PD control group. This comparison would
have been valuable to determine whether depression in PD is relatively more harmful to QOL
than in other medical populations, in addition to being more prevalent. Another weakness to this
study is the heterogeneity of the control group in terms of chronic illness, which prevented the
authors from matching samples based on duration and severity of illness. Despite these
limitations, this study supports the argument that depression in PD is higher than can be
explained by chronic illness, and these higher rates of depression ultimately contribute to poorer
QOL.
Several other studies have attempted to parse apart the relative strength of factors
contributing to QOL using regression analyses. Schrag and colleagues (2000) found that BDI
depression score accounted for 54% of the variance in QOL, as measured by a disease-specific
QOL  measure,  the  Parkinson’s  Disease Questionnaire (PDQ-39). Degree of disability, postural
instability, and cognitive impairment were also significant contributors to poor QOL, accounting
for an additional 18% of the variance. A similar study also used the PDQ-39 as an outcome
measure for QOL, however they expanded their predictor variables to include other NMS
(Gallagher et al., 2010). Gallagher and colleagues (2010) found that depression was the strongest
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predictor of QOL in multivariate regression analyses (adjusted R2 = 0.53, p = 0.005), followed
by fatigue severity and autonomic functioning. Another study with a relatively large
community-based sample of PD patients (n = 282) used a non-disease-specific QOL measure
(SF-36) to assess factors relating to QOL (Kuopio et al., 2000). Depression again was a
significant predictor in all eight domains of the SF-36, and it accounted for the most QOL
variance across seven of the dimensions (ranging from 12% to 28% of the variance). In the
physical functioning dimension, clinical stage of PD (H/Y scale) explained the most variance
(48%), with depression accounting for an additional 8% of the variance. In summary, depression
is a critical outcome variable to assess in PD, due to its multidimensional etiology, its influence
from disease progression and functional impairment, and its impact on QOL.
Apathy in Parkinson’s  disease. Although apathy is often considered related to
depression, it is conceptualized somewhat differently in the context of PD. Apathy is essentially
a lack of motivation across three main domains: 1) lack of interest in new experience and
concern  over  one’s  problems  (cognitive),  2) lack of effort, productivity, initiation, and drive
(behavioral), and 3) flattened affect and lack of response to positive or negative events
(affective) (Kirsch-Darrow, Fernandez, Marsiske, Okun, & Bowers, 2006; Pandya et al., 2008).
In recent years, the Movement Disorder Society has called for research exploring apathy as a
“disorder  of  motivation”  that  deserves more attention within PD studies (Leentjens et al., 2008).
Prevalence of apathy. The frequency of apathy in PD has been typically assessed using
informant-based rating scales, given that motivation (or lack thereof) is an internal state and
clinician  ratings  may  not  be  accurate  due  PD  patients’  limitations  expressing  facial  emotions  
(e.g.,  “masked  facies”)  (Kirsch-Darrow et al., 2006). There are several scales that have been
developed to evaluate apathy in patient populations, with the Starkstein Apathy Scale (SAS)
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(Starkstein et al., 1992) recommended for use with PD patients by the Movement Disorder
Society task force (Leentjens et al., 2008). The task force also emphasized that the discrepancy
between the large amount of research exploring depression in PD and the limited research
focusing on apathy is unjustified because apathy symptoms are reported among a majority of PD
patients. There is still debate whether apathy should be considered a separate syndrome (see
Starkstein & Leentjens, 2008 for a review), or if it should parsimoniously remain classified as a
characteristic of other disorders, such as depression and dementia.
Despite  the  continued  discussion  of  apathy’s  place  in  research  and  how  it  should  be  
assessed, prevalence rates of apathy in PD are high, ranging from 38% to 60% in various studies
(Pedersen, Larsen, Alves, & Aarsland, 2009; Oguru et al., 2010). One study examined apathy
and depression in PD patients and a group of patients with dystonia (Kirsch-Darrow et al., 2006).
PD patients had higher frequency and severity of apathy than the dystonia patients (measured by
the Apathy Evaluation Scale [AES; Marin, Biedrzycki, & Firinciogullari, 1991]). Apathy was
present in 51% of PD patients but only 20% of dystonia patients, and PD patients had
significantly higher scores on the AES than the dystonia patients. There were also differences
between the two groups when evaluating comorbidity of apathy and depression. Approximately
29% of PD patients exhibited clinically significant apathy scores in the absence of clinically
significant depression scores, while none of the dystonia patients demonstrated apathy without
depression. The groups had comparable frequencies of depression symptoms alone (4% for PD,
10% for dystonia) and comorbid apathy and depression symptoms (23% for PD, 20% for
dystonia).
A slightly different pattern of findings emerged in another population-based study of PD
patients, with 38% of the patients showing some symptoms of apathy (Pedersen et al., 2009).
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Nearly equal percentages of patients demonstrated apathy without depression (9%) as did with
depression (10%). Pedersen and colleagues (2009) used a validated single motivation/initiation
item from the UPDRS I to detect apathy rather than one of the longer apathy-specific scales,
which may explain the lower prevalence rates compared to the Kirsch-Darrow and colleagues
(2006) study. Despite the limitations of using a single item to detect a symptom, their study
supports the argument that apathy is common in PD patients and can present independently of
depression. Both of these studies highlight the need to assess apathy separately than just in the
context of depression, since a notable portion of patients exhibit apathy but do not meet criteria
for clinically significant depression scores.
Pathophysiology of apathy versus depression. Researchers believe apathy symptoms are
due to frontal subcortical dysfunction, similarly to depression (Pluck & Brown, 2002). This
hypothesis is supported by presence of apathy symptoms in other neuropsychiatric disorders with
similar  neurodegenerative  processes  as  PD  (e.g.,  Alzheimer’s  disease;;  Levy  et  al.,  1998).    
Despite some overlaps in clinical presentation and pathophysiological basis, depression and
apathy have subtle differences. Some of these differences are evident in non-PD patient groups.
In a study of patients with various neuropsychiatric disorders (left or right hemisphere stroke,
probable  Alzheimer’s  disease  (AD), and major depression), apathy and depression were
correlated but clinically distinct within and across diagnostic groups (Marin, Firinciogullari, &
Biedrzycki, 1994). For example, AD and right hemisphere stroke patients most frequently had
elevated apathy scores without depression, while left hemisphere stroke and major depression
patients had elevated levels of both apathy and depression. A similar study of patients with
various dementia syndromes, including both AD and PD patients, found that apathy and
depression were correlated in the PD group but not in any other dementia syndrome groups
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(Levy et al., 1998). Levy and colleagues (1988) also found that apathy and depression were
related to different neuropsychiatric symptoms. Apathy was more associated with disinhibition
and abnormal motor behavior, while depression was associated with agitation, irritability, and
anxiety.
Other research also supports the argument that apathy in PD, like depression, does not
represent  just  “premature  social  aging”  and  may  be  due  to  a  unique  pathophysiology.    Pluck  and  
Brown  (2002)  designed  a  study  to  further  explore  Singer’s  (1973)  observations  of  limited  social  
functioning in PD patients. They compared PD patients with osteoarthritis patients, arguing that
osteoarthritis patients are an appropriate control group because of similar patient age and the
chronic, progressive, disabling nature of the disease. There were no significant differences
between the two groups regarding degree of disability, however the PD group had clinically
significant apathy scores while the osteoarthritis patients showed no evidence of apathy. Their
results support the idea that apathy, similarly to depression, is a distinct feature of PD and cannot
be solely explained as a reactive or psychological response to motor impairment and subsequent
disability.
Another study looked at subtypes of PD with presumed differing pathophysiology and
found notable differences between apathy and depression (Moretti et al., 2012). They compared
PD patients with akinetic-rigid type and tremor-dominant type, with the former characterized by
absence of voluntary movement and the latter characterized by involuntary tremors and
movements. The akinetic-rigid patients performed more poorly on cognitive tasks involving the
frontal lobe, showed more insight into their condition, had lower depression scores but
significantly higher apathy scores. Conversely, the tremor-dominant type patients did better on
cognitive tasks, had less insight, higher depression scores but less apathy. These findings
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suggest that there is an independent pathophysiological mechanism underlying apathy that may
be different from the deteriorating dopaminergic pathways thought to be a pathophysiological
contributor to depression in PD. As more investigations continue to tease apart apathy and
depression in PD (e.g., Kirsch-Darrow et al., 2006), there is substantial evidence to support
studying apathy a distinct feature of PD.
Apathy and quality of life. Not surprisingly, there is strong support in the literature for
the negative relationship between apathy and QOL. In a study of apathy, depression, and QOL in
PD patients (n = 150), Oguru and colleagues (2010) found high overall prevalence rates (60% for
apathy, 56% for depression) and similar rates of apathy in the absence of depression (17%) and
depression in the absence of apathy (13%) as compared to previously mentioned studies. Both
depression and apathy were significantly correlated with patient QOL and UPDRS subscales.
Apathy, however, was correlated with H/Y stage and cognitive dysfunction (as measured by the
MMSE), while depression was not. Although apathy and depression were both predictors of
QOL (as measured by the PDQ-39), there were some nuanced differences between the variables
and the PDQ-39 subscales. Variance in apathy scores was mainly explained by cognition and
stigma, while depression scores were explained by emotional well-being and communication.
Oguru et al. (2010) concluded that while both apathy and depression are related to QOL and
disease progression, they can occur independently and may have a differing underlying
pathophysiology that is not fully understood.
There is some evidence that apathy may be subjectively more detrimental for QOL in PD,
even compared to other NMS. In a large multicenter survey (n = 1,072), Barone and colleagues
(2009) used semi-structured interviews to examine a range of NMS in PD patients. NMS were
highly prevalent (98.6% of patients), with psychiatric symptoms as the most frequently reported.
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Although general psychiatric symptoms were present in 67% of all patients, apathy was present
in 31% of PD patients and associated with the worst QOL compared to all other NMS on the
PDQ-39.
Another study examined apathy, depression, and QOL in PD patients diagnosed within
the past two years (Benito- León, Cubo, & Coronell, 2012). These researchers recruited from
557 patients from 102 outpatient clinics and found similar patterns of prevalence rates to those
seen in the Oguru et al. (2010) and Pedersen et al. (2009) studies (overall prevalence rates: 52%
apathy, 45% depression, 22% apathy alone, 14% depression alone, 30% comorbid apathy and
depression). They used logistic regression models to predict which variables could differentiate
between patients that had high versus low QOL (based on cutoff index score) on both a selfreported questionnaire and a QOL visual analog scale. Even after adjusting for significant
covariates, including UPDRS motor score, H/Y stage, motor fluctuations, and depression,
apathetic patients (based on clinical cut-off score) were nearly 2.5 times as likely as nonapathetic
patients to have low QOL on the self-reported questionnaire and 3.6 times as likely to have low
QOL on the visual analog scale. This study demonstrates that apathy affects QOL even during
early stages of the disease, which again emphasizes the importance of recognizing and measuring
apathy as a separate feature of PD and not subsumed as a symptom of depression.
Resilience. In contrast to the previously reviewed research of PD and negative impacts
on  patients’  lives,  another  research  area  within  psychology  and  social  science  explores  how  
people cope and successfully adjust to health problems to generate more positive outcomes. This
study of resilience within psychology and social sciences over the past 50 years represents a shift
from a disease model toward a model that accounts for positive adaptation as well. Resilience
research reflects this integration of risks and positive influences and emphasizes understanding
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what factors help people have successful outcomes, rather than disease-model research, which
studies the risk factors that result in poor outcomes.
Definition of resilience. The resilience construct was initially conceptualized and
explored with children and adolescents that overcame adverse childhood environments (Rutter,
1989; Werner, 1996). Although no single definition exists, researchers generally agree that
resilience involves three main characteristics: recovery, sustainability, and growth. Recovery
refers  to  how  well  people  can  “bounce  back”  from  challenge  and  stressors,  or  the  ability  to  return  
to baseline levels of functioning (Zautra, Arewakisporn, & Davis, 2010; Zautra, Hall, & Murray,
2010). People demonstrating the recovery characteristic of resilience regain psychological and
physiological homeostasis after a stressful event. For example, a majority of New York City
residents had few or zero posttraumatic stress disorder (PTSD) symptoms during the six months
following the September 11th terrorist attacks, which the researchers viewed as quick recovery
from an acute stressor (Bonanno, Galea, Bucciarelli, & Vlahov, 2007).
Resilience also involves sustainability, or the capacity to maintain psychological health
and well-being while continuing forward in the face of challenge, adversity, and daily stressors
(Bonanno, 2004; Zautra, Arewakisporn, & Davis, 2010). Sustainability is often measured as the
extent to which people continue engaging in positive life pursuits and experiencing positive
emotions. A person maintaining low levels of depression following bereavement (Bonanno,
2004) or continuing with average levels of daily physical functioning during a chronic pain
episode (Zautra, Hall, & Murray, 2010) demonstrates an ability to sustain well-being through
stress. After the recovery from an adverse event and sustainability of meaningful living, resilient
individuals often display growth, or an enhanced capacity for adaptation (Zautra, Arewakisporn,
& Davis, 2010). People may have an enriched understanding of an experience or a new, adaptive
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perspective on life, which is similar to the concept of posttraumatic growth or stress-related
growth (Aldwin & Levenson, 2004). Considered altogether, resilience involves recovery from
an adverse event, maintenance of values and purposeful life pursuits, and new learning or
advances as a result of the adversity.
Late life resilience. With the expanding demographic of older adults expected to
compose 20% of the U.S. population by 2030 (Federal Interagency Forum on Aging-Related
Statistics, 2008), some researchers have begun studying resilience towards the end of the
lifespan. Older adults generally experience more stressful life events than younger adults,
including dealing with personal losses, increases in disease vulnerability, and numerous
functional limitations (Allen, Haley, Harris, Fowler, & Pruthi, 2011). Despite these challenges
and  declines,  a  growing  body  of  research  has  found  a  “paradox  of  aging,”  with  old age often
characterized by various heightened abilities and growth-oriented goals (Bauer & Park, 2010;
Carstensen & Hartel, 2006). Resilience and the related construct of successful aging (Rowe &
Kahn, 1987) often involve the maintenance of psychological well-being in the face of common
and age-specific stressors, such as trauma, loss, or illness.
One consistent finding within mental health and aging research is that many older adults
have good psychological well-being, including high ratings of happiness, self-esteem, and
satisfaction with QOL (e.g., Crocker & Wolfe, 2001; Diener & Suh, 1997; Herzog & Rodgers,
1981; Uhlmann & Pearlman, 1991). Although older adults face declines in physiological and
cognitive functioning, evidence suggests that emotional well-being remains very stable, and it
may even grow more complex and mature as adults reach old age (Carstensen & Hartel, 2006;
Carstensen et al., 2011; Isaacowitz, Charles, & Carstensen, 2000). This emotional stability and
adaptiveness is seen in studies of trauma, with older adults recovering more quickly from PTSD
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symptoms (Kato, Asuki, Miyaki, Minakawa, & Nishiyama, 1996) and being three times more
likely to demonstrate resilience (as measured by one or zero PTSD symptoms) than younger
adults following a traumatic event (Bonanno et al., 2007). Studies of overall prevalence rates
also find that older adults have lower PTSD rates and other anxiety disorders than their younger
counterparts (Creamer & Parslow, 2008; Wolitzky-Taylor, Castriotta, Lenze, Stanley, & Craske,
2010).
Late  life  resilience  is  also  evident  when  comparing  older  and  younger  patient’s  
differential adjustment to illness and health stressors. A recent review of 22 studies of patients
with disabilities found an age-related depression trend, with younger patients at higher risk for
depression than older patients (Bombardier et al., 2010). Another noteworthy study examined a
large group of patients (n = 758) across six different chronic illnesses and found that older
patients (>60 years old) had better total mental health scores than middle-aged or younger
patients in all psychological diagnostic groups (Cassileth et al., 1984). Similar age-related
differences in psychological outcomes are seen in studies of limb amputation (Williamson,
Schulz, Bridges, & Behan, 1994), cancer (Williamson & Schulz, 1995), pain (Gibson & Helme,
2001), and heart transplant (Shamaskin et al., 2012). Many of these studies suggest that adaptive
coping, emotion regulation, and stress inoculation due to prior experience with health stressors
account  for  the  older  patients’  comparatively  better  adjustment.  
Although researchers were initially puzzled by these findings, a perspective that is
gaining increasing support views  aging  as  the  “maintenance  of  development  in  the  face of
cumulative  risks”  (Ong  et  al.,  2009, p. 1779). This lifespan approach to human development
highlights growth and adaptation as characteristics of aging, not only compensation and
accommodation. While the basic framework for resilience (recovery, sustainability, growth) is

26

applicable to all populations, there are important developmental changes with age that should be
considered as unique elements of late life resilience.
Age-related resilience components. A variety of research has attempted to explain the
“paradox  of  aging,”  exploring  how  psychological  well-being is maintained and even
strengthened in late life despite losses and declines across numerous domains. The construct of
resilience initially conceptualized how children from adverse environments could have adaptive
outcomes, and this phenomenon has since been studied in many populations facing different
challenges. There has not been, however, an exploration of late life resilience as a qualitatively
different construct from that which is applied to younger populations. The following sections
integrate developmental theories of aging with new frontiers in the stress and coping literature to
suggest unique age-related components of resilience.
Positivity and meaning-focused coping. The stress and coping literature is a natural body
of  research  for  comparison  to  resilience.    When  faced  with  a  stressor,  people’s  experiences  and  
abilities to cope with that stress partially determine whether they will have an adaptive outcome.
Lazarus  and  Folkman’s  (1984) transactional model of stress and coping explains that outcomes
depend on initial stressor appraisals and the subsequent type of coping used to address the
problem. More specifically, the primary appraisal of a stressor involves evaluating the situation
or stressor as a harm, threat, or challenge. During secondary appraisal, people evaluate their
resources and abilities to cope with the situation. The primary appraisal of the stressor and
secondary appraisal of coping options often interact to determine the emotional effect of the
stressor. After the appraisal process, individuals can engage in either problem-focused or
emotion-focused coping. Problem-focused coping frequently involves problem-solving strategies
(e.g., generating alternatives, weighing costs and benefits), and it is most effective in situations
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when specific actions and proximal tasks can change the stressor. Emotion-focused coping, on
the other hand, aims to regulate emotions and distress (e.g., selective attention, avoidance,
minimization) when a situation cannot be changed through direct action. According to the model,
if coping attempts are ineffective or unsuccessful, the appraisal-coping process repeats and can
result in chronic stress.
There is some evidence of age differences in coping based on this model. Folkman,
Lazarus, Pimley, and Novacek (1987) found that younger adults (M = 41 years, SD unavailable)
generally used more active, interpersonal, problem-focused methods of coping, while older
adults (M = 68 years, SD unavailable) used more passive, intrapersonal, emotion-focused forms
of coping. The older adults also reported fewer hassles than the younger adults, a finding
consistent with other studies demonstrating age-related decreases in stressor frequency (Almeida
& Horn, 2004; Charles & Carstensen, 2010) and stressor severity (Aldwin, Sutton, Chiara, &
Spiro, 1996). Other research suggests that the experience gained with age plays an important
role in the coping process. One study found that age was positively correlated with less
perceived control, however older adults did not appear to use more avoidant coping strategies, as
would be predicted by feeling less control (Aldwin, 1991). This strategy ultimately lessened the
adverse effects of less perceived control, which Aldwin suggested reflected a skill developed out
of years of experience learning effective and ineffective coping techniques.
Folkman later identified a shortcoming of the original stress and coping model: It only
explained how coping could manage distress and did not account for positive emotions. The
revision to her model stemmed from her longitudinal study of caregiving partners of men with
AIDS (Folkman, 1997). In this study, she found that positive emotionality played an
unexpectedly prominent role in the caregiving and bereavement processes. Folkman suggested
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that positive emotions help people find meaning from an event and positively reappraise the
situation, instead of repeating the appraisal-coping process. Since this revision, researchers have
found that positive emotions and this type of coping, termed meaning-focused coping, have an
important function in the stress and coping process and are distinct from simply regulating
negative emotions (Folkman, 2008; Folkman & Moskowitz, 2000). Meaning-focused coping can
occur when people experience distress from a discrepancy between their global meaning
(enduring beliefs and valued goals) and situational meaning (initial appraisal of meaning from an
event)  (Park  &  Folkman,  1997).    This  process  incorporates  people’s  beliefs  and  existential  goals  
to motivate coping and well-being during difficult situations, often through goal revision or repriotization. Folkman (2008) reviews how one’s  meaning-making ability incorporates positive
emotions (e.g., positive reappraisal, infusion of ordinary events with positive meaning), but the
process can also generate positive emotions out of an unfavorable resolution. Some researchers
suggest a connection between positivity and resilience (Ong, Bergeman, Bisconti, & Wallace,
2006; Tugade & Fredrickson, 2007), such that people who can successfully use positive
emotions in the coping process have more resilient outcomes. This interplay between positive
emotions and coping is at the heart of understanding late life resilience, primarily due to agerelated changes in emotion regulation.
In  conjunction  with  Folkman’s  (1997)  revised  model,  which  created  a  place  for  positivity
in the stress process, other developmental theories of aging suggest that positive emotions have
an  especially  salient  role  as  we  age.  An  extension  of  the  “paradox  of  aging”  findings  includes  
research that demonstrates general increases in positivity with increasing age (Gross et al., 1997;
Mroczek  &  Kolarz,  1998).  In  the  context  of  Folkman’s  (1997)  revised  model,  this  age-related
heightened positivity could lead to relative proficiency in meaning-making ability. One
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theoretical explanation supporting positivity as mechanism that promotes meaning-focused
coping is socioemotional selectivity theory (SST).
SST is a motivational theory of aging suggesting that time perspective, or a sense of how
much time people have left to live, is integrally related to how they select goals (Carstensen,
Fung, & Charles, 2003). When time does not seem limited, such as when people are younger,
Carstensen  and  colleagues  suggest  that  a  “future  time  perspective”  motivates  them  to  seek  
information and make new social contacts. When time feels limited, which occurs toward the
end  of  the  lifespan,  people  take  on  a  “limited  time  perspective”  and  are  instead  motivated  to  
pursue emotion-focused goals that can be satisfied in the short-term. This theory is supported by
reliable and robust age differences in time perspective (Kennedy, Fung, & Carstensen, 2001;
Lang & Carstensen, 2002) and pursuit of emotionally satisfying goals (Fredrickson &
Carstensen, 1990).
The clear preference for emotion-related goals among older adults is often displayed in
social network size and composition. Older adults tend to selectively prune their social networks
to discard unimportant relationships, such that they have smaller social networks composed of
emotionally close partners (Carstensen et al., 2003). Rooted within SST, an emerging body of
research also highlights the extensive role of positive emotion and improved emotion-regulation
with age. Older adults prefer, attend to, and remember positive information more so than
negative information (Mather & Carstensen, 2005). This positivity effect has been demonstrated
in studies of working-memory (Mikels, Larkin, Reuter-Lorenz, & Cartensen, 2005),
autobiographical memory (Kennedy, Mather, & Carstensen, 2004), and memory for age-relevant
health information (Shamaskin, Mikels, & Reed, 2010). There is substantial evidence in both
longitudinal and cross-sectional designs demonstrating this predominance of positive
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emotionality among older adults (e.g., Carstensen & Mikels, 2005; Charles, Reynolds, & Gatz,
2001; Scheibe & Carstensen, 2010). Researchers also suggest that older adults demonstrate
emotional complexity and improved emotion-regulation abilities, as seen through the cooccurrence of positive and negative emotions (Carstensen et al., 2011; Ong & Bergeman, 2004)
and increased stability in emotional experiences (Gross et al., 1997; Röcke, Li, & Smith, 2009).
This age-related increase in positive emotionality can have a direct effect on coping
options and ultimately an increased ability  to  make  meaning  from  adversity.    Fredrickson’s  
(1998, 2001) broaden-and-build model offers an explanation of how positive emotions can
facilitate coping with stress. Positive emotions allow people to broaden their scope of attention
(Fredrickson & Branigan, 2005), promote flexible and creative thinking (Isen, Daubman, &
Nowicki, 1987), and undo the physiological effects of negative emotions (Fredrickson, Mancuso,
Branigan, & Tugade, 2000). The broaden-and-build model suggests that over time, these positive
emotions help people build a repertoire of physical, social, and intellectual resources that can
facilitate future coping (Aron, Norman, Aron, McKenna, & Heyman, 2000; Fredrickson, 2000).
Fredrickson (2000) hypothesized that because positive emotionality promotes broadened
thinking  and  resources,  this  increases  one’s  ability  to  find  positive  meaning.  Additionally,  
people’s  abilities  to  find  positive  meaning  in  turn  predict  more  positive  emotionality  
(Fredrickson, Tugade, Waugh, & Larkin, 2003). This reciprocal relationship between positive
emotions and positive meaning creates an  “upward  spiral”  of  emotional  well-being and resilience
(Fredrickson, 2001). Considered altogether, finding positive meaning triggers positive emotions,
which subsequently broadens thinking, builds personal resources, and ultimately increases the
likelihood of adaptive, meaning-focused coping in the future. Among older adults, this emphasis
on positivity and meaning-focused coping presumably enhances their ability to maintain well-
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being and make meaning from potentially negative elements of aging (i.e., physical, cognitive,
and functional declines). Fredrickson (2001) and others (Ong & Bergeman, 2004; Tugade &
Fredrickson, 2007) highlight this ability to utilize positive emotions as a central component of
psychological resilience. Given the relationship between positivity and aging, there is good
reason to believe this skill is a particularly important contributor to late life resilience.
In summary, SST and supporting evidence of age-related changes in emotion regulation
demonstrate the salient role of positivity as people age. The broaden-and-build model outlines
how these positive emotions contribute to meaning-focused coping and resilience. Therefore,
positive emotions and meaning-making abilities are conceivably very relevant components of
late life resilience. Some researchers even argue that positivity not only contributes to resilience,
but it also acts as the underlying mechanism of understanding resilience in older adults
(Bonanno, Westphal, & Mancini, 2012).
Goal-flexibility. Another perspective for understanding coping and well-being involves
goals, specifically how people deal with unattainable goals. Although being unable to reach a
goal is a common experience across the lifespan, older adults in particular often face unattainable
goals due to declines in physical health and cognitive functioning (Wrosch, 2011). Wrosch
(2011) and colleagues (Wrosch, Scheier, Miller, Shulz, & Carver, 2003) argue that the ability to
disengage from personal goals is an adaptive self-regulation process. The self-regulation of
unattainable goals involves two main components: goal disengagement and goal re-engagement
(Wrosch, 2011). A person disengages from a goal by withdrawing effort and commitment
toward that goal, for example, choosing to stop running after an injury. Goal re-engagement
requires shifting efforts to pursue other meaningful goals, such as seeking out a new hobby or
interest. This process has similarities to the optimization and compensation components of the
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SOC  model  (Baltes  &  Baltes,  1990),  as  well  as  the  role  of  goal  adjustment  in  Folkman’s  (1997)  
meaning-focused coping.
In addition to the age-related changes in positivity and meaning-focused coping, there is
some  evidence  for  older  adults’  enhanced  abilities  in  goal  adjustment  and  flexibility.    Several  
studies demonstrate that older adults can disengage from goals more fully than their younger
counterparts (Heckhausen, 1997; Wrosch, Bauer, & Scheier, 2005; Wrosch et al., 2003; Wrosch
& Heckhausen, 1999). Successful goal disengagement has subsequent benefits, including
improvements in physical health (Wrosch, Miller, Scheier, & de Pontet, 2007) and buffering
against depressive symptoms (Dunne, Wrosch, & Miller, 2011). Older adults can also more
easily accommodate and find new goals to pursue compared to younger adults (Wrosch et al.,
2003). There is good evidence that this goal re-engagement is a critical component of adaptive
goal-flexibility. Wrosch et al. (2003) found that goal disengagement was associated with
increased subjective well-being, but only if older adults could re-engage in other meaningful
activities. Another study drew similar conclusions by examining older adults one year after
illness onset that required abandonment of physical activities (Duke, Leventhal, Brownlee, &
Leventhal, 2002). Those older adults that pursued other goals had higher positive affect than
those that did not replace their lost activities. The flexibility required in the disengagement and
re-engagement process is consistent with other perspectives of age-related changes in goal
adjustment, such as the transition from tenacious goal pursuit to flexible goal adjustment
(Brandtstädter & Renner, 1990). Overall, adaptive self-regulation of unattainable goals has
positive effects on well-being. As people age, proficiency in this processes becomes an
increasingly important part of maintaining QOL and resilience due to the inevitable
developmental constraints on personal goals.
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In summary, there is a strong argument for positivity, meaning-making ability, and goalflexibility as unique components of late life resilience. Age-related changes in emotion
regulation and positivity contribute to improved abilities to cope and make positive meaning
from adverse situations. Goal-flexibility is an increasingly important skill in later life, and older
adults that are able to disengage and re-engage in activities can satisfy goals without extensive
demand on resources. These components may be important characteristics of resilience that are
unique to older adults. Continued research is necessary, however, to study resilience in late life,
understand the variables implicated in the late life resilience process, and learn how these agerelated strengths may play a role adjusting to health stressors and disease.
Resilience measurement. In exploring the construct of late life resilience, one basic
challenge stems from the interdependence of construct conceptualization and assessment.
Appropriate measurement depends on a clear understanding of the construct to be assessed, but
our understanding of the construct relies upon research and measurement. Although there is basic
agreement on the three main characteristics of resilience (recovery, sustainability, and growth),
there is still disagreement as to the qualitative nature resilience. Some researchers view resilience
as a resource utilized during periods of stress. For example, Aldwin, Sutton, and Lachman (1996)
found that 80% of men undergoing a stressor reported drawing resources from a past experience,
however only 23% said they drew from a similar stressful experience. The rest of the men used
more generalized resources, such as emotion regulation skills that were developed after dealing
with a previous stressor.
Resilience is also studied as an outcome, or the result of successful adaptation in the face
of adversity (Masten & Wright, 2010). One advantage to this approach is that researchers can
more easily focus on single outcomes (e.g., academic achievement, psychological well-being)
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and use variable-focused statistical analyses to predict outcomes based on specific risk and
protective factors. Other researchers view resilience as an individual resource involving
temperament and personality factors (Block & Block, 1980) or as dynamic process that cannot
be simplified as an individual trait (Bonanno, 2004; Luthar, Cicchetti, & Becker, 2000). Luther
et  al.  (2000)  suggest  that  confusing  terminology  partially  contributes  to  the  field’s  difficulty  
clarifying the nature of resilience. For example, even researchers that argue resilience is best
conceptualized  as  a  process  refer  to  “resilient  children,”  “resiliency,”  or  other  terms  that  carry  the  
connotation of resilience as a personality trait or individual attribute. Despite the somewhat
misleading terminology, the process approach has strong empirical support within resilience
research. Resilience as a process not only accounts for risk and protective factors, but it
incorporates how they function to create positive growth outcomes, which is a similar interactive
conceptualization seen in stress and coping models (Lazarus & Folkman, 1984).
These differences in how resilience is defined also pose challenges for how it is best
measured. If resilience is conceptualized as an individual dispositional trait, it could presumably
be measured and observed at any time, not contingent upon whether or not the individual was in
a period of high stress that might require resilience. On the other hand, if resilience reflects a
dynamic process, researchers could assess within the context of a stressful encounter to better
understand how resilience develops. Resilient outcomes, as well, must be measured after a
stressful or adverse event. More research is needed to clarify the nature of resilience and how it
should be best measured (see Luthar et al., 2000 for a review). While it is important to recognize
these larger construct conceptualization challenges in resilience research, the present study will
not attempt to comprehensively explore the qualitative nature of the construct. This study will
instead take a more applied approach and focus on the commonly used tools for studying
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resilience, specifically self-report resilience scales. The current investigation will address the
limitations of using resilience scales with an older population, hypothesize about unique agerelated components of resilience, and test the impact of these components within an older adult
population.
In a recent review of resilience scales (Windle, Bennet, & Noyes, 2011), very few scales
have been developed with and validated for use with older adults (See Table 1). Only the
Resilience Scale (Wagnild & Young, 1988) was developed initially with exclusively an older
adult population, however further analysis of its original development reveals some important
weaknesses and limitations. Wagnild and Young (1988) recruited a small convenience sample of
Caucasian older women (n = 24) from senior centers who had shown successful adaptation to a
major life event. High scores on the Philadelphia Geriatric Center Morale Scale (PGCMS) and
active  participation  in  the  senior  center  characterized  “successful  adaptation,”  though  it  is  
unclear how the researchers assessed active participation. The women were interviewed and
asked to reflect on a loss they had experienced within the past five years. The small sample size
and homogeneous sample makeup represent one clear limitation in terms of generalizability to
other populations. Another important weakness of the RS is the interview framework that guided
participants to reflect on a recent loss. There is still debate whether resilience should be observed
in the context of a stressor, or whether it can be assessed in people who have yet to experience
significant adversity. In this sense, the RS is only based on characteristics of adaptation that
occurred  in  response  to  a  stressor,  but  may  not  include  the  hypothesized  “psychological reserve
capacity”  elements  of  resilience  in  older  adults  (Smith  &  Hayslip,  2012;;  Staudinger  et  al.,  1995).  
The Connor-Davidson Resilience Scale (CD-RISC), though not developed with an older
adult sample, has received some support in the literature for use with older adults (Table 1). The
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subscales, however, are somewhat poorly defined, and there is some evidence that the factor
structure may be different with an older adult population. Lamond and colleagues (2008) used
the CD-RISC to study resilience in older women, and they found that the acceptance and
tolerability of negative affect factor emerged as a higher-order factor than compared to the factor
structure in the Connor and Davidson (2003) development sample of younger and middle-aged
adults. They suggested that perhaps resilience in an older population reflects a different process
that involves contributions from acceptance and toleration of negative affect (Lamond et al.,
2008). This finding is also consistent with research on affective changes with increasing age
(Gross et al., 1997), which lends further support to the hypothesis that positivity and enhanced
emotion regulation skills are important contributors to older adult resilience.
On the other hand, the Resilience Scale for Adults (RSA) included older adults in its
development sample and has received good support in the literature as one of the highest quality
resilience scales (Windle et al., 2011). The RSA is unique compared to the other resilience
measures listed in Table 1 for two main reasons. First, the questionnaire was originally
developed using a theory-driven approach rather than using qualitative responses from a target
population, as was used to develop the RS (Wagnild & Young, 1993). The RSA scale
developers followed a qualitative method for scale development (DeVellis, 2003; Kazdin,
2010a); they identified a specific construct definition of resilience, conducted a thorough
literature review to generate categories of protective resilience factors, generated a wide range of
possible items, and finally winnowed the items down using an expert panel and an exploratory
principal components analysis (Hjemdal, 2007).
Second, the RSA scale development process was conducted with specific intention to
target the three overarching protective categories based on the longitudinal studies of pioneering
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resilience researchers (Garmezy et al., 1984; Rutter, 1989; Werner, 1996): 1) individual
dispositions or attributes, 2) family support and interpersonal relationships, and 3) wider
environmental and social supports. During the literature review of protective resilience factors,
the scale developers identified 15 clusters of protective factors, but they ultimately generated a
six-factor structure scale that included the three fundamental protective factors identified by
previous researchers. Therefore, the six RSA subscales more comprehensively reflect resilience
theory than other resilience scales and subscales. For example, the BRS and ER-89 subscales
target individual protective factors, but they do not measure family or external social support.
The CD-RISC was also closely tied to resilience theory in its development, however Connor and
Davidson (2003) emphasized Kobasa’s  (1979) hardiness concept in their conceptualization. This
ultimately led to their resilience construct and subsequent subscales as reflecting an individual’s  
stress coping ability (i.e., hardiness) that buffers the effect of stress and negative life events, but
again does not account for family or external social support.
As seen in Table 1, there is a wide range of subscales across the different resilience
measures, which reflects the continued need for consensus in resilience definition and
measurement (Luthar et al., 2000). For the purposes of the present study, the RSA will be used
to measure resilience due to its highly-rated psychometric properties (see scale description in
Methods section) and clear link to the three major categories of resilience factors. The RSA
subscales are also easily interpretable and straightforward (e.g., positive perceptions of self)
compared to other resilience scales, such as the CD-RISC, which seems to have double-barreled
subscale names (e.g., trust/tolerance/strengthening effects of stress).
Given the numerous questions regarding resilience, many researchers emphasize the need
for more longitudinal or cohort-sequential study designs (Zautra & Reich, 2011). This direction
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is particularly important for late-life resilience research, because the cumulative life experiences
of older adults likely affect how they experience and cope with stress (Eysenck, 1983). Although
longitudinal designs may be the most fruitful method for understanding resilience, there is still
value in using self-report scales to better understand the resilience construct. Several available
resilience scales have adequate psychometric properties and represent an easy and cost-effective
method to measure resilience. As previously explained, the present study will use the RSA to
assess resilience (Friborg, Hjemdal, Rosenvinge, & Martinussen, 2003), given its theory-driven
development, strong psychometric qualities, and comprehensive and easily interpretable
subscales.    Additionally,  there  have  been  no  studies  to  this  author’s  knowledge  that  have  
examined the RSA with exclusively an older population, and it may be valuable to use this scale
in assessing the additional components of resilience (i.e., optimism, goal-flexibility, and
meaning-making ability) that may be unique to older adults.
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Table 1
Highest Quality Resilience Scales in Windle et al. (2011) Reviewa
Number of

Development

subscales (items)

sample

Validation studies with older

Measurement scale

Subscales
population Y/N

Two adult samples (one

The Resilience Scale
for Adults (RSA)

6 (33)

(Friborg et al., 2003)

outpatient psychiatric

Positive perception of self;

sample; n = 59, mean

positive perception of future;

age range 18 – 75

social competence; family

years; one control

coherence; structured style;

sample; n = 276; mean

social resources

N

age range 25-50 years)
Five adult samples (n =

Personal competence,

Y

806) (general

trust/tolerance/strengthening

Lamond et al., 2009 (n = 1,395, M = 73

population and

effects of stress, acceptance

psychiatric outpatient

of change and secure

Montross et al., 1996 (n = 205, M =

samples; M = 43.8

relationships, control,

80.4 years, SD = 7.5 years)

years, SD = 15.4 years)

spiritual influences

The Connor-Davidson
Resilience Scale (CDRISC)

years, SD = 7.2 years)

5 (25)

(Connor & Davidson,
2003)
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Confident optimism;
The Ego-Resiliency89 (ER 89)

4 (20)

(Klohnen, 1996)

Three adult samples (n

productive and autonomous

= 594; mean age range

activity; interpersonal

18 to 48 years)

warmth and insight; skilled

N

expressiveness
Psychological

Sample drawn from

Resilience

secondary data analysis

Self-esteem; personal
3 (19)

competence; interpersonal

(Windle, Markland, &

(n = 1,847; mean age

Woods, 2008)

range 50 – 90 years)

N

control
Y
Wagnild & Young, 1993 (n = 810, M =
The Resilience Scale
Female adults (n = 24;
(RS)

71 years, SD = 6.5)
Acceptance of life and self;

2 (25)

M = 78 years, SD

Wagnild & Young, 1988 (n = 39, M =
Individual competence

(Wagnild & Young,
unavailable)

71 years, SD = 7.9)

1988)
Wagnild & Young, 1991 (n = 43, M =
73 years, SD = 11.7)
The Brief Resilience

Four adult samples (n =

Individual ability to bounce

354) (two student

back or recover from stress

1 (6)
Scale (BRS) (Smith et

N
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al., 2008)

samples, two
behavioral medicine
samples; mean age
range 19-63 years)

a

Quality assessment based on ratings of content validity, internal consistency, criterion validity, construct validity, reproducibility
agreement, reproducibility reliability, responsiveness, floor and ceiling effects.
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Resilience in Parkinson’s  disease. Resilience in PD has only recently been gaining
attention as an area of research. One qualitative study interviewed PD patients, other progressive
neurological diseases, and their caregivers to determine which demographic, disease factors, and
coping strategies contributed to better adjustment (total n = 30; 28-50 years old, n = 10; 51-70
years old, n = 16, 70+ years, n = 4) (McCabe  &  O’Connor,  2012). Participants were split into
two groups (high and low adjustment) based on self-reported QOL and score on a mood
measure, although the cut-off criteria for high or low QOL or mood were not clearly indicated.
The  researchers  conceptualized  “resilient  participants”  as  those  who  were  in  the  high-adjustment
group. The structured interview questions generally focused on adjustment mechanisms, coping
strategies, and resources used by patients and families. For both the high and low adjustment
groups, social support was reported most helpful in coping with the illness. There were also
some notable differences between the two groups regarding positivity; having a positive attitude
was frequently cited as a useful strategy in the high-adjustment group, but not cited by any
participants in the low-adjustment group.
Another important distinction between the two groups was how they used social support.
The high-adjustment group used their social support to make changes to their lives that would
enhance enjoyable experiences (e.g., frequent family visits to increase social interaction), while
the low-adjustment group used their social support for instrumental needs (e.g., providing
assistance around the house). One major limitation of this study is the small sample size (n = 30;
17 patients, 13 caregivers). Not only does this small sample limit generalizability, but the
researchers could not make any comparisons across patient groups due to even smaller disease
group subsamples (Motor  neurone  disease,  n  =  1;;  Huntington’s  disease,  n  =  1;;  multiple  sclerosis,  
n = 7; PD, n = 8). Nonetheless, this study highlighted the importance of positivity and using
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social support to make meaningful life adjustments as importance elements of coping with the
illness.
Another recent study examined the relationships between resilience, disease severity,
disability, QOL, and NMS in a sample of PD patients (n = 83) (M age = 66.3 years, SD = 10.6
years) (Robottom et al., 2012). They conceptualized  resilience  as  a  measurable  “individual  trait”
that reflects an  ability  to  “spring  back  in  the  face  of  adversity.”    They  used  the  15-item
Resilience Scale (RS; Wagnild & Young, 1993), which as previously explained, has good
psychometric support and is a commonly used resilience scale. Resilience was significantly
correlated with less disability (performance on ADLs and IADLs) and better QOL (SF-12), but
not correlated with disease severity (UPDRS total and motor). Regarding NMS, resilience was
significantly correlated with overall less psychiatric symptom burden, including less depression,
anxiety, somatization, apathy, and fatigue. Lastly, higher resilience scores were also correlated
with personality features of greater optimism and less pessimism.
Several important conclusions can be drawn from the Robbotom et al. (2012) study.
First, resilience was unrelated to disease severity, but it was associated with less disability and
better QOL. This finding supports the idea that resilience does reflect some stable individual
feature that is related to disease adjustment but not necessarily disease progression. Robottom
and colleagues (2012) argued that resilience might protect patients from disability and poor
QOL, serving as a buffer against the known detrimental effects of PD. Another notable finding
was the correlation between resilience and positivity. This result is consistent with the McCabe
and  O’Connor  study  (2012)  and  previous  research  highlighting  the important role of positivity in
aging (Carstensen et al., 2003, Mather & Carstensen, 2005). Robottom and colleagues (2012)
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note that the correlations between resilience and optimism were strong (r = 0.57, p <.001), but
not high enough to suggest the scales were measuring the same latent construct.
The  Robottom  et  al.  (2012)  and  McCabe  and  O’Connor  (2012)  studies  provide  useful  
building blocks for continued research in resilience in PD. Both studies highlight positivity as
important components that are related to QOL and generally better outcomes. McCabe and
O’Connor  (2012)  also  suggest  that  using  social  supports  for  assistance  with  goal adjustment is
associated with better outcomes. The major limitations of these studies, however, lie within their
methodology.    The  resilience  construct  is  poorly  defined  in  McCabe  and  O’Connor’s  (2012)  
study, and although Robottom and colleagues (2012) used a common resilience scale, there are
unanswered questions as to whether these scales comprehensively assess resilience in older
populations. Additionally, Robottom et al. (2012) limited their analyses to include only
correlations, and their findings could have been more informative by using additional
sophisticated statistical techniques.
Statement of the problem. The previously reviewed literature emphasizes the clear need
to better understand resilience in an older population. By integrating ideas from developmental
theories  of  aging  with  the  field’s  current  understanding  of  the  resilience  construct,  there  is  good
support for late life resilience to stand as a unique construct encompassing different components
than resilience in younger populations. These hypothesized unique components include
positivity, goal-flexibility, and meaning-making ability. Therefore, late life resilience may not
be adequately assessed with current measurement tools, given that many of the tools were not
developed while considering these developmental changes.
Rationale. Parkinson’s  disease  is  an  appropriate  and  potentially  useful patient population
in which to study resilience. The generally older patient group faces many challenges with
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adjustment to their illness, including some mental health issues that have a pathophysiological
etiology. Additionally, there is good evidence that QOL and mental health outcomes are
modifiable and cannot be solely predicted by disease progression or motor impairment. There is
also a small but growing body of resilience research in older populations, and very limited
research on resilience in PD. A project that can explore both the construct of late life resilience
and provide more information about positive adjustment in PD patients will address important
gaps in the literature. Therefore, the present study investigates the relationships between PD
NMS and functional impairment, mental health, and resilience. More specifically, this project
studies whether resilience moderates the relationship between PD NMS and functional
impairment, and mental health outcomes. Resilience was measured both with a validated
resilience scale and with the hypothesized components of resilience that are unique to the older
population. Multiple moderation and hierarchical multiple regression analyses will determine
whether the hypothesized late life resilience components account for some unique variance in the
relationship between PD NMS, functional impairment, and mental health outcomes.
Hypotheses. This study has two related but distinct goals in understanding resilience in a
PD population. The first goal is to establish the relationship between PD NMS and functional
impairments, resilience, and mental health outcomes. The second goal is to determine whether
late life resilience involves other features not captured with a standard resilience scale. See
Figure 1 for a theoretical conceptualization of hypotheses.
H1: PD NMS, functional impairment, and disease symptom-related QOL will be
significant predictors of poorer mental health/adjustment-related QOL outcomes.
H2: Resilience, as measured by a standard resilience scale, will moderate the relationship
between PD NMS, functional impairment, and disease symptom-related QOL and
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mental health/adjustment-related QOL outcomes. Patients with greater resilience
will have a weaker relationship between their PD NMS, functional impairments,
and disease symptom-related QOL and mental health/adjustment-related QOL
outcomes.
H3: The variables of positivity, goal-flexibility, and meaning-making ability will account
for a significant amount of variance in the relationship between PD NMS,
functional impairment, and disease symptom-related QOL and mental
health/adjustment-related QOL outcomes, above and beyond the variance
explained by the standard resilience measure.
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Hypothesized age-related resilience components
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PD Nonmotor symptoms (NMSQuest)
Functional impairment (FIM-SR)
Mobility (PDQ-39)
Activities of daily living (PDQ-39)
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Adjustment
Depression (BDI-II)
Apathy (SAS)
QOL: emotional well-being, stigma,
social support, cognitions,
communication (PDQ-39)
Satisfaction with Life (SWLS)

Figure 1. Theoretical conceptualization of hypotheses tested through proposed multiple moderator model.
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An underlying theme within this project is to explore the relationship between age and
resilience, however the previously reviewed literature highlights several challenges in this
investigation. First, most resilience scales were not developed or validated for use with an older
population. Second, there is compelling evidence within the developmental literature to suggest
that the theoretical construct of resilience contains unique components in an older population,
which are not currently incorporated into existing resilience scales. Although an ideal study
might explore the relationship between age and resilience using a sample of adults across the
lifespan reporting on a single, widely-applicable scale, no such resilience measure exists that is
indicated for use across the entire lifespan (Windle et al., 2011). Therefore, the present study
will focus specifically within an older population to determine whether additional resilience
components do, in fact, account for unique variance above and beyond the variance captured by
a standard resilience measure. In an effort to capture the widest age range possible, the study will
not limit the age-range of PD patients eligible to participate, and age will be analyzed as part of a
secondary hypothesis.
H4: Age will moderate the relationship between the unique age-related components of
resilience and the standard resilience scale. As patient age increases, the variables
of positivity, goal-flexibility, and meaning-making ability will account for
significantly more variance in the relationship between PD NMS and functional
impairments and mental health/QOL outcomes.
Method
Participants
Participants in this study were recruited  through  the  VCU  Parkinson’s  and  Movement  
Disorders Center (PMDC) in Richmond, Virginia. Upon IRB approval to conduct the present
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study (IRB #HM14988), recruitment involved the IRB approved advertisement shared with
collaborators in the following community organizations as well as the PMDC website and
listserv:  the  Southeast  Parkinson’s  Disease  Research,  Education  and  Clinical  Center  at  the  
Hunter  Holmes  McGuire  Veteran’s  Medical  Center,  the  Richmond  Chapter  of  the  American  
Parkinson’s  Disease  Association  (APDA),  and the APDA Information and Referral Center at the
University of Virginia. Advertising was utilized with the goal of reaching the widest audience
possible within the movement disorders community, including individuals typically underserved
by movement disorder specialists. In addition to advertising through community organizations,
Dr. Lageman, the PMDC’s  clinical  neuropsychology  core  director, recruited patients with PD
from  the  VCU  Parkinson’s  and  Movement  Disorders  Center  (VCU  PMDC)  by  discussing  the  
study with patients who had been identified from review of VCU PMDC neuropsychological
evaluations included in the PMDC Neuropsychological Data Collection Registry (IRB #
HM13254). Eligible individuals had a confirmed medical diagnosis of PD. The populations
eligible to participate in this study were adults, ages 21-90+. Exclusion criteria included:
individuals  with  other  movement  disorders  (e.g.,  Essential  Tremor,  Huntington’s,  Dystonia,  etc.),  
and individuals who were unable to speak and understand English.
Power analyses are necessary to determine the required sample size for a study, given
certain parameters about the study design, including desired effect size. In multiple regression
analyses,  Cohen’s  ƒ2 is used as an effect size measure, which essentially equals the unique
variance explained by the interaction term in moderation divided by the sum of the error and
interaction variables (Cohen, 1988). The effect sizes of 0.02, 0.15, and 0.35 indicate small,
medium, and large effects, respectively. In the present study, an a priori power analysis was used
to calculate the minimum sample size required in order to detect a medium effect size and 80%
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power (α  =  .05,  1  - β  = .80). These parameters were based on Cohen’s  (1992) recommendations
that studies should have an 80% probability of detecting an effect when one exists, with no more
than 20% probability of making a Type II error (β   = .20). It is difficult to estimate the expected
effect size for the proposed study, given that the only study examining resilience and PD
conducted only correlations and did not involve regression analyses. In other PD studies that
have predicted mental health outcomes based on disease-specific variables (e.g., disease
progression, motor impairment), effect sizes in ranged from medium (Kuopio et al., 2000) to
large (Oguru et al., 2010). After establishing the desired medium effect size, significance level (p
< .05), and power (80%), the necessary sample size was 131 participants. This sample size was
based upon the maximum number of predictors and control variables in any of the statistical
analyses (13 potential predictors in most comprehensive model). The study sought to recruit 150
participants to account for potential attrition during survey completion.
Procedure
Participant recruitment occurred between April 2013 and October 2013. The study was
advertised as a web-based survey, with paper copies made available upon request. Patients who
chose to complete the survey electronically signed an online waiver of documentation of consent
to approve using an online web-based survey as the primary data collection tool. They read a
statement that outlined the purpose of the study, the risks involved, reminded them that their
participation was voluntary, and granted them permission to end the study at anytime.
Participants also read a statement describing the use of protected health information (PHI) in this
study, including the type of information collected, the restriction of access to this data to all but
necessary study personnel, reasons why this information represented the minimum necessary to
complete the study, and the security precautions in place to protect PHI. Participants either
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signed (paper questionnaire) or checked a box (electronic questionnaire) indicating that they
agreed with these statements before completing the questionnaire. Patients entered their data into
an electronic project database, which was protected with a complex password and stored on a
secure network behind a VCU firewall (RedCap). The electronic project database and scanned
files were secured to be kept indefinitely. If participants requested a paper copy of the survey to
complete, the completed physical copies of the data were kept in a locked office and locked file
cabinet. The physical copies were destroyed once the data was scanned and entered into the
online survey database.
The majority of the participants learned about this study electronically and completed the
web-based survey in their homes. If requested, paper copies were mailed for participants to
complete in the privacy of their homes. The primary researcher on the study facilitated sending
the paper survey, a consent form, and a stamped and addressed return envelope to the requesting
individual. If individuals wished to complete the survey at the PMDC, they were provided a
computer in a private room. There was no compensation for participation in this study. The
survey required 45-60 minutes to complete.
Measures
The survey contained ten questionnaires intended to comprehensively assess the
hypothesized PD, resilience, and psychologically-related variables. Furthermore, several
spirituality-related items from the CD-RISC (Connor & Davidson, 2003) and an illness
uncertainty item (Rybarczyk et al., 2007) were included to analyze possible additional effects
from these variables. The CD-RISC items were summed and averaged to create a spirituality
composite score. Basic demographic information was also gathered for all patients, including
age, sex, race, marital status, income level, education level, depression history, duration of time
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since symptoms begin, and duration of time since diagnosis. The instruments are described
below and listed in the Appendix.
The Resilience Scale for Adults (RSA; Friborg et al., 2003; Friborg et al., 2005). The
33-item RSA measures the protective resources that promote resilience in adults. The RSA has
six factors: perception of self, perception of future, social competence, structured style, family
coherence, and social resources. Two separate reviews of resilience scales rated the RSA as one
of the highest quality scales (Ahern, Kiehl, Sole, & Byers, 2006; Windle et al., 2011). As
previously mentioned, the RSA has good conceptual support as a tool to measure resilience,
because the six factors of the scale correspond closely to the three main categories of resilience
outlined by early resilience researchers: dispositional attributes, family cohesion and support,
and external support systems (Garmezy et al., 1984; Werner, 1993). This scale has also received
some support for use in a medical population (White, Driver, & Warren, 2008).
The RSA has been modified into several versions with differing item numbers and itemresponse styles (e.g., 37- and 33- item RSA with five point semantic-differential scale format).
Despite some decreases in reliability with using the semantic-differential scale format, research
demonstrated that the semantic version had better model fit and unidimensionality (Friborg,
Martinussen, & Rosenvinge, 2006). The current version of the RSA involves rating items on a 5point semantic differential scale. Each item contains a stem with two responses at either end of
the  scale  (e.g.,  “In difficult periods I have a tendency to: view everything gloomy–find
something good that helps me strive”).  The  participant  marks  one  of  the  five boxes indicating
how he or she has felt overall for the past month.
The RSA has adequate psychometric properties, as demonstrated in numerous studies
(Friborg et al., 2003; Friborg et al., 2005; Hjemdal, 2007). Hjemdal (2007) reported that in the
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initial scale development, the RSA had good internal consistency reliability (α = .93), and
satisfactory alpha scores have been found in other validation studies (α = .76 to .87) (Friborg et
al., 2005). The RSA also has adequate test-retest correlations (4 months), ranging from r = .69
to .84 in an adult outpatient sample (Friborg et al., 2003). The six-factor structure has been
demonstrated in several studies using exploratory and confirmatory factor analyses (Friborg,
Hjemdal, Martinussen, & Rosenvinge, 2009, Hjemdal, Friborg, Stiles, Rosenvinge, &
Martinussen, 2006). The RSA has good predictive validity as well; one study found that RSA
scores could predict psychiatric symptoms after exposure to a stressful life event, suggesting that
resilience may buffer or protect against negative outcomes (Hjemdal et al., 2006).
The RSA also has adequate convergent and discriminant validity. It correlated positively
with the Sense of Coherence Scale (SOC; Antonovsky, 1993) (subscale correlations ranged from
r = .29 to .75, p < .001) and negatively with the Hopkins Symptom Checklist-25 (HSCL; Rickels,
Lipman, Garcia & Fisher, 1972) (subscale correlations ranged from r = -.19 to -.61, p < .001)
(Friborg et al., 2003). Another study using a previous five-subscale version of the RSA (Friborg
et al., 2005) established convergent and discriminant validity by using the Big Five personality
factors (McCrae & Costa, 1997). Perception of self and perception of future correlated strongly
with emotional stability (r = .79 and .57, respectively), social competence was correlated with
extroversion (r = .58) and agreeableness (r = .59), and structured style was correlated with
conscientiousness (r = .83). Although the factors were inter-correlated (ranging from r = .31
to .57), there were clear patterns of stronger and weaker correlations between the RSA factors
and Big Five personality factors. Resilience scores were also positively correlated with scores on
social intelligence measures and not significantly related to cognitive intelligence, which
demonstrates additional convergent and discriminant validity.
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Another unique element of the RSA is that it provides some clarity regarding a debated
topic in resilience research: Is resilience more than simply the absence of pathology (Sroufe,
1997), and if so, do resilience measures assess beyond the latent continuum of vulnerability and
psychopathology (Friborg et al., 2009)? If researchers cannot psychometrically differentiate
between resilience as the absence of pathology and resilience as fostering psychological growth
(Carver, 1998), they risk interpreting scores on resilience and vulnerability measures as positive
and negative characteristics of mental health within the same underlying dimension. A recent
study by Friborg and colleagues (2009) investigated this question by performing a second-order
factor analysis on the primary factor scores from subscales of resilience and
psychopathology/vulnerability. Two second-order factors emerged, with the majority of the RSA
subscale factors loading onto a different factor than psychopathology/vulnerability. They also
examined interactions between the RSA and psychopathology/vulnerability in hierarchical
regression analyses and determined that the RSA contributed uniquely to the model. Thus, the
RSA seems to measure the resilience construct as conceptually different than the
operationalization of vulnerability and psychopathology. This distinction represents an important
step forward in resilience research by providing a measure that  adequately  reflects  the  literature’s  
understanding of the construct as involving recovery, sustainability, and growth (Zautra,
Arewakisporn, & Davis, 2010).
Sense of Coherence Scale (SOC-13; Antonovsky, 1993). The SOC-13 is a 13-item
scale  that  measures  one’s  global  orientation  towards  feeling  confident  that  one’s  environment  is  
predictable and that things will work out as can be reasonably expected (Antonovsky, 1993).
The SOC-13 is composed of three factors: comprehensibility, or the belief that the stimuli
deriving  from  one’s internal and external environments in the course of living are structured,
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predictable, and explicable; manageability, or the belief that resources are available for one to
meet the demands posed by these stimuli; and meaningfulness, the belief that these demands are
challenges, worthy of investment and engagement in an effort to make meaning (Antonovsky,
1993). Research demonstrates that the two factors of comprehensibility and manageability are
highly correlated with the SOC total (r = .98 to 1.00), while the meaningfulness factor is
significantly but slightly less correlated (r = .82) (Feldt et al., 2007). Items are rated on a 7-point
semantic differential  scale  with  two  opposite  anchoring  phrases  (e.g.,  “How  often  do  you  have  
the  feeling  that  there’s  little  meaning  in  the  things  you  do  in  your  daily  life?”  1  =  never,  7  =  
always). Five of the items are negatively worded to avoid acquiescent response bias.
The SOC-13 has adequate psychometric properties. In a review of 127 studies that have
used the SOC-13, the scale had acceptable internal consistency reliability (α = .70 to .92) and
temporal stability (α = .78 to .54 between 1 and 10 years). Construct validity has been
established through studies using factor analyses, and although there is some evidence for a onefactor or five-factor scale structure (Eriksson & Lindstrom, 2005), the three-factor solution is
generally best supported in the literature (Feldt et al., 2007). The SOC-13 also has good criterion
and predictive validity. Eriksson  and  Lindstrom’s  (2005)  review  summarizes  numerous  studies  
that show positive correlations between the SOC-13 and optimism, self-esteem, and general
health, as well as negative correlations between the scale and depression and anxiety.
Additionally, several studies have demonstrated that scores on the SOC-13 can predict patient
outcomes after orthopedic and bariatric surgeries (Ray, Nickels, Sayeed, & Sax, 2003; Rister,
Andersson, Johansson, Johansson, & Ponzer, 2000).
Tenacious Goal Pursuit/Flexible Goal Adjustment scales (TENFLEX;
Brandtstädter, & Renner, 1990). The TENFLEX is a 30-item scale intended to measure
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peoples’ assimilative and accommodative tendencies on a dispositional level. These two
complementary types of coping involve: a) transforming circumstances in accordance with
personal preference (assimilation), and b) adjusting personal preferences to situational
constraints (accommodation) (Brandtstädter, & Renner, 1990). According to the scale
developers’  theoretical  formulations,  assimilative  coping  strategies  correspond  to  tenacious  goal  
pursuit tendencies, while accommodative coping strategies correspond to flexible goal
adjustment. Items are rated on a 5-point Likert scale, and participants rate the degree to which
they  agree  with  each  statement  (e.g.,  “To  avoid  disappointments,  I  usually  don’t  set  my  goals  too  
high”,    -2 = strongly disagree, 2 = strongly agree). There are 13 reverse items in the scale to
avoid acquiescent response bias. The 30 items are split into two 15-item scales: Tenacious Goal
Pursuit and Flexible Goal Adjustment.
Initial validation studies demonstrated that the TENFLEX has adequate internal
consistency reliability for the flexibility scale (α = .83, item-total correlations ranged from r = .35
to .60) and the tenacity scale (α = .80, item total correlations ranged from r = .30 to .59)
(Brandtstädter, & Renner, 1990). Flexible goal adjustment and tenacious goal pursuit also had
very low variance overlap (r = .06), indicating that they reflect distinct constructs. Both scales
had good convergent and discriminant validity. Flexible goal adjustment and tenacious goal
pursuit were significantly negatively correlated with depression (r = -.41 and -.17) and
significantly positively correlated with life satisfaction (r = .36 and .26) and optimism (r = .53
and .28). There is also evidence of an age-related change in coping tendencies, such that there is
a transition from assimilative to accomodative tendencies with increasing age (Brandtstädter, &
Renner, 1990). A cross-sectional study of 890 adults divided into five cohorts (30 to 60 years
old) demonstrated a significant main effect of age cohort, with tenacious goal pursuit scores
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decreasing (F(4, 865) = 2.92, p < .05) and flexible goal adjustment scores increasing (F(4, 862) =
6.09, p < .01) with age. These findings are consistent with the previously reviewed research
suggesting that goal-flexibility is an important age-related shift in coping mechanisms that can
reflect a unique component of resilience among older adults.
Nonmotor Symptoms Questionnaire (NMSQuest; Chaudhuri et al., 2006). The
NMSQuest is a 30-item questionnaire targeting 10 different domains of PD-specific nonmotor
symptoms. The domains are: gastrointestinal tract, urinary tract, sexual function, cardiovascular,
apathy/attention/memory, hallucinations/delusions, depression/anxiety/anhedonia, sleep/fatigue,
pain,  and  miscellaneous  (e.g.,  weight  loss).  Respondents  are  instructed  to  respond  “yes”  or  “no”  
as to whether they have experienced each symptom within the past month.
The NMSQuest has received good empirical support in the literature as one of the first
formal assessments of NMS in PD (Martinez-Martin et al., 2007). It has adequate specificity and
sensitivity, with recent study demonstrating 71.8% sensitivity for clinically significant non-motor
problems (i.e., those serious enough to warrant treatment) and 88.5% specificity across items
(Romenets et al., 2011). The NMSQuest can distinguish between PD patients and a control group
based on median total NMS scores (PD patient median NMS score = 9 (interquartile rank, 5-13),
control group median NMS score = 4 (interquartile rank, 2-8); Mann-Whitney test, p < .0001)
(Chaudhuri et al., 2006). NMSQuest scores also correspond to other expected disease indicators.
For example, higher NMSQuest scores were significantly correlated with H/Y stage (r = .31, p =
.0006), though scores were unrelated to age, gender, or PD subtype. Lastly, the NMSQuest has
good face and content validity, with 75% of patients and 80% of caregivers reporting that the
items in the NMSQuest would improve their physician’s  ability  to  treat  their  PD  (Chaudhuri  et  
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al., 2006). Over 90% of patients and caregivers reporting the issues were relevant for their dayto-day lives.
The Functional Independence Measure-Self-Report (FIM-SR; Keith, Granger,
Hamilton, & Sherwin, 1987). The FIM assesses physical and cognitive disability, as well as the
associated burden of care. The original FIM was developed for administration by an independent
rater, typically a physician, nurse, or therapist, however it has been validated for use as a selfreport version as well (Grey & Kennedy, 1993). The 18-item scale contains six subscales: selfcare (e.g., feeding, grooming), sphincter control (e.g., bladder and bowel movement), mobility
(e.g., transferring in and out of bed), locomotion (e.g., walking), communication (e.g.,
comprehension, expression), and social cognition (e.g., social interactions, memory). For each
item, respondents can rate their level of independence on a 7-point Likert scale (1 = total
assistance needed, 7 = totally independent).
The FIM-SR has not yet been studied with PD patients specifically, although it has been
used extensively in rehabilitation medicine and is considered one of the highest quality disability
assessment tools (Furlan, Noonan, Singh, & Fehlings, 2011). It has been validated for use with
similar patient populations to PD, for example patients with neuromuscular disease and chronic
pain (Jensen, Abresch, & Carter, 2005). Another validation study used a sample of spinal cord
injury (n = 84) and amputation (n = 38) patients, finding that internal consistency reliability of
the FIM-SR total score was adequate both pre- and post-treatment (α = .95 and .94 for spinal
cord injury patients; α = .57 and .87 for amputation patients) (Masedo, Hanley, Ehde, &
Cardenas, 2005). The test-retest coefficients of scores at pre- and post-treatment were adequate
for the spinal cord injury patients (r = .89, p < .005) but comparatively low for the amputation
patients (r = .47, p < .005), which the researchers suggest may have been due to restricted range
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of scores and ceiling effects. In a study with neuromuscular disease and chronic pain patients (n
= 141), the FIM-SR demonstrated good convergent validity with significant correlations between
the Short Form Health Survey (SF-36) physical functioning scale and the FIM-SR self-care (r =
.38), mobility (r = .41), locomotion (r = .49), and motor scales (r = .42) (Jensen et al., 2005).
Additionally, the SF-36 social functioning scale was significantly correlated with the FIM-SR
communication (r = .30) and social cognition scales (r = .25).
Starkstein Apathy Scale (SAS; Starkstein et al., 1992). The SAS is a 14-item scale
that  measures  an  individual’s  degree  of  apathy,  specifically  targeting  the  diminished  motivation,  
behavioral, cognitive, emotional, and insight aspects of apathy. The items are phrased as
questions to be answered on a 4-point  Likert  scale  (e.g.,  “Are  you  indifferent  to  things?”  0  =  not  
at all, 3 = a lot), with several items worded in the positive direction and reverse scored  (e.g.,  “Do  
you  have  plans  and  goals  for  the  future?”  0  =  a  lot,  3  =  not  at  all).  Responses  are  summed  for  a  
total score. In a recent review of apathy rating scales, the Movement Disorder task force reported
that the SAS was the most appropriate psychometric tool for assessing apathy in PD patients
(Leentjens et al., 2008).
The SAS has acceptable psychometric properties with PD patients. In the original scale
validation study with PD patients, the SAS had adequate internal consistency reliability (α = .76),
inter-rater reliability by two independent raters (r = .81, p < .01), one-week test-retest reliability
(r = .90, p < .01), and 66% sensitivity and 100% specificity using a cut-off score compared with
neurologist ratings (Starkstein et al., 1992). In a more recent study with 212 PD patients, the SAS
had acceptable internal consistency reliability (α = .69), and most items had good item-total
correlations (r > .30, p < .0005) (Pedersen et al., 2012). Although one item had a negative and
nonsignificant correlation  with  the  total  score  (“Are  you  concerned  about  your  condition?”),  
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there has not yet been enough psychometric research to warrant a modified 13-item SAS. The
SAS has a two-factor structure, with Factor 1 representing cognitive-behavioral aspects of apathy
(α = .74) and Factor 2 representing general apathy including aspects of insight (α = .52). Lastly,
the SAS has adequate discriminant validity with other psychological and PD-specific scales. In
the Pedersen and colleagues (2012) psychometric study, the total SAS score had weak to
moderate correlations with the Mini Mental State Exam (r = -.17, p < .05) and the Unified
Parkinson’s  Disease  Rating  Scale  motor  subscale  (r  =  .21, p < .005). It also had a significant but
relatively weak correlation with the Montgomery-Aasberg Depression Rating scale (r = .25, p
< .005), which is consistent with previous research emphasizing the conceptual and clinical
differences between depression and apathy.
Parkinson’s  Disease  Questionnaire  (PDQ-39; Peto, Jenkinson, & Fitzpatrick, 1998).
The PDQ-39 is a 39-item QOL measure for PD. The scale has eight discrete QOL domains:
mobility, activities of daily living, emotional well-being, stigma, social support, cognitions,
communication, and bodily discomfort (Jenkinson, Fitzpatrick, Peto, Harris, & Saunders, 2008).
Respondents rate each item reflecting the degree of task difficulty he or she experienced within
the  past  month  due  to  their  PD  (e.g.,  “Due  to  having  Parkinson’s  disease,  how  often  during  the  
last month have you avoided situations which involve eating or drinking in public?”).  Item  
responses are on a 5-point scale (0 = never, 1 = occasionally, 2 = sometimes, 3 = often, 4 =
always (or cannot do at all, if applicable). Scores for each dimension are summed and then
transformed to a scale from 0 to 100 in order to ease comparisons across domains (0 = no
problem at all, 100 = maximum level of problem).
The PDQ-39 has adequate psychometric support through numerous validation studies
(see Jenkinson et al., 2008 for a review). In a study surveying with PD patients, internal
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consistency reliability was adequate across all domains at Time 1 (n = 227; α = .66 to .95), and it
remained adequate at a six-month Time 2 follow-up (n = 223; α = .73 to .95). Respondents at
Time 2 were also requested to complete a second copy of the PDQ-39 within three to six days
after completing the first survey. Of those that completed this second questionnaire within three
to six days (n = 167), test-retest reliability was acceptable (r = .68 to .94, p < .001). Construct
validity was also supported with many of the scale domains correlating with relevant scales from
the SF-36: Social Support (PDQ-39) correlated with Social Function (SF-36) (r = -0.34, p
<.001); Mobility (PDQ-39) correlated with Physical Function (SF-36) (r = -0.80, p <.001);
Activities of Daily Living (PDQ-39) correlated with Role Limitations due to physical problems
(SF-36) (r = -0.36, p<.001); Emotional Well-being (PDQ-39) correlated with Mental Health
(SF-36) (r=-0.71, p <.001); Bodily Discomfort (PDQ-39) correlated with Pain (SF-36) (r=-0.66,
p <.001). Correlation coefficients were negative due to the different directions in which the
PDQ-39 and SF-36 scales are scored.
The Life Orientation Test-Revised (LOT-R; Scheier, Carver, & Bridges, 1994). The
LOT-R is a 10-item  scale  that  was  developed  to  measure  an  individual’s  degree  of  dispositional  
optimism. There has been some disagreement among researchers whether the LOT-R has one or
two dimensions (optimism alone versus optimism and pessimism) (Herzberg, Glaesmer, &
Hoyer, 2006). The original validation study of the LOT-R suggested that the scale should be
treated as unidimensional (Scheier et al., 1994), however recent investigations have lent support
to a bidimensional factor structure with optimism and pessimism as separate subscales (Glaesmer
et al., 2012; Herzberg et al., 2006; Kubzansky, Kubzansky, & Maselko, 2004). There is also
evidence that age may moderate the relationship between the two factors, such that optimism and
pessimism become more independent of each other with increasing age (Herzberg et al., 2006).
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The LOT-R  consists  of  three  items  that  assess  optimism  (e.g.,  “In  uncertain  times,  I  usually  
expect  the  best”),  three  items  that  assess  pessimism  (e.g.,  “I  rarely  count  on  good  things  
happening  to  me”),  and  four  filler  items  (“e.g.,  “It’s  easy  for  me  to  relax”).  Respondents  indicate  
the degree to which they agree with each item on a 5-point Likert scale (1 = strongly disagree, 5
= strong agree). The scores of the optimism and pessimism items are separately summed to
generate two subscale scores.
The LOT-R has adequate psychometric properties. In the original validation study,
psychometric analyses were conducted with the six main scale items, but the four filler items
were removed from analyses (Scheier et al., 1994). Item-scale correlations ranged from .43 to
.63, which suggested that items were partially measuring the underlying construct but were not
redundant with other items. The LOT-R also demonstrated adequate internal consistency
reliability for the six items (α = .78) and generally good test-retest reliability over 4 months (r
= .68), 12 months (r = .60), 24 months (r = .56), and 28 months (r = .79). In a more recent
psychometric evaluation, the LOT-R had good internal consistency reliability for both the
optimism (α = .70) and pessimism (α = .74) subscales, while the correlations between the two
subscales was low (r = -.20, p < .001) (Glaesmer et al., 2012). Convergent and divergent validity
were established between the LOT-R and other psychological scales. The optimism subscale was
positively correlated with life satisfaction (General Life Satisfaction Module; Henrich &
Herschbach, 2000) (r = .44, p < .001) and self-reported state of health using a visual analog scale
(r = .33, p < .001), and it was negatively correlated with anxiety (r = -.22, p < .001) and
depression (r = -.31, p < .001) (Patient Health Questionnaire; Loewe et al., 2004). The pessimism
subscale was positively correlated with anxiety (r = 0.19, p < .001) and depression (r = .13, p
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< .001), and negatively correlated with life satisfaction (r = -.28, p < .001) and self-reported
health (r = -.18, p < .001).
Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996). The BDI-II is a
commonly used screening instrument for depression. The self-report measure includes 21 items
rated on a 4-point Likert scale ranging from 0 to 3. Respondents are instructed to choose
statements characterizing how they have felt over the past two weeks. Item responses are
summed for a total score and classified within a severity range (0 – 13 = minimal depression, 14
– 19 = mild depression, 20 – 28 = moderate depression, 29 – 63 = severe depression) (Beck et
al., 1996). The BDI-II has been used in a variety of PD research (e.g., Ehman et al., 1990; Levin
et al., 1988; Schrag et al., 2000), is considered a valid screening tool for depression in a PD
population (Williams et al., 2012), and has been validated specifically for use with older adults
(Segal, Coolidge,  Cahill,  &  O’Riley, 2008; Steer, Rissmiller, & Beck, 2000). The BDI-II is also
the preferred depression measure at the VCU PMDC versus other measures that might be
appropriate for an older disease population (e.g., the Geriatric Depression Scale) due to the wider
PD population age range and for the purposes of future comparison data within the PMDC.
In a study of psychometric properties of the BDI-II with community-dwelling adults (n =
376), the scale had adequate internal consistency reliability (α = .90) and item-total correlations
(r = .25 - .64) (Segal et al., 2008). When the sample was divided into older adults (n = 157; M
age = 70.3 years; age range 55-90 years) and younger adults (n = 229; M age = 19.6 years; age
range 17-29 years), internal consistency reliability remained acceptable for the two samples (α
= .86 and .92, respectively). Among older adults, the BDI-II correlated significantly and
positively correlated with the Center for Epidemiological Studies Depression Scale (CES-D;
Radloff, 1977) (r = .69, p < .001) and the depression subscale of Coolidge Axis II Inventory
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(CATI; Coolidge & Merwin, 1992) (r = .66, p < .001), which supported convergent validity.
Regarding discriminant validity, the BDI-II scores for the older adults were significantly and
negatively correlated with Short Psychological Well-Being Scale total score (SPWB; Ryff, 1989)
(r = - .60, p < .001) and six SPWB subscales (r = -.31 to -.64, p < .001). Construct validity was
established using a Principal Components Analysis, with a one-component solution accounting
for 30% of the variance and all 21 items loading above a set criterion of .40.
Satisfaction with Life Scale (SWLS; Diener, Emmons, Larsen, & Griffith, 1985). The
SWLS  is  a  brief  instrument  used  to  assess  an  individual’s  life  satisfaction.  The  self-report
measure includes 5 items rated on a 7-point Likert scale. Individuals rate from 1 to 7 the degree
to which they agree or disagree with a given statement. Scores are summed and can range from 5
to 35, with higher scores indicating greater life satisfaction.
The SWLS has adequate psychometric properties. In the initial validation study, the
scale had acceptable two-month test-retest correlation (r = .82) and internal consistency
reliability (α = .87) (Diener et al., 1985). The SWLS also had convergent and discriminant
validity, positively correlating with the well-being subscale of the Differential Personality
Questionnaire (r = .68) and the positive affect subscale of the Affect Balance Scale (r = .50),
and negatively correlating with the negative affect subscale of the Affect Balance Scale (r = .37). It also did not correlate significantly with the Marlowe-Crowne social desirability scale,
demonstrating discriminant validity. The SWLS is recommended as a compliment to emotional
well-being  scales  because  it  assesses  an  individual’s  judgments  of  his  or  her  own  life  according  
to his or her criteria (Pavot & Diener, 1993).
Statistical analyses
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Statistical analyses were completed using SPSS Statistics 22 software. Statistical
assumptions within the data set were checked, including missing data, required sample size,
outliers, and univariate and multivariate normality. Regarding survey attrition rates and data
cleaning, a total of 224 surveys were initiated during the April 2013 and October 2013 data
collection period. Of these, 62.5% (n = 140) met criteria for use in the final data set. The
remaining 37.5% (n = 84) were unable to be used for two main reasons: 1) initiated but
incomplete survey with more than half of the data missing (n = 71), and 2) duplicates completed
by  same  participant  more  than  once  (n  =  13;;  in  these  instances,  the  earlier  version  of  participant’s  
completed data was used to avoid response bias). There was 1 completed survey that was
ultimately  eliminated  from  the  data  set  because  the  participant’s  responses  were  outliers  in  
several normality tests. This resulted with a final sample size of 139. Of the surveys that were
eliminated and not used in the data set, the large majority of surveys initiated did not even have
basic demographic data complete (i.e., survey was initiated but ended before any responses were
entered). Only 15 participants initiated surveys and completed some demographic information,
therefore these participants were compared to the final usable sample as seen in the table below.
The participants that had incomplete surveys and were not included in the final sample were not
significantly different in terms of demographic data compared to those who completed the entire
survey.
Throughout the data collection process, any participants who submitted online or paper
surveys with missing items were contacted via phone, and missing item responses were
completed over the phone. Only three participants were unable to be reached because their phone
number was no longer working, however these participants had minimal missing data (one
participant had five missing items, one participant had four missing items, one participant had
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one missing item). Missing data were analyzed using  Little’s  (1998)  MCAR  test; nonsignificant
results indicated that the missing items were missing at random across all scale items, with 0.7%
as the maximum percentage of missing data for any item (χ2(182) = 11.63, p = 1.0). Missing
values were replaced using the Expectation-Maximization (EM) method, which is a
recommended method for missing data within a multivariate model because it produces a nearly
unbiased estimate of means and variances (Schafer & Olsen, 1998). The procedure involves
SPSS and first estimates the parameters, then estimates the missing values, then fills in the data
set to re-estimate the parameters, then uses the re-estimated parameters to estimate missing
values, and so on until the process converges on stable estimates.
Univariate normality and outliers were checked for all variables of interest by using
skewness and kurtosis cut-off values of +/- 1 and by analyzing converted z-score values to
identify outliers. One participant was eliminated from the dataset based on scores on multiple
measures that were outliers, as well as a self-reported comorbid diagnosis of schizophrenia.
Other univariate outlier scores were windsorized to achieve normality, or assigning a raw score
to the non-normal variable that is one unit larger (or smaller) than the next most extreme score in
the distribution (Tabachnick & Fidell, 2001). The functional impairment measure was highly
negatively skewed and kurtotic, with most participants reported relatively high functioning. After
a reverse score transformation, which is indicated in negatively skewed data (Field, 2009), and a
log transformation, the functional impairment variable achieved normal distribution with no
outliers. As a result, although the functional impairment measure typically has higher scores
indicating better functioning, the reverse score transformation changes the interpretation of
results such that higher scores indicate poorer outcomes.
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Throughout multiple regression analyses, all assumptions were met as well, including
multivariate normality, linearity, homoscedasticity, and multicollinearity as analyzed through
residual plots, Mahalanobis distance analyses, and tolerance and VIF scores (cut-offs of greater
than 0.1 or less than 10, respectively, indicating no multicollinearity). During preliminary
analyses and multiple regression analyses, there were several multivariate outliers (determined
by Mahalanobis distance). Though these cases were statistical outliers, they appeared to be
outliers only based on their demographic characteristics; the outliers were either ethnic
minorities  or  they  had  unusual  early  onset  PD  (diagnosed  during  their  30’s).  When  these  cases  
were eliminated from analyses, there were no multivariate outliers based on IV and DV scores of
interest, confirming that these cases were outliers based solely on demographic characteristics.
Therefore, these cases were included in analyses in order to maximize degrees of freedom and
statistical power. Lastly, bivariate Pearson correlations among the target variables, with all cases
included within the study, indicated that no two variables correlated above .76 (see Table 2).
All scales were administered in their entirety in the initial administration of the
assessment in order to retain psychometric properties (Kazdin, 2010b), however potential subject
fatigue was assessed to determine whether the survey should be shortened to only include
subscales that reflect variables of interest. If participants did not complete the survey in its
entirety, the most common pattern was for participants to cease completion during the
demographic section or during the first questionnaire; the vast majority of participants completed
the entire survey. Therefore, the decision was made to keep all scales and subscales in the survey
because the length did not seem to be a barrier to survey completion. As previously mentioned,
although all scales were completed, the Meaningfulness subscale (meaning-making ability, SOC-
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13), Flexible Goal Adjustment subscale (goal-flexibility, TENFLEX), and optimism subscale
(positivity, LOT-R) scores were separated from the parent scale scores and included in analyses.
Additionally, the NMSQuest was administered in its entirety for the purposes of
gathering comprehensive useful data for the VCU PMDC, however the items that targeted
neuropsychiatric symptoms (i.e., apathy/attention/memory, hallucinations/delusions,
depression/anxiety/anhedonia) were excluded from analyses, given that these symptoms
correlated strongly with the mental health outcome variables. Furthermore, the PDQ-39 was
administered in its entirety but assessed using different subscales in the analyses. The subscales
that reflected disease symptoms (mobility, activities of daily living, and bodily discomfort) were
summed and averaged to create a composite variable termed disease symptom-related QOL. The
subscales that reflect disease adjustment (emotional well-being, stigma, social support,
cognitions, communication) were summed and averaged to create a composite variable termed
adjustment-related QOL. Lastly, in each regression equation, the following control variables
were entered: age, sex, ethnicity, years of education, income level, and disease duration (as
measured by years since diagnosis).
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Table 2.
Bivariate correlations of outcome variables
1

2

3

4

5

6

7

8

9

10

11

__

__

__

__

__

__

__

__

__

__

__

2 Apathy1

.64**

__

__

__

__

__

__

__

__

__

__

3 Life satisfaction

-.53**

-.36**

__

__

__

__

__

__

__

__

__

4 Adjustment-related
quality of life1
5 Nonmotor
symptoms1,2
6 Disease symptomrelated quality of life 1
7 Functional
impairment1

.76**

.50**

-.57**

__

__

__

__

__

__

__

__

.32**

.22*

-.15

.41**

__

__

__

__

__

__

__

.51**

.33**

-.34**

.68**

.51**

__

__

__

__

__

__

.35**

.37**

-.36**

.57**

.39**

.63**

__

__

__

__

__

8 Resilience

-.63**

-.57**

.66**

-.62**

-.18*

-.30**

-.31**

__

__

__

__

9 Meaning-making
ability

-.62**

-.58**

.50**

-.53**

-.18*

-.33**

-.26**

.71**

__

__

__

10 Goal-flexibility

-.49**

-.33**

.45**

-.49**

-.24**

-.29**

-.29**

.55**

.50**

__

__

11 Optimism

-.51**

-.41**

.52**

-.53**

-.09

-.27**

-.27**

.63**

.56**

.48**

__

1 Depression1

1

Higher scores indicate poorer outcomes.
Seven items from this scale were excluded from analyses and total score calculation due to conceptual similarities to mental
health/QOL outcome variables (i.e., nonmotor neuropsychiatric symptoms).
* p< .05
**p<.001
2
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Results
Demographic and Clinical Characteristics
The demographic characteristics of the 139 participants are listed in Table 3. The
participants in the study were in their mid-sixties (M = 64.25, SD = 10.12, age range 34-89
years), slight majority female (54%) and retired (54.4%), mostly Caucasian (95%), and welleducated  (65.9%  had  Bachelor’s  degree  or  higher).    Participants  reported  first  noticing  PD  
symptoms an average of 3.28 years ago (SD = .99, range 1-5 years ago), received a PD diagnosis
6.39 years ago (SD = 5.02, range 1-32 years), with 44.9% reporting their disease progression as
stable. A majority of participants reported no comorbid diagnoses other than PD (58.3%). For the
few participants that did not report their PD diagnosis year, their reported number of years since
they first noticed symptoms was substituted instead in analyses.
The mean score for the BDI-II was 12.1 (SD = 7.79), with 35% reporting clinically
significant levels of depression (score ≥  14). Based on the BDI-II  manual’s  score  interpretation  
guidelines (Beck et al., 1996), 18.7% of study participants had mild depression, 12.9% had
moderate depression, and 3.5% had severe depression. This depression frequency is greater than
another sample of non-demented PD patients (Kirsch-Darrow, Marsiske, Okun, Bauer, &
Bowers, 2011) in which one quarter of the sample had clinically significant depressive
symptoms. The mean score for the SAS was 12.22 (SD = 6.18), with 46% of study participants
scoring above the clinical cut-off for apathy (Starkstein et al., 1992). This apathy frequency is
higher than the Kirsch-Darrow and colleagues (2011) PD sample, in which 33.5% of participants
had clinically significant levels of apathy (score > 14).  The  present  study’s  average  apathy  score  
is lower, however, compared to another sample of early untreated PD patients (M = 15.5, SD =
4.6) (Pedersen et al., 2012). Additional analyses compared mental health prevalence rates to
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other studies that looked at concomitant apathy and depression (e.g., Benito-Leon, Cubo, &
Coronell, 2012). In the present study, 17.3% had clinically significant apathy alone (n = 24),
6.5% had clinically significant depression alone (n = 9), 28.8% had comorbid apathy and
depression (n = 40), and 47.5% had neither depression nor apathy (n = 66). These rates are
similar to those reported in the Benito-Leon et al. study (22% apathy alone, 14% depression
alone, 30% comorbid apathy and depression).
Regarding life satisfaction, the mean score for study participants was 23.46 (SD = 7.06),
which is within the average life satisfaction score range (Diener et al., 1985) and similar to life
satisfaction reported in other PD samples (Lucas-Carrasco, Den Oudsten, Eser, & Power, 2014).
As previously mentioned, the average scores for adjustment-related quality of life and disease
symptom-related  quality  of  life  represent  composite  scores  from  combinations  of  the  Parkinson’s  
Disease Questionnaire-39 subscales (Jenkinson et al., 2008). While these composite scores are
meaningful within the context of this project for the purposes of differentiating between
adjustment-related QOL (emotional well-being, stigma, social support, cognitions,
communication) and disease symptom-related QOL (mobility, activities of daily living, and
bodily discomfort), there are no other studies to this writer’s  knowledge  that  have  created  these  
composites. Therefore, the PDQ-39 Single Index (SI) score was used to compare to other
normative samples. According to the PDQ-39 manual (Jenkinson et al., 2008), the PDQ-39 SI is
a meaningful alternative to the eight scales of the PDQ-39 and is calculated by summing and
averaging  the  scores  from  the  eight  dimensions.  Participant’s  average  SI  score  in  the  present  
study was 24.83 (SD = 13.54), which is slightly lower than the normative sample scores reported
in the PDQ-39 manual (Jenkinson et al., 2008), indicating slightly better QOL and less negative
impact  of  PD  on  participants’  daily  lives.  
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Participants reported an average of 11.76 nonmotor symptoms (total NMS score) (SD =
4.90; median = 11.5, mode = 15, range 1-23). These NMS scores are similar to those that have
been previously reported with other PD populations (Chaudhuri et al., 2006). Although the
functional impairment (FIM) variable was highly negatively skewed and required transformation
prior to multiple linear  regression  analyses,  participants’  scores  on  the  FIM  were  comparable  to  
other PD studies (Muslimovic et al., 2008). The average score on the FIM was 121.60 (SD =
7.19), with most participants reporting high ADL independence (scale maximum score = 126).
Study  participants’  average  score  on  the  RSA  was  126.99  (SD = 17.45), which is very
similar to a large normative sample of adults (Friborg et al., 2009) and a high-risk group of
young women (Jowkar, Friborg, & Hjemdal, 2010). Of note, while there was a normal
distribution of scores on this scale, the cluster of scores was toward the higher end of the scale.
RSA scores can range from 33 to 165, however the range in the present study was from 75 to
163. Considering the average total score of 126.99 another way, the average response on a given
item was 3.85 (33 items, 5-point scale), with the large majority of participants reporting high
resilience across items. By using the 3 value on the scale as a midpoint, only 6% of participants
reported average resilience scores below the midpoint and 94% rated themselves at or above the
midpoint across items.
Meaning-making ability was assessed using the meaningfulness subscale of the SOC
(Antonovsky, 1993), and the average score was 21.80 (SD = 4.5). Because other studies with
PD patients used the entire SOC scale (comprehensibility, manageability, and meaningfulness
components), the average total SOC score is reported in Table 3 for comparison purposes. Study
participants scored slightly higher on total SOC (M = 67.91, SD = 12.96) compared to other
studies of PD patients (Caap-Ahlgren & Dehlin, 2003) and similar to a study of community-
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dwelling older adults (Gurina, Frolova, & Degryse, 2011). Goal-flexibility was measured using
the flexible goal adjustment subscale (FGA) of the TENFLEX (Brandtstädter & Renner, 1990).
The mean score on the FGA was 37.41 (SD = 6.98), which is comparable to other FGA scores
reported in samples of spinal cord injury patients (van Lankveld, van Diemen, & van Nes, 2011)
and middle-aged and older patients recruited from a community-based rehabilitation agency
(Boerner, 2004). Lastly, optimism was assessed using the LOT-R optimism subscale (Scheier et
al., 1994), with a mean score of 8.59 (SD = 2.68). These scores are similar to average optimism
subscale scores in a large population-based sample (M = 8.5, SD = 2.3) (Glaesmer et al., 2012)
and slightly higher than optimism scores from PD patients at a university-affiliated  Parkinson’s  
Disease and Movement Disorders Center (M = 7.7, SD = 2.5) (Robottom et al., 2012).
Table 3.
Mean Scores on Demographic and Study Variables
Demographic variables
Age
Sex (% Female)
Ethnicity (% Caucasian)
Education  (%  Bachelor’s  degree  or  higher)
Employment (% Retired)
Yearly income ($)
Years since PD diagnosis
Self-reported depression history (% yes)
Study variables
Outcome variables
Depression
Apathy
Life satisfaction
Adjustment-related quality of life
Predictor variables
Nonmotor symptoms1
Disease symptom-related quality of life
Functional impairment2
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M
64.25
54
95
65.9
54.4
70,200
6.39
27.5

SD
10.01
27,502
5.02
-

M
D12.10
12.22
23.46
21.63

SD
7.79
6.18
7.06
13.21

11.76
29.98
121.60

4.90
16.84
7.19

Resilience
Meaning-making ability
Goal-flexibility
Optimism

126.99
21.80
37.41
8.59

17.45
4.49
6.98
2.68

Note. Measures used to assess these variables listed in Method section.
1
The total scores for the Nonmotor Symptoms Questionnaire (NMSQuest) are reported
here, however several items from the scale were excluded in analyses due to conceptual
overlap with mental health/QOL outcome variables (i.e., nonmotor neuropsychiatric
symptoms). The correlation values presented in Table 2 reflect the NMS Total score with
items excluded.
2

The raw scores of the functional impairment measure (FIM-SR) are reported here.
However, as previously noted in the statistical analyses section, the scores were reverse
scored and a log transformation was performed such that the variable achieved normality
and met assumptions for multiple regression analyses. This reverse score transformation
switches the direction of interpretation of functional impairment scores; with the raw
variable, higher scores indicated better functioning, but with the transformed variable,
higher scores indicate poorer functioning.

Regression Analyses
Table 3 presents the means and standard deviations for the variables of interest, and
Tables 4-7 depict the beta weights, incremental changes in R2 with each model, and
corresponding F values for the final models. For each dependent variable, the control variables
and main predictor variables (nonmotor symptoms, functional impairment, and disease
symptom-related quality of life) were entered into multiple linear regression models.
Hierarchical multiple regression analyses were used to test the moderating effects of resilience
and hypothesized age-related resilience variables. One advantage to hierarchical multiple
regression is that variables are entered into the model in theoretically-specified order, which
allows each variable to be evaluated based on its predictive value after earlier-entry variables
account for other variance. This a priori assumption about variable entry order is theory-driven
and appropriate for the present study given the conceptual exploration of late life resilience.
Main outcome variables.
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Depression. The regression model significantly predicted BDI-II scores and explained
32.6% of the variance in depression, F(9,123) = 6.61, p <.001, R2 = .33 (Table 4). Significant
predictors  of  depression  included  age  (β  =  -.17, t(123) = -2.19, p = .031) and disease symptomrelated  QOL  (β  =  .38,  t(123) = 3.55, p = .001). The other hypothesized predictor variables,
nonmotor  symptoms  and  functional  impairment,  were  not  significant  predictors  (β  =  .10,  t(123) =
1.13, p = .259; β  =  .08,  t(123) = 0.82, p = .413, respectively).
Apathy. The regression model significantly predicted Starkstein Apathy Scale scores and
explained 20.9% of the variance in apathy, F(9,123) = 3.62, p <.001, R2 = .21 (Table 5). The
only  significant  predictor  of  apathy  was  functional  impairment  (β  =  .28,  t(123) = 2.58, p = .011).
As functional impairment scores increased (indicating less ADL independence), apathy also
increased. The other hypothesized predictor variables, nonmotor symptoms and disease
symptom-related  QOL,  were  not  significant  predictors  (β  =  .08,  t(123) = 0.84, p = .402; β  =  .10,  
t(123) = 0.86, p = .391, respectively).
Life satisfaction. The regression model significantly predicted Satisfaction With Life
Scale scores and explained 25.7% of the variance in life satisfaction, F(9,123) = 4.73, p <.001,
R2 = .26  (Table  6).The  significant  predictors  of  life  satisfaction  were  income  (β  =  .31,  t(123) =
3.44, p = .001)  and  functional  impairment  (β  =  -.23, t(123) = -2.22, p = .028). As functional
impairment scores increased (indicating less ADL independence), life satisfaction decreased. The
other hypothesized predictor variables, nonmotor symptoms and disease symptom QOL, were
not  significant  predictors  (β  =  .05,  t(123) = .58, p = .566;;  β  =  -.14, t(123) = -1.29, p = .199,
respectively).
Adjustment-related quality of life. The regression model significantly predicted
adjustment-related QOL scores and explained 58.3% of the variance in adjustment-related QOL,
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F(9,123) = 19.12, p <.001, R2 = .58 (Table 7). The significant predictors of adjustment-related
QOL  were  age  (β  =  -.30, t(123) = -4.92, p < .001),  income  (β  =  -.16, t(123) = -2.40, p = .018),
disease symptom-related  QOL  (β  =  .43,  t(123) = 5.12, p < .001),  and  functional  impairment  (β  =  
.27, t(123) = 3.47, p = .001). Poorer disease symptom QOL and lower ADL independence were
associated with worse adjustment-related QOL. The nonmotor symptoms variable was not a
significant  predictor  (β  =  .08,  t(123) = 1.17, p = .245).
Resilience as a moderator. For each of the previous main analyses, the resilience
variable was entered into the models in Block 2 to test Hypothesis 2 whether resilience
moderates the relationship between the significant predictor and outcome variables. Given that
there was a main effect of disease symptom-related QOL on depression, resilience was entered
into the model as a moderator variable. There was a significant main effect of resilience on
depression  (β  =  -.51, t(124) = -7.62, p<.001) such that as resilience increases, depression
decreases. Resilience uniquely accounted for an additional 21.9% of the variance in depression
above and beyond age, income, and disease symptom-related QOL. The interaction term,
however, was not significant, and the effect of disease symptom-related QOL on depression did
not depend on resilience (β  =  .04,  t(123) = .54, p = .592).
Resilience was entered as a moderator variable into the model with functional impairment
predicting  apathy.  There  was  a  significant  main  effect  of  resilience  on  apathy  (β  =  -.48, t(124) = 6.09, p<.001) such that as resilience increases, apathy decreases. Resilience uniquely accounted
for an additional 18.5% of the variance in apathy above and beyond functional impairment. The
interaction term, however, was not significant, and the effect of functional impairment on apathy
did not depend on resilience (β  =  .01,  t(123) = .10, p = .919).
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Resilience  was  also  a  significant  predictor  of  life  satisfaction,  (β  =  .56,  t(124) = 8.05,
p<.001), with higher resilience scores associated with higher life satisfaction. Resilience
uniquely accounted for 25.8% of additional variance in life satisfaction above and beyond
functional impairment. The effect of functional impairment on life satisfaction, however, did not
depend on resilience (β  =  -.01, t(123) = -.18, p = .856).
Lastly, resilience was a significant predictor of adjustment-related  QOL,  (β  =  -.44, t(123)
= -8.47, p <.001) and uniquely accounted for an additional 15.5% of the variance above and
beyond age, income, functional impairment, and disease symptom-related QOL. Higher
resilience scores were associated with better adjustment-related QOL. Resilience was not a
significant moderator, however, of the relationship between adjustment-related QOL and disease
symptom-related  QOL  (β  =  .03,  t(121) = .56, p = .574) nor the relationship between adjustmentrelated  QOL  and  functional  impairment  (β  =  -.05, t(121) = -.86, p = .392). While both functional
impairment and disease symptom-related QOL were significant predictors of adjustment-related
QOL, neither was affected by resilience. Education also emerged as a significant predictor, such
that those with greater education had better adjustment-related QOL (β  =  .12,  t(121) = 2.34, p =
.021).
Hypothesized resilience-related variables. Although the resilience variable was not a
significant moderator between disease-related symptoms (nonmotor symptoms, functional
impairment, disease symptom-related QOL) and mental health/QOL (depression, apathy, life
satisfaction, adjustment-related QOL), resilience and other hypothesized resilience variables
were highly correlated with several outcome variables (Table 2). Therefore, hierarchical multiple
regression analyses were conducted with resilience entered into Block 2 and the hypothesized
age-related resilience variables (meaning-making ability, goal-flexibility, and optimism) entered
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into Block 3. All previously entered control variables from the initial analyses were included in
these models, however nonsignificant predictor variables were dropped from analyses to
generate the most parsimonious model with the highest available degrees of freedom for other
variables. Finally, a set of models for each outcome variable was run with all significant
predictor variables, the resilience variable, and all hypothesized resilience variables entered
simultaneously. Results of these models are reported only for instances in which a previously
nonsignificant hypothesized resilience variable became significant (i.e., the resilience variable
entered in Block 2 was obscuring the effects of the hypothesized resilience variable in Block 3).
Regarding depression, the 3rd model with the hypothesized age-related resilience
variables accounted for the highest proportion of variance (R2 = .57) and was significantly better
than the previous models, ΔF(3,121) = 3.74, p = .013. This improved model was solely driven by
the addition of the meaning-making ability variable. After including control variables, disease
symptom-related QOL, and resilience, meaning-making ability significantly predicted depression
and uniquely accounted for an additional 2.1% of the variance (β  =  -.22, t(121) = -2.49, p =
.014). Goal-flexibility  and  optimism  did  not  significantly  predict  depression  (β  =  -.09, t(121) = 1.21, p = .229; β  =  -.06, t(121) = -.71, p = .476, respectively). This pattern of significance did
not differ when all variables were entered simultaneously, with disease-symptom related QOL,
resilience, as meaning-making ability as the only significant variables.
Similarly for apathy, the 3rd model with the hypothesized age-related resilience variables
accounted for the highest proportion of variance (R2 = .45) and was significantly better than the
previous models, ΔF(3,121) = 4.77, p = .004. This improved model was again driven primarily
by the meaning-making ability variable. After including control variables, functional
impairment, and resilience, meaning-making ability significantly predicted apathy and accounted
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for  6.4%  of  additional  variance  (β  =  -.38, t(121) = -3.73, p < .001). Goal-flexibility and optimism
did not significantly predict apathy  (β  =  .04,  t(121) = .666, p = .68; β  =  .01,  t(121) = .12, p =
.904, respectively). This pattern of significance did not differ when all variables were entered
simultaneously, with functional impairment, resilience, as meaning-making ability as the only
significant variables. Meaning-making  ability  actually  became  a  stronger  predictor  (β  =  -.38,
t(121) = -3.73, p < .001)  than  resilience  (β  =  -.25, t(121) = -2.24, p = .027) and functional
impairment  (β  =  .23,  t(121) = 2.90, p = .004) when entered at the same step and given an equal
chance at accounting for variance in apathy.
The 3rd model with the hypothesized age-related resilience variables also accounted for
the most variance in life satisfaction (R2 = .54) and was significantly better than previous models,
ΔF(3,121) = 2.90, p = .038. Goal flexibility was the only significant additional variable in the
final  model  (β  =  .17,  t(121) = 2.14, p = .034). Neither meaning-making ability (β  =  -.06, t(121) =
-.61, p = .542) nor optimism (β  =  .14,  t(121) = 1.64, p = .104) were significant predictors of life
satisfaction. This pattern of significance differed slightly when all variables were entered
simultaneously, with functional impairment becoming non-significant  (β  =  -.10, t(121) = -1.39, p
= .167). Sex was also a significant predictor in this final model (β  =  .13,  t(121) = 2.12, p = .036),
with female sex associated with greater life satisfaction.
Regarding adjustment-related QOL, the 3rd model with the hypothesized age-related
resilience variables accounted for the most variance (R2 = .75) but was not significantly better
than previous models, ΔF(3,120) = 2.31, p = .08. None of the hypothesized age-related
resilience variables were significant predictors; neither meaning-making ability, goal-flexibility,
nor optimism significantly predicted adjustment-related  QOL  (β  =  .03,  t(120) = .48, p = .631; β  
= -.09, t(120) = -1.45, p = .149;;  β  =  -.12, t(120) = -1.92, p = .058, respectively). This pattern of
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significance did not differ when all variables were entered simultaneously, with age, education,
disease symptom-related QOL, functional impairment, and resilience as the only significant
variables.
Given the exploratory nature of this project in understanding the relationships among
coping and resilience variables in an older, chronic disease population, a post-hoc mediation
analysis was completed. There is good theoretical support for a relationship between meaningmaking ability and optimism as key  features  of  Fredrickson’s  (1998)  broaden-and-build model of
coping, therefore optimism was tested as a mediator of the relationship between meaning-making
ability and depression. Using the Baron and Kenny (1986) method for testing mediation, a
significant relation between meaning-making ability and depression was first established,
(F(1,137) = 85.89, p < .001; R2 = .39, β  =  -.62). Next, meaning-making ability was found to have
a significant effect on optimism (F(1,137) = 62.96, p < .001; R2 = .32, β  =  .56). After controlling
for meaning-making ability, participants who had greater optimism had less depression than
those with less optimism (F(2,136) = 49.44, p < .001; R2 = .42, β  =  -.23). Using the Sobel test, it
was found that the magnitude of the relationship between meaning-making ability and depression
decreased significantly when optimism was included (z = -2.74, p = .007). Therefore, optimism
partially mediated the effect of meaning-making ability on depression. When the same analyses
were run with optimism mediating the relationship between meaning-making ability and apathy,
optimism  was  not  a  significant  mediator  (β  =  -.13, t(136) = -1.54, p = .126).

81

Table 4.
Summary of Hierarchical Regression Analysis for Variables Predicting Depression
Model 1
β
SE
p-value
β
Variable

Model 2
SE

p-value

β

Model 3
SE
p-value

Age

-.17

0.06

.031*

-.12

0.05

.058

-.10

0.05

.128

Sex

.03

1.18

.726

.04

0.98

.494

.04

0.95

.500

Ethnicity

.11

2.75

.146

.05

2.23

.373

.05

2.19

.431

Education

.03

0.37

.684

.06

0.31

.364

.06

0.30

.415

Income

-.17

0.37

.061

-.04

0.32

.584

-.06

0.31

.482

Years since PD diagnosis

-.04

0.13

.655

-.04

0.10

.506

-.05

0.10

.582

Disease symptom-related QOL

.38

0.05

.001**

.36

0.03

.000***

.30

0.03

.000***

Nonmotor symptoms

.10

0.18

.259

Functional impairment

.08

1.61

.413

Resilience

-.51

0.03

.000***

-.28

0.04

.004**

Disease symptom-related QOL x resilience

.04

0.00

.592

Meaning-making ability

-.22

0.16

.014*

Goal-flexibility

-.09

0.09

.229

Optimism

-.06

0.24

.476

R2
F for final model

.326

.592

.573

6.61***

15.68***

14.75***

Note. Ethnicity was dichotomously coded (1 = Non-Caucasian, 2 = Caucasian).
*p < .05. **p < .01. ***p < .001
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Table 5.
Summary of Hierarchical Regression Analysis for Variables Predicting Apathy
Model 1
β
SE
p-value
β
Variable

Model 2
SE
p-value

β

Model 3
SE
p-value

Age

-.01

0.05

.905

.03

0.05

.732

.06

0.04

.366

Sex

-.05

1.01

.540

-.03

0.89

.692

-.02

0.86

.821

Ethnicity

.02

2.36

.773

-.03

2.08

.699

-.02

2.00

.781

Education

-.14

0.32

.132

-.11

0.28

.182

-.13

0.27

.096

Income

-.14

0.32

.131

-.04

0.29

.620

-.01

0.28

.908

Years since PD diagnosis

-.05

0.11

.576

-.05

0.10

.558

-.07

0.09

.375

Disease symptom-related QOL

.10

0.04

.391

Nonmotor symptoms

.08

0.15

.402

Functional impairment

.28

1.39

.011*

.23

1.05

.005**

.23

1.01

.004**

Resilience

-.48

0.03

.000***

-.25

0.04

.027*

Functional independence x resilience

.01

0.05

.919

Meaning-making ability

-.38

0.14

.000***

Goal-flexibility

.04

0.08

.666

Optimism

.01

0.21

.904

R2
F for final model

.209

.380

3.62***

8.37***

Note. Ethnicity was dichotomously coded (1 = Non-Caucasian, 2 = Caucasian).
*p < .05. **p < .01. ***p < .001
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.445
8.84***

Table 6.
Summary of Hierarchical Regression Analysis for Variables Predicting Life Satisfaction
Model 1
Model 2
β
SE
p-value
β
SE
p-value
Variable

β

Model 3
SE

p-value

Age

.12

0.06

.142

.07

0.05

.276

.06

0.05

.340

Sex

.14

1.12

.075

.11

0.91

.085

.13

0.90

.036*

Ethnicity

.06

2.61

.482

.11

2.13

.114

.13

2.08

.055

Education

.00

0.35

.981

-.02

0.28

.806

-.02

0.28

.726

Income

.31

0.35

.001**

.19

0.29

.014*

.22

0.29

.004**

Years since PD diagnosis

-.06

0.12

.497

-.04

0.10

.596

-.07

0.10

.334

Disease symptom-related QOL

-.14

0.05

.199

Nonmotor symptoms

.05

0.17

.566

Functional impairment

-.23

1.53

.028*

-.15

1.07

.044*

-.10

1.05

.167

Resilience

.56

0.03

.000***

.43

0.04

.000***

Functional independence x resilience

-.01

0.05

.856

Meaning-making ability

-.06

0.15

.542

Goal-flexibility

.17

0.08

.034*

Optimism

.14

0.22

.104

R2
F for final model

.257

.506

.539

4.73***

13.98***

12.85***

Note. Ethnicity was dichotomously coded (1 = Non-Caucasian, 2 = Caucasian).
*p < .05. **p < .01. ***p < .001
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Table 7.
Summary of Hierarchical Regression Analysis for Variables Predicting Adjustment-related QOL
Model 1
Model 2
β
SE
p-value
β
SE
p-value
Variable
Age
-.30
0.08
-.25
0.06
.000***
.000***

β
-.25

Model 3
SE
0.06

.000***

Sex

-.02

1.57

.740

-.01

1.26

.887

-.02

1.25

.726

Ethnicity

.01

3.66

.904

-.04

2.95

.388

-.06

2.89

.242

Education

.10

0.49

.146

.12

0.40

.021*

.13

0.39

.011*

Income

-.16

0.49

.018*

-.06

0.41

.317

-.08

0.41

.147

Years since PD diagnosis

-.03

0.17

.609

-.03

0.14

.548

-.02

0.13

.760

Disease symptom-related QOL

.43

0.07

.000***

.43

0.05

.000***

.40

0.05

.000***

Nonmotor symptoms

.08

0.24

.245

Functional impairment

.27

2.15

.000***

.17

1.82

.011*

.16

1.74

.011*

Resilience

-.44

0.04

.000***

-.35

0.06

.000***

Disease symptom-related QOL x resilience

.03

0.00

.574

Functional independence x resilience

-.05

0.09

.392

Meaning-making ability

.03

0.20

.631

Goal-flexibility

-.09

0.11

.149

Optimism

.12

0.31

.058

R2
F for final model

.583

.736

.748

19.12***

30.59**

29.74***

Note. Ethnicity was dichotomously coded (1 = Non-Caucasian, 2 = Caucasian).
*p < .05. **p < .01. ***p < .001

85

p-value

Depression subtypes. Exploratory analyses with depression subtypes were conducted to
determine whether any variables of interest differentially affected the cognitive versus somatic
symptoms of depression (Dozois, Dobson, & Ahnberg, 1998). BDI-II scores were calculated
with items split into Cognitive-Affective and Somatic-Vegetative subscales (e.g., items assessing
self-dislike, worthlessness, guilty feelings, and sadness in the former subscale; items assessing
fatigue, irritability, agitation in the latter subscale). The same multivariate regression model steps
were run as were completed for the total BDI-II score.
For the Cognitive-Affective Depression subscale with control variables and main
predictors included, the model was significant and explained 26.2 % of the variance in cognitiveaffective depressive symptoms, F(9,123) = 4.86, p <.001.  Significant  predictors  included  age  (β  
= -.21, t(123) = -2.60, p = .01) and disease symptom-related  QOL  (β  =  .28,  t(123) = 2.52, p =
.013). The other hypothesized predictor variables, nonmotor symptoms and functional
impairment,  were  not  significant  predictors  (β  =  .03,  t(123) = 0.36, p = .718; β  =  .13,  t(123) =
1.27, p = .208, respectively). When resilience was added as a moderator, there was a significant
main effect of resilience on cognitive-affective  depression  (β  =  -.61, t(124) = -9.35, p <.001)
such that as resilience increases, depression decreases. Resilience uniquely accounted for an
additional 30.9% of the variance in depression above and beyond age and disease symptom
QOL. The interaction term, however, was not significant, and the effect of disease symptom
QOL on cognitive-affective  depression  did  not  depend  on  resilience,  β  =  .02,  t(123) = 0.32, p =
.751.
The model improved further with the hypothesized age-related resilience variables
included. This final model accounted for the highest proportion of variance (R2 = .60) and was
significantly better than the previous models, ΔF(3,121) = 4.33, p = .006. This improved model
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was driven by the goal flexibility variable. Although goal flexibility did not account for unique
variance above and beyond resilience as a predictor for total depression, it did significantly
predict cognitive-affective depression symptoms and uniquely accounted for an additional 1.6%
of the variance (β  =  -.17, t(121) = -2.26, p = .026). Neither meaning-making ability nor optimism
significantly predicted cognitive-affective  depression  (β  =  -.17, t(121) = -1.94, p = .055;;  β  =  -.05,
t(121) = -0.62, p = .539, respectively).
For the Somatic-Vegetative Depression subscale with control variables and main
predictors included, the model was significant and explained 32.5% of the variance in somaticvegetative depressive symptoms, F(9,123) = 6.57, p <.001. Disease symptom-related QOL was
the  only  significant  predictor  in  this  model  (β  =  .42,  t(123) = 3.98, p < .001). The other
hypothesized predictor variables, nonmotor symptoms and functional impairment, were not
significant  (β  =  .15,  t(123) = 1.71, p = .090;;  β  =  .01,  t(123) = .14, p = .888, respectively).
Resilience was tested as a moderator for the relationship between disease symptom-related QOL
and somatic-vegetative depression. There was a significant main effect of resilience on somaticvegetative  depression  (β  =  -.34, t(124) = -4.48, p <.001) such that as resilience increases,
depression decreases. Resilience uniquely accounted for an additional 9.6% of the variance in
depression above and beyond income and disease symptom QOL. The interaction term, however,
was not significant, and the effect of disease symptom QOL on somatic-vegetative depression
did  not  depend  on  resilience  (β  =  .04,  t(123) = .52, p = .605).
Lastly, when the hypothesized age-related resilience variables were included in the last
block, the model was not significantly better than previous models with disease symptom-related
QOL and resilience predictor variables(ΔF(3,121) = 2.42, p = .069). This final model accounted
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for the highest proportion of variance (R2 = .44), however, primarily driven by the meaningmaking ability variable as the only significant added predictor (β  =  -.24, t(121) = -2.37 p = .019).
Other moderation analyses.
Hypothesized resilience variables as moderators. Given that resilience itself was not a
significant moderator, however several hypothesized age-related resilience variables were
significant predictors, further analyses were run to test whether these other resilience variables
could moderate the relationship between main predictor and outcome variables. The variables
were tested as potential moderators only for significant predictor variables in previous analyses.
Meaning-making ability did not significantly moderate the relationship between disease
symptom-related  QOL  and  total  depressive  symptoms  (β  =  .07,  t(123) = .99, p = .323) nor
somatic-vegetative  depression  symptoms  (β  =  .08,  t(123) = 1.01, p = .32), such that the effect of
disease symptom-related QOL on depression did not depend on meaning-making ability.
Meaning-making ability also did not significantly moderate the relationship between functional
impairment  and  apathy  (β  =  .01,  t(123) = .16, p = .873).
Goal-flexibility did not significantly moderate the relationship between disease symptomrelated QOL and cognitive-affective  depression  symptoms  (β  =  -.06, t(123) = -.81, p = .420).
Although both disease symptom-related QOL and goal-flexibility were predictors of cognitiveaffective depression symptoms, the effect of disease symptom-related QOL on depression did
not depend on goal-flexibility. Similarly, goal-flexibility did not moderate the relationship
between  functional  impairment  and  life  satisfaction  (β  =  -.01, t(123) = -.15, p = .878).
Age as a moderator. Age was also tested as a moderator between outcome variables and
significant hypothesized age-related resilience variables. For example, as seen in Table 4,
meaning-making ability was a significant predictor of depression. Therefore, an analysis was
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conducted to determine whether age influenced the effect of meaning-making ability on
depression. There was a significant main effect of meaning-making  ability  on  depression  (β  =  .59, t(126) = -8.31, p <.001), such that as meaning-making ability increases, depression
decreases. Meaning-making uniquely accounted for 32.6% of the variance in depression. The
interaction term between age and meaning-making  ability  was  also  significant  (β  =  .17,  t(124) =
2.32, p = .022. For all participants, greater meaning-making ability was associated with lower
depression, however this effect was greater for younger participants (Figure 2). There was also a
significant moderating effect of age on the relationship between optimism and adjustment-related
QOL  (β  =  .18,  t(124) = 2.38, p = .019). The effect of optimism on adjustment-related QOL was
greater for younger participants (Figure 3). Age did not moderate the relationship between
meaning-making  ability  and  apathy  (β  =  .13,  t(124) = 1.69, p = .093) nor goal-flexibility and life
satisfaction  (β  =  -.10, t(124) = -1.35, p = .179).
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Figure 2. Age as a moderator in the relationship between meaning-making ability and depression. The buffering effect of meaningmaking ability on depression scores is greater for younger participants.
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Figure 3. Age as a moderator in the relationship between optimism and adjustment-related QOL (higher scores = poorer outcomes).
The buffering effect of optimism on adjustment-related QOL is greater for younger participants.
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Moderated mediation. Given that meaning-making ability appeared to be a key variable
in several models, and the effect of age on these relationships was a primary goal of this study,
exploratory analyses were conducted to determine if there were moderated mediation effects. A
moderated mediation (conditional indirect effects) path model was constructed using AMOS
16.0  (Arbuckle,  2007)  following  Preacher,  Rucker,  and  Hayes’  (2007)  methodology.    In  the  
bootstrap  model,  resilience  was  speciﬁed  to  mediate  the  effect  of  meaning-making ability on
depression. To examine whether the strength, direction, or presence of these hypothesized
mediated effects differed by patient age, a median split of the sample created a younger (age
range 34-64 years) and older group (age range 65-89 years). Models were run separately but
simultaneously for the younger and older groups.
In  Figure  4,  for  the  younger  group,  the  standardized  indirect  (mediated)  effect  was  β  =.134, p = .156, indicating that resilience did not mediate the path from meaning-making ability to
depression  for  this  group.  For  the  older  group,  however,  the  standardized  indirect  effect  was  β=.345, p = .001, indicating the presence of statistical mediation. Because the direct effect of
meaning-making ability on depression was not  statistically  signiﬁcant  while  controlling  for  
resilience, this is considered a full mediation. The combination of a full mediation for older
participants and no mediation for the younger group indicates a moderated (by age group)
mediation. To test whether the difference in indirect effects being moderated as a function of
young  vs.  old  was  statistically  signiﬁcant,  a  heterogeneity  test  (Altman,  2003)  was  performed.  
This test suggested that the difference in indirect effects between the two groups was statistically
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signiﬁcant,  z  =  2.85,  p  =  .004.

Note. ** = p<.01, *** = p <.001. Path coefficients in parentheses are from the younger group,
and coefficients not in parentheses are from the older group.
Figure 4. Moderated mediation model: the influence of resilience on the relationship between
meaning-making ability and depression, with age as moderating variable.
Illness uncertainty. Following the previous models based on primary hypotheses,
additional exploratory variables were tested as possible predictors. Additional multiple
regression analyses were run using the control variables and significant predictors from Model 3
in Tables 4-7, with the variable illness uncertainty included as an independent variable. Illness
uncertainty accounted for 1.8% of unique variance as a significant predictor of depression (β  =  
.15, t(122) = 2.30, p = .023). Participants who reported greater concern about the uncertainty of
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their illness had higher depression scores. The final model including the previously significant
predictors from Table 3 remained significant (F(10,122) = 17.03, p < .001, R2 = .58). Illness
uncertainty was also a significant predictor  of  life  satisfaction  (β  =  -.20, t(122) = -3.01, p = .003)
and accounted for 3.3% of unique variance. Greater concern about illness uncertainty was
associated with lower life satisfaction. The final life satisfaction model remained significant with
the illness uncertainty variable included (F(10,122) = 15.62, p < .001, R2 = .56). Lastly, illness
uncertainty significantly predicted adjustment-related  QOL  (β  =  .15,  t(122) = 3.04, p = .003) and
accounted for 1.9% of unique variance. The final adjustment-related QOL model remained
significant (F(10,122) = 37.11, p < .001, R2 = .75). The only outcome variable that illness
uncertainty did not significantly predict was apathy (β  =  -.07, t(122) = -0.87, p = .336).
Spirituality. Spirituality, as measured through a composite variable of three spirituality
items from the CD-RISC (Connor & Davidson, 2003), was also analyzed as an additional
predictor variable into the final models from Tables 4-7. Spirituality was not a significant
predictor  of  depression  (β  =  .02, t(122) = 0.03, p =  .976),  life  satisfaction  (β  =  .09,  t(122) = 1.33,
p = .188), adjustment-related  QOL  (β  =  .01,  t(122) = 0.21, p =  .838),  nor  apathy  (β  =  -.13, t(122)
= -1.78, p = .078.
Resilience subgroup comparisons. Further analyses of the resilience variable were
conducted given that resilience was a significant predictor in all main analyses and it was a
primary variable of interest in this project. Additionally, the range of scores on the RSA was
restricted to the upper end of the scale for the large majority of participants. Therefore, there
were participants who reported moderate resilience characteristics yet also had clinically
significant depression and apathy scores. There is some precedent for creating resilience
subgroups based on median split scores (Friborg et al., 2006), however there are no guidelines
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for cut-off  scores  on  the  RSA  that  are  considered  “high  versus  low”  resilience.    In  the  present  
study, participants were divided into low, medium, and high resilience groups based on percentile
splits at the 33rd and 66th percentile in order to compare groups. There were 46 participants in the
low resilience group (RSA range 75-120), 51 participants in the medium resilience group (RSA
range 121-136), and 42 participants in the high resilience group (RSA range 137-163).
While using resilience scores as a continuous variable was a powerful predictor in
regression analyses, it is helpful to determine whether there are differences between participants
with relative differences between their resilience scores. Analysis of variance tests were
conducted to compare scores on the outcome variables of interest between the three resilience
groups. For variables in which there was a significant  Levene’s  statistic,  indicating that the
assumption of homogeneity of variance was violated, the test statistic and corresponding degrees
of freedom reported were calculated with equal variances not assumed (Field, 2009). Table 8
shows the overall results comparing the three different resilience groups across the main
outcome variables and the three main predictor variables (nonmotor symptoms, disease
symptom-related QOL, and functional impairment). Planned contrasts were used to determine
which groups differed significantly from each other.
As seen in Table 8, there were significant differences between the low, medium, and high
resilience groups in an overall analysis of variance test, except for the overall group differences
in nonmotor symptoms once a Bonferroni correction was applied. There was also a significant
difference between the three groups for nearly all contrasts, meaning that the low, medium, and
high resilience groups had significantly different scores on the outcome variables of interest. The
low resilience group had significantly higher NMS scores (more nonmotor symptoms) compared
to the medium resilience group (t(136) = -2.50, p = .013) , but not the high resilience group
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(t(136) = -1.55, p = .124). The low resilience group also had poorer disease symptom-related
QOL compared to the high resilience group (t(136) = -3.72, p <.001). Similarly, the low
resilience group had poorer functional impairment compared to the medium (t(136) = -2.66, p =
.009) and high resilience groups (t(136) = -3.08, p = .003), however the medium and high
resilience groups did not differ significantly (t(136) = -0.56, p = .578). Thus, when there were
overall differences between the three groups, it was primarily due to the lower resilience group.
This suggests that degree of resilience may make a difference in terms of reported disease
symptoms (e.g., disease symptom-related QOL, functional impairment, NMS); those with
comparatively lower resilience also report significantly worse disease symptoms.

96

Table 8.
Outcome variables across three resilience groups
Low resilience
N = 46
M (SD)
18.26 (7.87)

Depression1

Medium resilience
N = 51
M (SD)
11.04 (5.90)

High resilience
N = 42
M (SD)
6.48 (4.19)

F
41.38

Low vs. medium
Low vs. high
Medium vs. high
Apathy

16.74 (5.23)

11.55 (4619)

8.07 (5.60)

18.61 (6.27)

Low vs. medium
Low vs. high
Medium vs. high
Adjustment-related QOL
31.03 (12.21)
Low vs. medium
Low vs. high
Medium vs. high
Nonmotor symptoms
10.37 (3.38)
Low vs. medium
Low vs. high
Medium vs. high
Disease symptom-related QOL
35.95 (17.13)

23.29 (6.58)

19.61 (11.70)

8.40 (3.86)

30.23 (16.88)
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28.98 (3.75)

13.79 (9.47)

9.10 (4.36)

23.12 (14.02)

df
2, 119.21

p
<.001

-5.07
-8.87
-4.35

82.96
69.85
89.19
2, 136

<.001
<.001
<.001
<.001

-4.97
-7.91
-3.25

136
136
136
2, 123.22

<.001
<.001
.001
<.001

3.59
9.50
5.22

94.70
74.59
81.71
2, 136

.001
<.001
<.001
<.001

-4.99
-7.18
-2.48

136
136
136
2, 136

<.001
<.001
.014
.044

-2.50
-1.55
0.86

136
136
136
2, 136

.013
.124
.393
.001

31.99

Low vs. medium
Low vs. high
Medium vs. high

Life Satisfaction1

t

35.21

27.03

3.19

6.94

Low vs. medium
Low vs. high
Medium vs. high
Functional impairment
.63 (.51)

-1.74
-3.72
-2.11
.38 (.42)

.33 (.45)

5.57

136
136
136
2, 136

.084
<.001
.037
.005

Low vs. medium
-2.66
136
.009
Low vs. high
-3.08
136
.003
Medium vs. high
-0.56
136
.578
1
Homogeneity of variance assumption was not met, therefore Brown-Forsythe F statistical test was used. According to Field (2009),
the Brown- Forsythe F-ratio is a robust alternative F-ratio that weighs the group variance by the inverse of their sample sizes to reduce
the impact of large sample sizes with large variance.
Note. Significance values adjusted with a Bonferroni correction, such that the critical value is set to p < .017
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Discussion
The present study explored the relationships between PD symptoms and mental
health/QOL outcomes in a broad age range of PD patients. The project further sought to examine
the construct of resilience in a generally older population, integrating the developmental aging
and coping literatures with the resilience research rooted in child and adolescent studies. As is
well established, advancements in medicine and technology have resulted in a worldwide aging
population, along with an increasing prevalence of chronic disease as a common health burden
among middle-aged and older adults. It is therefore imperative we learn more about the
relationships between demographic, disease, and individual characteristics that can influence or
predict quality of life in order to develop targeted and meaningful interventions. One way to
conceptualize this focus within the present study is with a goal to reduce excess disability, or
disability components that are created by environmental, social, or psychological barriers
(Rybarczyk et al., 1992). A chronic, neurodegenerative disease such as PD maintains a degree of
certainty regarding eventual functional limitations, at least until neurological and
pathophysiological research advances further. Therefore, the results of this study are important
for identifying psychological strengths that may buffer against disease symptoms or protect
mental health/QOL within a population in which functioning is often compromised.
Main Predictors of Mental Health and QOL
Demographic predictors. Age was an initial demographic predictor of depression (older
age associated with less depression), however the variable became nonsignificant after resilience
was added into the model. This finding is consistent with other research that finds older patients
with chronic disease are less depressed than younger chronic disease patients (Cassileth et al.,
1984). In the Cassileth et al. study, participants had an average of 4.4 years since diagnosis,
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which is less than the approximate 6.5 years since PD diagnosis in the present study. They did
find, however, that those whose illnesses had been diagnosed for shorter periods had greater
depression and anxiety and poorer overall mental health than those had been diagnosed for
longer. In the present study, time since diagnosis may have been a weaker predictor in the final
model because most participants had been diagnosed for several years.
Because age is often a proxy for other more potent variables (e.g., years of experience
managing other illnesses), it makes sense that age became nonsignificant when resilience was
added into the model and suggests their shared variance is better accounted for by the resilience
variable. On the other hand, age was a significant predictor of adjustment-related QOL and
remained significant even in the most comprehensive statistical model with resilience and related
variables included. In this study, self-reported QOL in terms of disease adjustment (emotional
well-being, stigma, social support, cognitions, and communication) increased with patient age.
These results are consistent with other research that also finds a positive relationship between
age and QOL in chronic disease and adjustment (Rustøen et al., 2005; Shamaskin et al., 2012;
Wenzel et al., 1999).
The explanation for these findings is not simply that older age leads to better QOL. The
literature on aging and coping suggests that because there is a decline in perceived stress and
increase in well-being with age, older adults may have better coping skills or use them more
effectively (Aldwin, 1991; Aldwin et al., 1996). In the context of chronic disease, however, it is
likely that other variables related to the aging process are playing a central role. For example,
older adults may have different expectations about disease and disability that makes the disease
course less psychologically upsetting compared to younger adults. They might also have more
experience around health issues (Aldwin, 1991), greater engagement in downward social
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comparison to more ill older adults (Heckhausen & Krueger, 1993), or view the physical
experiences and limitations of a chronic disease as a more normative part of aging (Neugarten,
1979; Williamson & Schulz, 2005). Furthermore, these mechanisms for different coping qualities
among older adults may interact with each other. One study exploring age differences in coping
with chronic pain found that older adults used a wider range of coping strategies than their
younger counterparts (Molton et al., 2008). The older adults tended to consistently use an
effective  cluster  of  strategies  regardless  of  pain  intensity,  while  younger  adults’  coping  efforts  
increased with greater pain severity. Perhaps more years of experience with general health
stressors allowed the older adults to have a wider repertoire of coping strategies, be more
proactive with their coping prior to increased pain intensity (i.e., proactive coping; Aspinwall,
2005), and have better intuition regarding which strategies would work effectively for them.
Higher income predicted better adjustment-related QOL but became nonsignificant when
resilience was added into the model, suggesting that resilience better accounted for the shared
variance between the two variables. Income was a robust predictor of life satisfaction and
remained significant even in the most comprehensive statistical model. This is presumably
because higher income provides greater access to resources important within chronic disease
(e.g., access to health care services, transportation, medication) that could improve life
satisfaction. A similar phenomenon might explain why more years of education was associated
with greater adjustment-related QOL.
Disease symptom-related QOL. Hypothesis 1 was partially supported in the present
study. Regarding depression, disease symptom-related QOL (comprised of QOL questions
related to mobility, ADLs, and bodily discomfort) was the only significant predictor. This
finding is consistent with other research that demonstrates a strong relationship between
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depression and QOL (Schrag, 2006). It also confirms the suggestion that the relationship
between depression and disease symptoms is dependent on measurement tool. Holroyd et al.
(2005)’s  research  found  that  depression  was  more  closely related to disease progression when
disease progression measurement included disease impact (e.g., ADLs) instead of exclusively
physical symptoms (e.g., Hoehn and Yahr scale, which defines levels of motor functioning).
Similarly, in the present study, depression was predicted by subscales of the PDQ-39 that were
related to disease symptoms and could reflect some adaptation and coping that presumably
shaped participants’  responses.  Depression  was  not  predicted  by  other  measures  that  could  
reflect symptomology or disease progression, such as disease duration or NMS ratings.
In addition to predicting depression, disease symptom-related QOL also significantly
predicted adjustment-related QOL, which further adds to the body of literature regarding the
multifactorial components of health-related  QOL  in  PD.    For  example,  in  Schrag’s  (2006)  review  
of depression and QOL, she included studies that demonstrate several disease-related factors as
influencing QOL, including freezing, dystonia, and akinesia (Kuopio et al., 2000). These diseaserelated factors are conceptually similar to the disease symptom-related subscales from the PDQ39 that made up composite predictor variable in the present study (i.e., mobility, ADLs, and
bodily discomfort). There are certain limitations to drawing conclusions from these findings,
given that the subscales composing the disease symptom-related QOL variable and adjustmentrelated QOL variable are from the same parent scale. However, their correlation value (r = .68, p
< .001) indicates a strong relationship without multicollinearity, thus the composite variables
represent distinct components of QOL. These findings further support the idea that disease
duration or symptom frequency/severity (e.g., Hoehn and Yahr scale, Nonmotor Symptoms
Questionnaire) may not be the best predictors of mental health/QOL outcomes for PD patients;
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instead, disease symptoms as they relate to QOL (e.g., mobility, ADLs, bodily discomfort) seem
to be the key variables for future study.
Nonmotor symptoms. Contrary to hypothesis, neither depression nor apathy were
predicted by degree of nonmotor symptoms (NMS). This study posited that because NMS are
qualitatively different than motor symptoms, and often underrecognized by treating neurologists,
and less likely to be disclosed during medical appointments (Chaudhuri et al., 2010), they might
be a useful predictor of mental health outcomes. This hypothesis, however, was not supported.
One possible explanation is that patients interpreted NMS as more similar to motor symptoms
than originally anticipated. If viewed as simply another uncontrollable or unpredictable element
of PD, NMS may not be perceived as modifiable through coping or adjustment; therefore, the
degree of NMS would be unrelated to depression. Another reason why NMS was not predictive
of apathy or depression may have been because NMSQuest items that were conceptually similar
to mental health/QOL outcomes (i.e., neuropsychiatric symptoms: depression, apathy, anxiety,
anhedonia, attention deficit, hallucinations, delusions) were excluded from the NMS total score.
NMS also did not predict life satisfaction or adjustment-related QOL, which is
inconsistent with other research finding a relationship between NMS and QOL (Martinez-Martin,
Rodriguez‐Blazquez, Kurtis, & Chaudhuri, 2011). Again, one reason for this finding may be
because mental health-related items were eliminated from the NMS total score, while other
studies included the entire NMS scale. Therefore, it is possible that the predictive value of NMS
lies in the neuropsychiatric symptoms primarily, as they might be the most emotionally draining
or  depleting  (e.g.,  “loss  of  interest  in  what  is  happening  around  you  or  in  doing  things”,  “feeling  
anxious,  frightened,  or  panicky”,  “difficulty  concentrating  or staying  focused”,  “believing  things  
are  happening  to  you  that  other  people  say  are  not”).   This hypothesized explanation is supported
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by other research that finds neuropsychiatric NMS, such as depression, anxiety, and cognitive
decline, are significant contributors  to  patients’  QOL  (Rahman, Griffin, Quinn, & Jahanshashi,
2008). With these symptoms eliminated from the NMS scale in the present study due to
confounds with other variables, the remaining more physical NMS may not have carried the
same emotionality  nor  be  as  distressing  or  disruptive  to  QOL  (e.g.,  “dribbling  of  saliva  during  
the  daytime”,  “getting  up  regularly  at  night  to  pass  urine”,  “talking,  or  moving  about  in  your  
sleep,  as  if  you  are  ‘acting  out  a  dream’”,  “double  vision”).    This  explanation would also be
consistent with the relatively high FIM scores in the present study; with a sample population that
has relatively high functional independence, any NMS reported (with neuropsychiatric
symptoms excluded) may not have been very disruptive to daily functioning.
Functional impairment. One unusual result from the study was that functional
impairment was not a significant predictor of depression. While there has been some research
establishing the relationship between functional impairment and emerging disability (Shulman et
al., 2008), there has been limited study of the relationship between functional impairment and
mental health in PD patients. There have been numerous studies demonstrating depression as an
important predictor for functional impairment in rehabilitation inpatients post-stroke (see Lenze
et al., 2001 for a review), while other studies find no associations between depression and
functioning (e.g., Dossa, Glickman, & Berlowitz, 2011).  However,  no  studies  to  this  writer’s  
knowledge have examined functional impairment as a predictor variable itself. It is therefore
difficult to interpret this finding within the context of other research, however the role of
functional impairment becomes somewhat clearer as a predictor of other dependent variables.
Notably, functional impairment was a significant predictor for the other three mental
health/QOL outcome variables. As a strong predictor of apathy, life satisfaction, and
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adjustment-related QOL, functional impairment appears to be a key variable of interest for future
research. This is consistent with another study that found degree of disability, as measured by the
Schwab and England scale, significantly predicted PDQ-39 SI scores (Rahman et al., 2008). It is
possible that the degree to which patients are able to maintain independence in their ADLs has a
stronger  relationship  with  broader  perceptions/interpretations  of  one’s  life  (i.e.,  life  satisfaction  
and adjustment-related QOL), however it has less influence on mood and internal selfevaluation. This finding also highlights another conceptual difference between depression and
apathy, such that patients with greater ADL functioning may be less vulnerable to the apathy
components of PD but still at risk for depressive symptoms. Furthermore, the
pathophysiological etiology of depression may make the symptoms less malleable to
psychological coping in general as compared to apathy, life satisfaction, and QOL.
Taken together, it seems that disease features within the context of coping or adjustment
(e.g., ADLs, functional impairment, mobility, and bodily discomfort) are more predictive of
mental health and QOL outcomes than more objective disease features (e.g., disease duration,
NMS). These trends are consistent with previous PD research (e.g., Suzukamo, Ohbu, Kondo,
Kohmoto, & Fukuhara, 2006) and  emphasize  the  value  in  focusing  on  changing  people’s  
perceptions of the influence PD has on their QOL. For example, there may be great benefit for
PD  patient’s  QOL  and  mental  health  through  further research and development of assistive
devices that allow people to transport or feed themselves independently. The recently developed
“Smart  Spoon”  is  one  example  of  this  type  of  technology  (Allen, 2014). This device tracks
vibrations and compensates for hand tremors by stabilizing the utensil and allows people with
PD to eat without food falling off of their utensil. This type of assistive device would increase
functional independence and potentially reduce stigma of eating in public, which would
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presumably have positive impacts on apathy, life satisfaction, and adjustment-related QOL.
The present study suggests that subjective experiences and disease features in the context
of adjustment and coping are important predictors of mental health/QOL. In this regard, it may
be  beneficial  for  clinics  or  treating  clinicians  to  identify  patient’s  most  distressing  disease  
features (e.g., through QOL questionnaires) and then provide a targeted intervention. High
distress regarding illness uncertainty, for example, might warrant interventions that emphasize
emotion-focused coping for dealing with disease-related stress outside  of  one’s  control. Other
psychological intervention, such as mindfulness meditation, may be beneficial for addressing
multiple symptomatic areas within PD. A meta-analysis of interventions using the Mindfulness
Based Stress Reduction program with chronically ill patients found consistent improvements in
coping and reduced distress and disability (Grossman, Niemann, Schmidt, & Walach, 2004).
Quantitative research on mindfulness in PD has been limited, however results from a qualitative
study suggested group mindfulness-based cognitive therapy (MBCT) could benefit people with
PD through group support and the experience of mindfulness meditation itself (Fitzpatrick,
Simpson, & Smith, 2010).
Resilience
Although resilience was a significant predictor for all main outcome variables,
Hypothesis 2 was not met. Resilience did not moderate the relationship between predictor and
outcome variables from Hypothesis 1. This null finding could  suggest  that  people’s  perceptions
of  their  resilience  or  ability  to  “bounce  back”  from  adversity  is  not  a  potent  enough  variable  to  
affect the relationship between functional impairment and apathy, for example. The most likely
explanation for this nonsignificant finding is due to the relatively limited range of responses on
the  RSA.  While  there  was  a  normal  distribution  of  scores,  participants’  total  scores  were  
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aggregated toward the higher end of the scale. It is somewhat puzzling that participants would
report relatively high resilience (RSA composed of: family coherence, structured style, social
resources, positive perception of self, positive perception of future, and social competence) while
still have slightly higher than normative depression and apathy scores. A likely explanation is
that the physiologically-based nature of depression and apathy in PD contributed to this higher
prevalence of mental health issues. The sample had, on average, PD for a relatively short amount
of time, and they were self-selected as participants, therefore they may not have yet reached the
point in their disease progression to experience significant adversity. Their perception of their
own coping ability and adaptive personal qualities remained strong while they simultaneously
experienced physiologically-based mental health symptoms. It would be useful for future
research to study other individual psychological factors that might clarify this relationship, for
example whether higher resilience affects self-efficacy or locus of control, both of which are
known to influence depression (Benassi, Sweeney, & Dufour, 1988; Maciejewski, Prigerson, &
Mazure, 2000).
What is the value or utility of self-perceived resilience, if those with even moderate
resilience scores are still at risk for poor mental health? Perhaps our conceptualization of
resilience within chronic illness is too narrow, as suggested by Trivedi and colleagues (2011).
Trivedi  et  al.  posits  that  the  additive  effects  of  chronic  disease  stressors  might  drain  individual’s  
psychological  reserve,  such  that  the  “resilient  response”  in  an  individual  changes  over  time  
depending on their disease course. Similarly, the timing of resilience measurement in chronic
illness becomes more complicated; some patients might experience initial distress following
diagnosis but regain resiliency over time through disease adjustment, while others might have an
initial resilient response but become distressed after lengthy rehabilitation or recovery. Trivedi
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proposes an alternate conceptualization of resilience, with the underlying assumption that
individuals exist in a state of equilibrium, and resilience is the process through which individuals
maintain or regain equilibrium over time. In  Trivedi’s  model,  resilience is a three-level construct
with each level indicating different clinical goals. Individuals demonstrating primary resilience
experience only a brief loss of emotional well-being in response to adversity. They have the
resources to achieve optimal outcomes, and their clinical goals are to maintain this equilibrium.
Within the secondary resilience level, individuals undergo moderate loss of well-being and
subclinical distress, but they are able to achieve the clinical goal to regain their own equilibrium
through personality traits, coping styles, and social resources. Those with tertiary resilience
experience significant loss of well-being and often develop psychiatric symptoms. Their
equilibrium is met after a length of time and often with professional intervention.
The advantage of this model with chronic disease populations is the fluidity of
intervention matching with the fluidity of the stress response; identifiable clinical goals can shift
depending  on  individual’s  changing  levels  of  resilience  throughout  the  disease.    Within  the  
context  of  the  present  study,  the  “snapshot”  cross-sectional research design leaves several
questions unanswered. It is probable that the self-reported  resilience  reflected  participants’  
perceptions  of  their  general  coping  and  ability  to  “bounce  back”,  perhaps  thinking  of  previous  
stressors or adversities at earlier points in the disease. Individuals may have viewed themselves
as within the primary resilience level, able to use their own resources thus far to cope with their
PD, but some may have instead been transitioning to secondary or tertiary resilience levels that
put them at higher risk for adverse outcomes. Future research in resilience with chronic disease
using this alternative conceptualization may provide further information about the dynamic
nature of the construct. Identification of individuals at these different levels might also have
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implications for intervention focus. Primary prevention measures could improve and maintain
resilience at the time of illness onset/diagnosis and on an ongoing basis; those detected early
with poorer coping might benefit from secondary prevention, and finally tertiary prevention
would be indicated through active interventions and outside referrals where necessary (Trivedi et
al., 2011).
The fact that the resilience variable was still a significant predictor of all main outcome
variables suggests that degree of resilience compared to others, more so than total score
compared to scale maximum score, is important. The findings from the planned contrasts of the
three resilience subgroups supports this explanation; the low resilience group appeared distinct
and differed from the medium and high resilience groups more than the medium and high
differed from each other. Thus, even those with comparatively lower resilience (M total score =
107.57, max score = 165; M item score = 3.26, max score = 5) seem to have poorer NMS,
disease symptom-related QOL, and functional impairment than those with relatively higher
resilience. Perhaps there is a minimum resilience threshold, such that those who fall below this
threshold have noticeable differences in their perceptions of disease symptoms.
Research findings suggest several methods for improving resilience, though the lack of
consensus regarding a definition and conceptualization of resilience poses a challenge for
studying resilience-promoting interventions. Some studies emphasize emotion regulation
strategies (Tugade & Fredrickson, 2007); one found that in-the-moment positive emotions
mediated change in resilience, supporting the broaden-and-build theory that suggests positive
emotions build resources to help people deal with life challenges (Cohn, Fredrickson, Brown,
Mikels, & Conway, 2009). Other research focusing on promoting psychological resilience in the
U.S. military found a range of individual, family, unit, and community-level factors that promote
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resilience (Meredith, Sherbourne, & Gaillot, 2011). Most resilience-promotion programs
emphasize the individual-level factors, such as positive thinking (which includes positive
reframing, making sense out of a situation, flexibility, and reappraisal), positive coping,
behavioral control, positive affect, and realism training.
Another way of comparing these differences is through the minimally important
difference (MID) estimate. The PDQ-39 manual (Jenkinson, 2008) suggests that MIDs vary
between dimensions depending on the subscale, such that subscales with relatively small effect
sizes indicate subjectively important changes. With composite scales created in the present study,
it is not possible to use the MID suggestions from the PDQ-39 manual itself to interpret results.
However, one systematic review of numerous health-related QOL instruments computed effect
sizes and concluded that the threshold of discrimination for change in QOL for chronic diseases
appears to be one half SD (Norman, Sloan, & Wyrwich, 2003). Using this estimate, the MID for
adjustment-related QOL would be 6.61 (adjustment-related QOL SD = 13.21). As seen in Table
8, there is not a MID between the medium and high resilience group adjustment-related QOL
scores (absolute difference between the groups = 5.82), while the difference between the low
resilience group compared to medium and high resilience is 11.42 and 17.24, respectively. The
MID for disease symptom-related QOL is 8.42 (disease symptom-related QOL SD is 16.84);
there is not a MID between the medium and high resilience disease symptom-related QOL scores
(absolute difference between the groups = 7.11), but there is a significant MID between the low
and high resilience groups (absolute difference between the groups = 12.83). This adds further
evidence to suggest that degree of resilience is important, with relatively lower resilience
associated with clinically significant poorer outcomes.
The resilience variable also had the highest standardized β  within most models,
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suggesting  that  it  has  the  greatest  “importance”  as  a  model  predictor.  For  example,  as  resilience  
score increased by one standard deviation (17.45 raw score increase on RSA), depression score
decreased by 0.51 standard deviations, or 3.95 points on the BDI-II. Similarly, one standard
deviation increase in resilience scores predicted a 2.97 point decrease in apathy, a 3.95 point
increase in life satisfaction, and 5.81 point decrease in adjustment-related QOL (lower scores
indicate better QOL; see discussion above regarding MID for this scale). Resilience was the
strongest statistical predictor in the depression and life satisfaction models. Meaning-making
ability became a stronger predictor than resilience when added into the apathy model (Table 5).
Hypothesized Resilience Components
Hypothesis 3 was partially supported, with other resilience variables serving as
significant predictors above and beyond the resilience measure and other PD symptoms. This is a
key finding because it suggests that within the context of an older, chronic disease population,
there are other important features that affect adjustment and might reflect unique elements of
resilience. As discussed in the literature review, the resilience construct was initially developed
with younger populations (Rutter, 1989; Werner, 1996), and there continues to be greater
integration of the construct into adult and medical population research (Rybarczyk, Emery,
Guequierre, Shamaskin, & Behel, 2012; Zautra, Hall, & Murray, 2010). Furthermore, there are
unique older adult coping styles and age-related strengths (i.e., adaptive emotion regulation,
positivity) that have had relatively limited incorporation into the resilience literature compared to
child, adolescent, and family-related variables. To that end, findings from the present study
highlight that meaning-making ability, goal flexibility, and optimism deserve more attention in
future research as potentially useful focus areas in disease coping and adjustment.
Meaning-making ability. Meaning-making predicted both depression and apathy above
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and beyond resilience, with participants who reported greater meaningfulness also reporting
lower depression and apathy. While meaning-making and resilience were strongly correlated (r =
.71, p <.001), its significance in Block 3 of the models suggests that meaning-making accounted
for some unique variance that was not captured in a standard resilience scale. Furthermore,
meaning-making was a stronger predictor of apathy than resilience when entered simultaneously
into a multiple regression. This is a critical finding since being able to find positive meaning
from adversity is known to be an important coping mechanism (Folkman, 2008; Park &
Folkman, 1997). This finding was also anecdotally observed during the missing data follow-up
phone calls; numerous participants commented on their gladness to participate in the study
because they found it meaningful to share their experience and help future generations of PD
patients.    The  meaningfulness  subscale  on  the  SOC  essentially  measures  people’s  belief  that  their  
lives are meaningful, and life demands are challenges worthy of investment. While one could
argue there are differences between meaning-making ability and meaningfulness (see Park, 2010
for an integrated review of the meaning making construct), these semantic nuances should not
preclude interpreting the findings in the present study. Meaning-making strategies can be taught
or guided through emotion-focused therapy (Greenberg, 2004). Some examples of strategies that
promote meaning-making are comparison processes that reduce discrepancies between
situational and global meaning, focusing on positive attributes, and benefit finding/reminding
(Park, 2010).
These results fit well with research in coping and chronic illness. Meaning-making and
other variants of the construct (i.e., meaningfulness, meaning reconstruction, benefit finding)
have been found as important variables in adjustment and coping in numerous chronic disease
studies, including multiple sclerosis (Mohr et al., 1999), lupus (Katz, Flasher, Cacciapaglia, &
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Nelson, 2001) and cancer (Lee, Robin Cohen, Edgar, Laizner, & Gagnon, 2006; Park,
Edmondson, Fenster, & Blank, 2008). Other research within PD specifically has found that
emotion-regulation coping is most commonly used when dealing with stressful disease
symptoms, and even with physical symptoms that may typically be more amenable to problemfocused coping (Frazier, 2000). Frazier suggests that because of the limited control patients
maintain over their mobility and motor symptoms (much depends on medication), promotion of
emotion-focused coping is critical with PD populations. Given that meaning-making is an
important element of the appraisal-emotion-coping-reappraisal process (Folkman, 2008),
continued exploration of this construct within PD is warranted.
Although not within PD, Park and colleagues (2008) studied cancer survivors and
attempted to differentiate between the meaning making process and meanings made (products of
the process). They used mediation analyses and found that meaning-making efforts were related
to positive adjustment through the creation of adaptive meanings made (i.e., growth, life
meaning), and it was these meaning-making products, more so than the process itself, that were
related to well-being. Translating this research to the current study, it may be beneficial for
future studies in PD to include different types of scales to assess meaning-related constructs. The
present study only used the meaningfulness subscale of the SOC, which presumably reflected a
straightforward measure of life meaningfulness. The significant predictive value of this 4-item
subscale suggests that meaning-related constructs (meaningfulness, meaning-making ability, and
meanings made) account for some unique variance that is not measured through standard
resilience scales and are ripe areas for future research. Additional studies could elucidate the
nature of these constructs by using more sophisticated or targeted measures, such as the Benefit
Finding Scale (Carver & Antoni, 2004; Tomich & Helgeson, 2004) for measuring posttraumatic
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growth and the Perceived Personal Meaning Scale (Wong, 1998) for measuring life meaning.
Another possibility is that benefit finding has a differential function over the course of chronic
disease (Stanton, Bower, & Low, 2006), emphasizing the importance of longitudinal design in
this area of research.
There is valuable room for intervention with PD patients to promote meaning-making and
other forms of emotion-focused coping that would likely positively affect mental health.
Potential interventions could include identifying patients using active problem-solving for
challenges that are not likely to change (e.g., tremors) before they become discouraged and/or
disengaged, and instead redirect them towards positive re-appraisal and more emotion-focused
reflection.    The  “Lifeline”  exercise  is  one  interesting  intervention used within cancer research
(Lee et al., 2006) and is designed to assist with meaning-making following a stressful health
event. This narrative approach guides participants through a review of their negative health
experience and encourages them to incorporate their experience into the context of other life
events. There is a specific focus on appraising emotional and cognitive responses to the health
issue, exploring past coping and how it influences present experiences, and reflection on life
priorities with an acknowledgment of mortality. This approach is similar to the Life Narrative
Interview, an intervention which reduces anxiety and increases emotion-focused coping among
briefly hospitalized patients (Rybarczyk & Auerbach, 1990; Rybarczyk et al., 1993).
Goal-flexibility. Goal-flexibility accounted for unique variance above and beyond
resilience in predicting life satisfaction, however not for depression, apathy, or adjustmentrelated QOL. The amount of unique variance accounted for by goal-flexibility, however, was
remarkably less than the resilience variable (1.7% vs. 6.9%, respectively). This finding suggests
that goal-flexibility may have a small influence on life satisfaction. The current study
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hypothesized that goal-flexibility would be a key variable in this aging, chronic disease
population,  given  that  the  literature  suggests  that  one’s  ability  to  give  up  unattainable  goals  and  
re-engage in new goals is an adaptive coping strategy when functional declines begin to limit
ability (Wrosch et al., 2003). These results are somewhat inconsistent with research that finds
goal-flexibility significantly impacts depression and physical symptoms among a large sample of
community-dwelling middle-aged and older adults (Kelly, Wood, & Mansell, 2013). One
explanation for the small effect of goal-flexibility in this study is that participants may not have
faced  many  unattainable  goals,  therefore  one’s  ability  to  disengage  and  re-engage in other goals
was an unnecessary coping strategy in this population.  The  participants’  relatively  high  ADL  
functioning on the FIM measure could support this explanation, such that this sample of
participants was highly functional and likely did not need to change their goals or expectations
for being able to achieve those goals. In future research measuring goal-flexibility, it would be
useful  to  measure  people’s  baseline  goal  expectations  or  inquire  about  their  required  goalflexibility in regards to disease-specific domains. The flexible goal adjustment subscale of the
TEN/FLEX  in  this  study  asked  about  people’s  general  disposition  to  tenaciously  pursue  goals  or  
flexibly adjust their goals. For the purposes of assessing coping and adjustment in chronic
disease populations, it might be beneficial to prompt participants to reflect on their goals within
specific domains (e.g., transportation, eating, dressing) and then measure their self-perception of
goal adjustment or goal pursuit.
It is also possible that the influence of goal-flexibility  depended  on  participants’  level of
tenacious goal pursuit. The original TENFLEX is validated to administer the flexible goal
adjustment and tenacious goal pursuit subscales separately (Brandtstädter, & Renner, 1990), but
there is recent evidence of a unique interdependent relationship between the two constructs.
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Kelly et al. (2013) found a significant interaction between the constructs in predicting wellbeing, such that individuals who were high in both flexibility and tenacity experienced lower
levels of depression. They suggested that tenacious goal pursuit was most beneficial when there
was simultaneous goal-flexibility for unattainable tasks; people could benefit from positive goal
pursuit without the negative effects of perseveration on unattainable goals. Although beyond the
scope of the present study, it is recommended that future research exploring these constructs in
more detail assess levels of both flexibility and tenacity.
Participants’  goal-flexibility was a significant predictor of cognitive-affective depression
above and beyond resilience, though not a predictor of the full depression scale nor somaticvegetative depression symptoms. The effect was again relatively small, with goal-flexibility
accounting for only 1.6% of the variance. Particularly for this PD population, in which the
somatic-vegetative symptoms endorsed on the BDI-II may overlap with other PD symptoms (i.e.,
low energy, sleep and appetite changes), it may be even more important to identify small
mechanisms that can influence mood and self-esteem. Taken together, it seems that goalflexibility and resilience generally share variance, such that the predictive effect of goalflexibility is only significant when entered into a model simultaneously with the resilience
variable. On the other hand, there seems to be something unique about goal-flexibility and the
cognitive-affective  components  of  depression;;  one’s  ability  to  be  flexible  in his/her goals has a
beneficial impact on the cognitive-affective symptoms of depression (e.g., feelings of guilt,
worthlessness) that is not measured on a resilience scale. Future research in this area is warranted
to replicate this finding, with the potential outcome to inform clinical practice and promote goalflexibility as a protective feature against cognitive-affective depression symptoms.
Optimism. Optimism did not account for unique variance above and beyond resilience
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for depression, apathy, life satisfaction, nor adjustment-related QOL. There is good evidence that
optimism and holding positive beliefs about an illness are associated with better mood and
health-related QOL in PD (Hurt et al., 2013). A meta-analytic review found that optimism was a
significant predictor of positive physical health, with larger effect sizes for studies using
subjective versus objective physical health measures (Rasmussen, Scheier, & Greenhouse, 2009).
Other research shows, however, that the relationship between optimism and health outcomes is
not completely straightforward. In a project using data from the Normative Aging Study,
researchers found that the beneficial effects of optimism were not consistent across all domains;
optimism greatly benefited psychological well-being, self-rated health, and freedom from bodily
pain, however did not affect physical, social, or role functioning (Achat, Kawachi, Spiro,
DeMolles, & Sparrow, 2000). In another study, the beneficial effects of optimism were found to
be illness-dependent, such that MS patients profited more from optimism than PD patients in
terms of physical autonomy and emotion-oriented coping (de Ridder, Schreurs, & Bensing,
2000).
While the role of optimism in health is complex and seems to be domain and illness
dependent, it still unclear why the variable was not a significant predictor for any outcome
variables. One study found a small but significant effect of optimism on health-related QOL in
PD (GPDS Steering Committee, 2002), with optimism simply assessed as self-reported    “current  
feelings  of  optimism”.  Thus,  it  is  most  likely  that  optimism  remains a variable of interest, but it
was not a robust predictor within the framework of the present study, which was to assess
whether optimism accounted for unique variance in the generally older population above and
beyond resilience (entered into the last block within hierarchical regression analyses). Optimism
and resilience were significantly correlated (r = .63, p < .001), and several components of the
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resilience construct as measured by the RSA included optimism and positivity-related constructs
(i.e., positive perception of self, positive perception of future). One might interpret this generally
nonsignificant effect of optimism as due to the common elements between optimism and
resilience as measured by the RSA. The resilience variable was a better overall predictor of the
outcome variables of interest, and measuring optimism separately did not appear to account for
any unique variance.
A similar project found that greater optimism predicted greater benefit finding in MS
patients, and improved depression and benefit finding were completed mediated by positive
affect and optimism (Hart, Vella, & Mohr, 2008). This research supported the broaden-and-build
model (Fredrickson, 1998) and has implications for future study of optimism and positive affect
in chronic illness population. Within the context of the current research project, it is possible that
the optimal method of measuring optimism and meaning-making is not as two discrete variables
each expected to account for unique components of resilience. Instead, as discovered the Hart
(2008) study, perhaps the significant effect of meaning-making on reducing depression and
apathy was partially mediated by optimism. This partial mediation relationship was tested and
supported in the present study; however, optimism partially mediated the relationship between
meaning-making and depression but not meaning-making and apathy. Consistent with the
research that highlights the conceptual differences between depression and apathy in PD
populations (Leentjens et al., 2008), it seems that optimism partially accounts for the protective
effect of meaning-making ability on depression, but it has no influence on how meaning-making
ability  affects  apathy.  Fredrickson’s  (1998)  broaden-and-build model also supports these results,
such that optimism as part of the reciprocal relationship between finding positive meaning and
positive emotionality plays a key role in the  “upward  spiral”  of  emotional  well-being. Apathy, on
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the  other  hand,  is  a  more  focused  symptom  cluster  reflecting  a  “disorder  of  motivation”  
(Leentjens et al., 2008) in which optimism may not have a prominent role. There are, of course
limitations to determining the causal nature of these effects due to the cross-sectional study
design. If this project were to be replicated with a longitudinal design, this would be a pertinent
hypothesis to test how the broaden-and-build model helps clarify our understanding of positive
emotions in the resilience process.
Moderating Effect of Age
Interestingly, age was a significant moderator in the opposite direction than predicted in
Hypothesis 4. Patient age affected the meaning-making-depression relationship and the
optimism-adjustment-related QOL relationship, such that the protective effects of meaningmaking and optimism was greatest for younger patients. The initial hypothesis of the current
project suggested that because emotional meaning and positivity are particularly adaptive and
salient within older populations (Carstensen et al., 2003), the protective nature of these variables
would be heightened with increasing age. One explanation for the reverse finding is that the
degree of meaning-making or optimism in the older participants may be more stable or fixed and
therefore have less powerful effects on outcomes. For the younger participants who have
comparatively less experience or practice coping, it is possible that those who have developed
adaptive meaning-making coping or optimistic outlooks experience significant benefit regarding
mental  health/QOL.  This  idea  is  consistent  with  other  hypotheses  that  older  adults’  prior  
experiences and illness familiarity affect how they cope (Esyenck, 1983), while younger adults
facing health stressors are in novel positions to shape or redefine their future goals and
expectations  (Bombardier  et  al.,  2010).  Bombardier  et  al.’s  review  of  aging  and  psychological  
functioning within disability found multiple studies that demonstrated greater benefit finding and
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posttraumatic growth among younger samples. They attributed this trend to the developmental
positioning of younger adults when faced with disability or major health stressors; they may be
more likely to shift their world-view or schemas to fit redefined goals. Older adults that view
health  stressors  as  a  more  “on-time”  event  (Neugarten, 1979) may be less stressed by the event
and therefore less prone to readjust existing schemas or find new meaning from the event. On the
other hand, a diagnosis of PD may involve some adjustment features different than other chronic
illnesses. Because most people with PD do not have a family history of the disease, the diagnosis
is often unexpected. Furthermore, the timing of illness onset can co-occur with retirement,
another stressful life event. It would be valuable to study how this moderating effect of age
functions in other chronic illnesses with different onset and course.
There was also a significant moderated (by age) mediation between meaning-making
ability, resilience, and depression. For younger patients, the effect of meaning-making on
depression was directly related, while this relationship was fully mediated by the resilience
variable for the older patients. This suggests that meaning-making ability contributes to
improved resilience in older adults, which then in turn reduces depression. Implications for this
finding suggest that meaning-making ability is a key variable in reducing depression, however
the mechanism of change differs depending on patient age. For younger patients, CBT-based
interventions that help people positively reframe or enhance the meaning of their disease may be
particularly central for targeting depression. For the older patients, their ability to make meaning
from their disease seems to contribute to their more global sense of resilience, which then
improves depression. Of note, there are likely other factors that differentiate the older and
younger patient groups beyond the median age split, such as employment status (e.g., working
vs. retired). This would be an important area to investigate in future studies. Perhaps when
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individuals are challenged to make meaning of their disease while also maintaining a work role
and responsibility as a family provider, there is a stronger direct effect on mental health than
when they are retired and have fewer roles that are presumably affected by PD.
The relationship between age and optimism is quite complex and warrants further
discussion. Optimism is a known strong predictor of well-being among older adults, although
some research finds this relationship is mediated by social support and perceptions of control
(Ferguson & Goodwin, 2010). Optimism is often considered a stable personality trait that does
not change with age, however some research suggests that optimism and pessimism are separate
constructs (Mroczek, Spiro, Aldwin, Ozer, & Bossé, 1993) and become more independent with
increasing age (Robinson-Whelan, Kim, MacCallum, & Kiecolt-Glaser, 1997). It is also
important to differentiate between optimism and positive affect; both positive and negative affect
decrease with age, though positive affect tends to remain more stable over time (Charles et al.,
2001). The positivity effect is an example within cognitive psychology of increasing age
associated with greater positivity in studies of preference, attention, and memory (Mather &
Carstensen, 2005), with positive bias often conceptualized as a pronounced decrease in
negativity (Charles, Mather, & Carstensen, 2003; Shamaskin et al., 2010). Other studies suggest
that affect within the context of socioemotional aging (Carstensen et al., 2003), accommodative
vs. assimilative proceses (Brandtstädter & Renner, 1990), and general meaning-making
processes are culture-dependent (Fung, 2013). Thus, there are numerous avenues to pursue in
explaining the moderating effect of age on the relationship between optimism and QOL in the
current study.
One explanation for this differential effect of optimism with age lies in the nuanced
differences between optimism and explanatory style (Isaacowitz, 2005). Isaacowitz argues that
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optimism as a dispositional trait is a more global, self-relevant construct that individuals carry
with them through different situations, while explanatory style may have different levels at
various points throughout adult development depending on domain. In line with socioemotional
selectivity theory, he found that positive explanatory style in the interpersonal domain was
greater among older compared to younger  adults.    On  the  other  hand,  Isaacowitz’s  study  found  
that the relationship between optimism and well-being did not vary by age. It is possible that the
disease-specific population in the present study is one reason why the moderation results are
inconsistent  with  his  findings.  The  population  in  Isaacowitz’s  study  (2005)  included  a  wide  age  
range (youngest participants 18 years old) and community-dwelling older adults. Therefore,
there may be something unique about how age, optimism, and well-being functions in PD
patients that is unseen in the normative healthy population. Perhaps the diagnosis of a
progressive, neurodegenerative disease has differential effect on comparatively younger patients,
such that their ability to engage in meaning-making or maintain an optimistic perspective is
particularly adaptive.
It is clear that future research in this domain would benefit from studying explanatory
style (the stylistic way in which people explain events that happen in their lives; Seligman, 1990)
within the context of chronic disease as it overlaps with dispositional optimism/pessimism and
conceptual similarities to meaningfulness and meaning-making. Smith and Spiro (2002) also
highlight the importance of exploring the moderating effect of age and life stage on the
relationship between personality and health outcomes. They suggest that life stage or personality
characteristics may affect health change patterns over time, again highlighting the value of
longitudinal research in understanding these how these lifespan theories can manifest in
empirical data.
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There may also be measurement issues that contributed to this finding. This study used a
relatively straightforward measure of dispositional optimism (LOT-R) and a study-specific
measure of QOL (a composite of adjustment-related QOL subscales from the PDQ-39);
therefore, one must exercise caution in comparing these findings with other studies that measure
other variants or extensions of optimism (e.g., positivity, positive affect, optimistic explanatory
style) or QOL (e.g., psychological well-being, subjective well-being, general health-related
QOL). Future research might benefit from measuring optimism, both positive and negative affect
(e.g., Positive and Negative Affect Scale; Watson, Clark, & Tellegen, 1988), and other potential
mediating effects such as social support and perceived sense of control in a longitudinal design.
Illness Uncertainty and Spirituality
Illness uncertainty was a small but significant predictor for all outcome measures except
apathy. This finding is consistent with other PD research that found illness perceptions (illness
identity, chronicity, perceived consequences, and personal control) affected depression and
psychological adjustment (Evans & Norman, 2009) and had a negative psychological impact for
both patients and caregivers (Sanders-Dewey, Mullins, & Chaney, 2001). Illness uncertainty has
also been highlighted as particularly salient within qualitative interviews of PD patients (StanleyHermanns & Engebretson, 2010). In their interviews, participants often reflected on general dayto-day activities but were unable to describe a typical day due to the unpredictable nature of PD.
The  overarching  study  theme  was  captured  by  the  authors  in  a  metaphor  “Sailing  the  Sea  in the
Eye  of  the  Storm”,  with  the  subthemes  as  “Daily  Negotiations  in  the  Midst  of  Uncertainty”  (the  
storm),  and  “Reconstruction  of  the  Self”  (the  traveler’s  voyage).  These  qualitative  findings  share  
some similarities to the results in the present study. The  theme  of  “Daily  Negotiations  in  the  
Midst  of  Uncertainty”  essentially  reflected  that  PD  determines  what  each  person  does  on  any  
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given day depending on their physical, psychological, and emotional state. This central theme of
uncertainty parallels the significant  predictive  value  of  the  single  “illness  uncertainty”  question  
in  the  present  study.    The  “Reconstruction  of  the  Self”  theme  represented  participant’s  tendency  
to reflect on their voyage of PD and its impact on how they redefined their own sense of self,
which ties nicely with the role of meaning-making as a significant predictor in many models in
the current study.
One potential reason why illness uncertainty was not a significant predictor of apathy
could be that apathy symptoms may be generally less influenced by disease characteristics. For
example, as seen in the Stanley-Hermanns and Engebretson study (2010), interviewees explained
that the PD experience of constant change required constant self-evaluation, such that they
determined what activities they would engage in based on their self-assessment of physical,
psychological, and emotional well-being. Thus, if an individual was highly apathetic, they would
presumably not engage in much self-evaluation, and their perception of illness uncertainty would
not affect their apathy level. Given the increased interest in apathy as a clinical characteristic of
PD (Leentjens et al., 2008) and its relationship with QOL (Oguru et al., 2010), it is noteworthy
that illness uncertainty, which is a consistent predictor of other outcome variables, does not seem
to affect apathy. Additionally, research shows that apathy is connected to the physiological
changes in PD, specifically frontal lobe dysfunction and frontal-subcortical circuits (Pluck &
Brown, 2002), and is likely not a reaction to illness uncertainty. This data is also further evidence
that apathy and depression are distinct constructs within PD and may not respond equally to
intervention (Kirsch-Darrow et al., 2006).
Spirituality was not a significant predictor in the current study, however it was a
predominant  area  in  many  participant’s  descriptions  in  qualitative  research  (Stanley-Hermanns &
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Engebretson, 2010). There has been a great deal of research on spirituality and its beneficial role
in health (see Koenig, 2013 for a review; Pargament, Koenig, Tarakeshwar, & Hahn, 2004), with
religion and spirituality beliefs and practices often used to cope with challenges of physical
illness. Spirituality and religion have also been interwoven into resilience research (Faigin &
Parament, 2011); religion can help provide a framework through which people can engage in
meaning-making and help them control, predict, and understand otherwise uncontrollable
negative life events (Park, Folkman, & Bostrom, 2001). Langer (2004) highlighted the role of
religious coping with older adults in particular, providing a model for a strength-based approach
to counseling that helps older adults integrate their spirituality into their individual resiliency.
Given the prevalence of spirituality and religiosity in resilience and coping, it is
surprising that spirituality was not a significant predictor in the present study. The most likely
explanation for this nonsignificance is that the variable was created as a composite of three
spirituality question items drawn from another resilience scale (the CD-RISC). The resilience
scale used in the study (RSA) was chosen for its psychometric properties, interpretability, and
because the scale developers included older adults in their development sample. Spirituality
items were included in the present study as an adjunct because the RSA did not include any
items or subscales regarding spirituality. In future studies, it is recommended to include a
validated measure of spirituality or religious coping, such as the RCOPE (Koenig, Pargament, &
Nielsen, 1998), brief RCOPE (Pargament, Koenig, Tarakeshwar, & Hahn, 2001), or Spiritual
Well-Being Scale (Belcher, Dettmore, & Holzemer, 1989). These validated measures would
provide a more psychometrically sound assessment  of  participants’  levels  of  
spirituality/religiosity and allow for comparison to other research using the same scales.
Limitations
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Several limitations in this study must be noted. Participants were recruited through
convenience sampling, which could have led to a biased group with characteristics not reflective
of the PD population in general. The study was advertised to those who sought treatment
through  the  Parkinson’s  and  Movement  Disorders  Center  (PMDC),  attended  various PD support
groups throughout Virginia, and those who saw advertisements online through the PMDC
website. Therefore, participants were likely a self-selected group who were engaged with their
care and motivated to learn about PD. While average scores on several study measures seemed
to match well with other PD samples, it is possible that this sample was biased to include a
generally healthier group of PD patients that were well enough to seek out and participate in
studies. It would be important for future studies to include several sampling methods (e.g.,
random and convenience) from multiple sources (community-based sources, general hospital
populations, PD specialty clinics) to get the widest variety of PD patients. This would allow for
greater generalization of findings to other PD samples. Furthermore, although the statistical
models were designed based on theory, the models found in this study might capitalize on the
particular properties of this sample, and results should be confirmed with another PD group.
Similarly, the findings from the present study may not extend to PD patients with
significant cognitive impairment or dementia. Degree of cognitive impairment was not measured
in the present study; however, of the 66 participants who had completed a baseline
neuropsychological evaluation at the VCU PMDC and given consent for their records to be used
for research purposes, 2 had a diagnosis of dementia and 46 (or 33% of entire sample) met
criteria for MCI. Rates of MCI in PD clinic samples are typically around 25-30% (Aarsland et
al., 2010). Therefore, the present sample is comprised of responses from individuals with
comparable MCI prevalence rates to other clinic samples. Evaluations were not completed on all

126

sample participants, however, therefore further analyses compared the known vs. unknown
samples  regarding  cognitive  impairment.  The  “known”  sample  was  defined  as  the  66  participants  
who received prior neurocognitive evaluations at the PMDC,  while  the  “unknown”  sample  was  
defined as the remaining 73 participants.
The two groups were compared on all demographic, control, and outcome variables.
Independent samples t-tests indicated that the groups differed significantly in terms of age, with
the average age  of    “known”  sample  of  participants  who  received  neurocognitive  testing  
approximately  5  years  older  than  the  “unknown”  sample  that  did  not  receive  testing;;  t(137) =
2.89, p = .005. This group difference is not unusual, as one might expect that those patients who
sought out and received neurocognitive testing would be older. The two groups did not differ on
all other demographic, control, and outcome variables.
It is likely that those with significant cognitive impairment self-selected out of the study
due to the cognitive resources necessary to complete the survey. Because dementia in PD is
relatively common (24%-31%; Aarsland et al., 2005), it would be worthwhile to test how the
relationships between these variables may differ in individuals with PD with greater cognitive
impairment. Further research in this area would greatly benefit from a broader sample of PD
patients with a wider range of functioning, as participants in the present study reported very high
functional independence.
As previously discussed, one major limitation to this study was the cross-sectional
design. With resilience generally thought of as recovery, sustainability, and growth through
adversity (Zautra, Arewakisporn, & Davis, 2010; Zautra, Hall, & Murray, 2010), there remains
debate whether resilience is a dispositional trait or a process that develops over time. In the
present  study,  it  was  difficult  to  determine  the  causal  effect  of  participants’  self-reported
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resilience. While greater resilience was associated with generally better outcomes in terms of
mental health/QOL, one cannot conclude that having higher self-perceived resilience actually
protected against adverse outcomes. An ideal longitudinal study might  measure  PD  patient’s  
resilience, mental health/QOL, and disease symptoms at multiple time points throughout the
disease. With this type of design, one could analyze whether levels of self-reported resilience at
one time point could predict outcomes at a later time point. One could also examine whether
resilience levels remained constant within individuals or developed over time throughout the
disease, which would help clarify the trait vs. process argument in resilience literature. Further
mediation tests could be conducted with a longitudinal design, as well. This would be useful for
confirming the mediating effect of optimism found in the present study, and it could also test
whether the effect of benefit-finding does change over the course of chronic disease, as
suggested by Stanton and colleagues (2006).
Lastly, there are certain limitations with measuring resilience using a self-report scale.
The RSA was chosen in the present study due to the multiple sub-factors that matched well onto
several resilience definitions and because the scale developers included older adults in their
validation study. However, the resilience construct is multifactorial and there continues to be
debate over the definition, particularly within an older population or chronic disease context
(Smith & Hayslip, 2012; Trivedi et al., 2011). It is unclear when resilience should be measured
(e.g., before, during, or after adversity), whether the assessment must occur in the context of
adversity, if stressors carry the same associated risk over the lifespan, or if adversity is even
required for resilience development.
Coon (2012) argues that multi-level and multi-method approaches may hold the most
potential for studying late life resilience, for example by incorporating cultural variables,
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accessibility and acceptability of services, and organizational factors to understand resilience in
caregiving. Others suggest that the construct of resilience, and subsequent measurement, need to
be adjusted within an older population (Smith & Hayslip, 2012), such that late life resilience
reflects maintenance of developmental capacities in the face of cumulating challenges (Ong et
al., 2009) instead of recovery from risk and adversity. Clarifying the resilience construct in an
older population was a primary goal of the present study, which is why meaning-making ability,
goal-flexibility, and optimism were measured in addition to the standard resilience scale. The
limitations of how resilience was assessed in this study in some regard reflect the state of the
resilience literature and challenges integrating the construct into mental and physical health
domains. It is hoped that these findings will add to our understanding of late life resilience and
clarify next steps for future research.
Summary and Conclusions
This study provided important contributions to several areas within psychological and
health literatures. First, resilience appears to play a critical role in the relationship between
disease variables and mental health/QOL outcomes, particularly for those with moderate selfreported resilience. While the majority of people rated themselves as relatively resilient in terms
of social resources and competence, structured style, family coherence, and perceptions of self
and future (RSA subscales), those that believe themselves to be slightly weaker in these domains
compared to others had worse disease-related symptoms. It is therefore the degree of resilience
that appears to be a critical factor; the protective value of resilience was strongest for those who
viewed themselves as highly resilient.
Furthermore, other coping factors represented some resilience elements that were not
captured on a standard resilience scale, primarily meaning-making ability and goal-flexibility.
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These other variables accounted for unique variance not encompassed by the resilience scale,
which warrants further exploration of these variables in the resilience and chronic disease
literature. Of note, the effectiveness of these factors was dependent on patient age. Younger
patients with PD compared to older patients appeared to gain more psychological benefit from
being able to draw meaning from their life circumstance and maintain an optimistic perspective.
This finding has key clinical implications, for example promoting emotion-focused coping
interventions with early-onset PD patients. Results from this study also argue for further
integration of a developmental perspective into our conceptualization and measurement of
resilience. Research into the effect of age within this literature may alter how we measure (i.e.,
what scale components), track (i.e., measuring growth through longitudinal designs), and
promote (i.e., age-specific interventions) resilience. It will also be important for future studies to
discern the underlying mechanism behind these age-related effects, for example examining other
experience-related variables (e.g., age at onset, years since diagnosis, comorbid conditions) that
may be truer reflections of the actual relationships between these variables.
This project adds to the sparse literature on resilience within PD. As an empirical
examination of the construct with a moderate sample size of PD patients and several
psychometrically sound measures, this study can serve as a platform for other studies in this area.
First, this sample appears comparable to other studies in several domains, suggesting that this
group is a normative sample. Mental health prevalence rates were only slightly higher than other
PD populations (Kirsch-Darrow et al., 2011) and scores on resilience measures were very similar
to other PD samples (Caap-Ahlgren & Dehlin, 2003) and large normative populations (Friborg et
al., 2009).  This  study  is  also  the  first  to  the  author’s  knowledge  to  measure  resilience  in  PD with
the widely-used Resilience Scale for Adults. Second, there were several areas in this project in
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which disease-related variables affected depression and apathy differently, which further adds to
the literature emphasizing the unique nature of apathy within PD as more than a symptom of
depression. Finally, the relationships between disease symptoms and mental health/QOL in PD
appeared more difficult to change than originally hypothesized; despite resilience as strongly
related to mental health and QOL, overall it did not seem to affect the relationship between
disease symptoms and mental health/QOL outcomes. Perhaps the progressive,
neurodegenerative nature of PD, as well as the underlying pathophysiology of depression
symptoms, make these areas less malleable to individual coping variables than in other chronic
diseases (e.g., Friborg et al., 2006). It would be beneficial for other studies to further examine
how resilience functions within PD, for example whether the uncertainty of disease progression
warrants measuring resilience as a three-level construct that correlates to different clinical goals
throughout the disease (Trivedi et al., 2011).
Demographic predictions worldwide indicate a growing portion of older adults and more
people living with chronic disease. These trends have created a shift in the nature of our health
and subsequent healthcare, which underscores the need for research to investigate improving
quality of life and psychological well-being in the face of disease and adversity. The current
project highlights the central role of resilience in this process, as well as some of the limitations
in our conceptualization and measurement of the construct within an older disease population.
As an area with great potential for intervention and treatment, the implications of this research
trajectory could have far-reaching effects towards enhancing the  quality  of  people’s  lives  as  they  
live with chronic disease.
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Appendix

List of Measures:
The Resilience Scale for Adults
Sense of Coherence Scale
Tenacious Goal Pursuit/Flexible Goal Adjustment scales
Nonmotor Symptoms Questionnaire
The Functional Independence Measure Self-Report
Starkstein Apathy Scale
Parkinson’s  Disease  Questionnaire
The Revised Life Orientation Test
Beck Depression Inventory-II
Satisfaction with Life Scale
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The Resilience Scale for Adults (Friborg et al., 2005)
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Sense of Coherence Scale- 13 (Antonovsky, 1993)
Here is a series of questions relating to various aspects of our lives. Each question has seven
possible answers. Please mark the number which expresses your answer, with numbers 1 and 7
being the extreme answers. If the words under 1 are right for you, circle 1; if the words under 7
are right for you, circle 7. If you feel differently, circle the number which best expresses your
feeling. Please give only one answer to each question.
1. (ME) Do  you  have  the  feeling  that  you  don’t  really  care  about  what  goes  on  around  you?*
1
very seldom
or never

2

3

4

5

7
very often

6

2. (C) Has it happened in the past that you were surprised by the behavior of people whom you
thought you knew well?*
1
never
happened

2

3

4

5

7
always
happened

6

3. (MA) Has it happened that people whom you counted on disappointed you?*
1
never
happened

2

3

4

5

7
always
happened

6

4. (ME) Until now your life has had:
1
no clear goals
or purpose at
all

2

3

4

5

6

7
very clear
goals and
purpose

5. (MA) Do you have the  feeling  that  you’re  being  treated  unfairly?
1
very often

2

3

4
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5

6

7
very seldom
or never

6. (C) Do  you  have  the  feeling  that  you  are  in  an  unfamiliar  situation  and  don’t  know  what  to  
do?
1
very often

2

3

4

5

7
very seldom
or never

6

7. (ME) Doing the things you do every day is:*
1
a source of deep
pleasure and
satisfaction

2

3

4

5

6

7
a source of
pain and
boredom

8. (C) Do you have very mixed-up feelings and ideas?
1
very often

2

3

4

5

6

7
very seldom
or never

9. (C) Does it happen that you have feelings inside you would rather not feel?
1
very often

2

3

4

5

6

7
very seldom
or never

10. (MA) Many people – even those with a strong character – sometimes feel like sad sacks
(losers) in certain situations. How often have you felt this way in the past?*
1
never

2

3

4

5

6

7
very often

11. (C) When something happened, have you generally found that:
1
you overestimated
or underestimated
its importance

2

3

4
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5

6

7
you saw things
in the right
proportion

12. (ME) How  often  do  you  have  the  feeling  that  there’s  little  meaning  in  the  things  you  do  in  
your daily life?
1
very often

2

3

4

5

7
very seldom
or never

6

13. (MA) How often do you have feelings that you are not sure you can keep under control?
1
very often

2

3

4

5

6

7
very seldom
or never

* Items are negatively worded and reverse scored; total sum score ranges from 13 to 91.
The  notation  to  the  left  of  each  item’s  corresponding  subscale: C = comprehensibility, MA =
manageability, ME = meaningfulness
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Tenacious Goal Pursuit/Flexible Goal Adjustment scales (Brandtstadter & Renner, 1990)

The following statements deal with reactions you may have to various situations in
which it is difficult to pursue personal goals or plans.
Please indicate your degree of agreement with each statement by providing a rating
on a scale ranging from –2  (‘strongly  disagree’)  to  +2  (‘strongly  agree’):
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Scoring the TGP/FGA Scales
Tenacious Goal Pursuit (TGP): 2, 3, 5, 6*, 7, 9*, 10*, 11*, 12*, 14*, 18*, 20*, 22*, 27, 28
Flexible Goal Adjustment (FGA): 1*, 4, 8, 13*, 15, 16, 17, 19, 21, 23, 24, 25, 26*, 29, 30*
* Reverse items.
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Functional Independence Measure Self Report (FIM-SR)
(Modified from Grey & Kennedy, 1993; Masedo et al., 2005)
Please rate your level of independence on a variety of daily activities using a 1-7 scale:
7 = Complete independence (fully independent)
6 = Modified independence (requiring the use of a device but no physical help)
5 = Supervision (requiring only standby assistance or verbal prompting or help with set-up)
4 = Minimal assistance (requiring incidental hands-on help only; perform >75% of the task)
3 = Moderate assistance (perform 50-75% of the task)
2 = Maximal assistance (perform 25-49% of the task)
1 = Total assistance (perform 0-25% of the task)

Self Care
Eating
Grooming
Bathing/Showering
Dressing upper body
Dressing lower body
Toileting
Sphincters
Bladder management
Bowel management
Mobility
Transfers: bed/chair/wheelchair
Transfers: toilet
Transfers: bathtub/shower

Locomotion
Locomotion: walking/wheelchair
Locomotion: stairs
Communication
Expression
Comprehension
Social Cognition
Social interaction
Problem solving
Memory
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Starkstein Apathy Scale
Apathy Scale
For each question, please place a mark in the response that best describes you.
Not at all
1. Are you interested in learning new
things?
2. Does anything interest you?
3. Are you concerned about your
condition?
4. Do you put much effort into things?
5. Are you always looking for something
to do?
6. Do you have plans and goals for the
future?
7. Do you have motivation?
8. Do you have the energy for daily
activities?
9. Does someone have to tell you what to
do each day?
10. Are you indifferent to things?
11. Are you unconcerned with many
things?
12. Do you need a push to get started on
things?
13. Are you neither happy nor sad, just in
between?
14. Would you consider yourself
apathetic?

(Starkstein et al., 1995)
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Slightly

Some

A lot

Parkinson’s  Disease  Questionnaire  (PDQ-39) (Jenkinson et al., 2008)
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170

171
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Revised Life Orientation Test (LOT-R) (Scheier, Carver, & Bridges, 1994)
Please be as honest and accurate as you can throughout. Try not to let your response to one
statement influence your responses to other statements. There are no "correct" or "incorrect"
answers. Answer according to your own feelings, rather than how you think "most people"
would answer.
1. (O) In uncertain times, I usually expect the best.
A
I agree a lot

B
I agree a little

C
I neither agree nor
disagree

D
I disagree a little

E
I disagree a lot

C
I neither agree nor
disagree

D
I disagree a little

E
I disagree a lot

D
I disagree a little

E
I disagree a lot

C
I neither agree nor
disagree

D
I disagree a little

E
I disagree a lot

C
I neither agree nor
disagree

D
I disagree a little

E
I disagree a lot

C
I neither agree nor
disagree

D
I disagree a little

E
I disagree a lot

2. It's easy for me to relax.*
A
I agree a lot

B
I agree a little

3. (P) If something can go wrong for me, it will.
A
I agree a lot

B
I agree a little

C
I neither agree nor
disagree

4. (O) I'm always optimistic about my future.
A
I agree a lot

B
I agree a little

5. I enjoy my friends a lot.*
A
I agree a lot

B
I agree a little

6. It's important for me to keep busy.*
A
I agree a lot

B
I agree a little

7. (P) I hardly ever expect things to go my way.
A
I agree a lot

B
I agree a little

C
I neither agree nor
disagree
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D
I disagree a little

E
I disagree a lot

8. I don't get upset too easily.*
A
I agree a lot

B
I agree a little

C
I neither agree nor
disagree

D
I disagree a little

E
I disagree a lot

D
I disagree a little

E
I disagree a lot

9. (P) I rarely count on good things happening to me.
A
I agree a lot

B
I agree a little

C
I neither agree nor
disagree

10. (O) Overall, I expect more good things to happen to me than bad.
A
I agree a lot

B
I agree a little

C
I neither agree nor
disagree

D
I disagree a little

* Items 2, 5, 6, and 8 are filler items. O = optimism, P = pessimism
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E
I disagree a lot

Beck Depression Inventory II (Beck, Steer, & Brown, 1996)
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Satisfaction with Life Scale (Diener et al., 1985)
Instructions:
Below are five statements with which you may agree or disagree. Using the 1-7 scale below,
indicate your agreement with each item by placing the appropriate number on the line preceding
that item. Please be open and honest in your responding.
The 7-point scale is:
1
Strongly
disagree

2
Disagree

3
Slightly
disagree

4
Neither
agree nor
disagree

5
Slightly
agree

6
Agree

_______1. In most ways my life is close to my ideal.
_______2. The conditions of my life are excellent
_______3. I am satisfied with my life.
_______4. So far I have gotten the important things I want in life.
_______5. If I could live my life over, I would change almost nothing.
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7
Strongly
agree
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